Fucosyltransferase and its use in producing fucosylated oligosaccharides
By identifying and expressing a new fucosyltransferase from the database, the enzyme uses lactose as a receptor molecule to solve the problem of low yield of fucosylated oligosaccharides in the prior art, achieving high efficiency Production of complex fucosylated oligosaccharides to meet commercial production needs.
Patent Information
- Application Number
- CN201880045583.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2017-07-07
- Filing Date
- 2018-07-06
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2038-07-06
AI Technical Summary
The existing fucosyltransferases have major changes in kinetics, substrate specificity, donor substrate affinity, acceptor molecules affinity, stability and solubility, affecting fucosylated oligosaccharides. The final yield is particularly difficult to efficiently produce complex fucosylated oligosaccharides such as fucosylated trisaccharides, tetrasaccharides, pentose or hexose.
By searching unknown fucosyltransferases from protein databases and nucleoglycerol sequence databases, a novel fucosyltransferase is identified and expressed, which uses lactite tetrasyl as the receptor molecule for its active use. Production of fucosylated oligosaccharides based on LNT and/or LNnT, transferring fucose residues from donor substrate to lactose by genetically engineered cells to express heterologous fucosyltransferase.
Achieve more efficient production of fucosylated oligosaccharides, improve the kinetic performance of fucosyltransferases and specificity to tetrasaccharides, and effectively synthesize complex fucosylated oligosaccharides. , such as fucocpenose, meets commercial production needs.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present invention relates to novel fucosyltransferases and their use in producing fucosylated oligosaccharides. Background Art
[0002] Approximately 200 structurally distinct human milk oligosaccharides (HMOs) have been identified to date. The HMOs are based on the disaccharide lactose, with additional monosaccharide residues based on N-acetyl-glucosamine, fucose, sialic acid and galactose. The concentration and composition of HMOs in human milk vary between individuals and range from up to 20 g / L in colostrum to 5-10 g / L in mature milk during lactation.
[0003] The milk of women belonging to the so-called "secretor phenotype" contains a higher content of α-1,2-fucosylated HMOs. These women express the FUT2 gene encoding the so-called "fucosyltransferase 2". The most abundant HMO in their milk is 2'-fucosyl-lactose (2'-FL;
[0004] Fuc(α1-2)Gal(β1-4)Glc) and lacto- N -fucopentose-I (LNPF-I;
[0005] Fuc(α1-2)Gal(β1-3)GlcNAc(β1-3)Gal(β1-4)Glc).
[0006] Human milk oligosaccharides are not digested as they move through the infant's gut. Due to their persistence in the infant's gut, they exhibit beneficial effects on children. More specifically, HMOs have been shown to be prebiotics because they serve as a carbon source for commensal microorganisms of the genera Bifidobacterium, Bacteroides, and Lactobacillus. Thus, HMOs support the proliferation of these microorganisms in the infant's gut.
[0007] Human milk oligosaccharides also directly reduce the colonization of pathogens in the infant gut because they prevent said pathogens from adhering to the glycan structures on the surface of the intestinal mucosa. HMOs act as decoys due to their structural similarity to epithelial surface glycans and inhibit the invasion of pathogens, thereby reducing the risk of infection.
[0008] α-1,2-fucosylated HMOs have been shown to confer protection against infection with Campylobacter jejuni, the most common etiological agent of bacterial diarrhea. α-1,2-fucosylated HMOs have also been associated with protection against diarrhea caused by heat-stable toxins of Escherichia coli. In addition, the risk of infection with diarrhea-mediating caliciviruses is reduced by higher levels of α-1,2-fucosylated HMOs in breast milk. HMOs, especially the fucosylated HMO lacto-N-fucopentose V (LNFP-V; Gal(β1-3)GlcNAc(β1-3)Gal(β1-4)[Fucα1-3]Glc), bind to the carbohydrate binding site of toxin A of Clostridium difficile, the most common cause of nosocomial diarrhea. Thus, HMOs appear to prevent the interaction of C. difficile toxin A with cellular receptors. Furthermore, the adhesion of Pseudomonas aeruginosa to epithelial cells was significantly inhibited by 2'-FL and 3-fucosyllactose (3-FL; Gal(β1-4)[Fucα1-3]Glc). Binding of norovirus (Norwalk-like virus, NLV), a major cause of acute gastroenteritis, to histo-blood group antigens was prevented by α-1,2-fucosylated HMO and α-1,3-fucosylated HMO. This suggests the potential of these HMOs to inhibit binding of norovirus capsid to host receptor glycans.
[0009] Due to the known benefits of HMOs, in particular the benefits of fucosylated HMOs, there is a need for an economically viable method for their synthesis. Biotechnological methods for the production of HMOs using metabolically engineered bacteria have been described. Several fucosyltransferases have been described for the production of fucosylated oligosaccharides by genetically engineered bacteria.
[0010] The α-1,2-fucosyltransferase WbgL of Escherichia coli O126 and FucT2 of Helicobacter pylori (EP 2 479 263 B1) for producing 2'-fucosyllactose (2'-FL), the α-1,2-fucosyl-transferase WblA of Vibrio cholera O22, FutD of Helicobacter bilis ATCC 437879, FutE of Helicobacter cinaede CCUG 18818, FutN of Bacteroides vulgatus ATCC 8482, FutO of Bacteroides ovatus ATCC 8483, WbgN of Escherichia coli O55:H7, and Bacteroides fragilis NCTC 9343's Bft1 and Bft3 (WO 2014 / 018596 A2), and the α-1,2-fucosyltransferase FucT2 of Helicobacter pylori for the synthesis of Lewis Y and Lewis B saccharides (US Pat. No. 6,670,160 B2).
[0011] The α-1,3-fucosyltransferase Amuc of Akkermansia muciniphila and FucT6 and FucT7 of Bacteroides fragilis (EP 2 439 264A1) for producing 3-fucosyllactose, and the α-1,3-fucosyltransferase FutA of Helicobacter pylori are described. In addition, WO 2016 / 040531 A1 discloses the α-1,3-fucosyltransferase CafC of Bacteroides nordii CL02T12C05 for synthesizing 3-fucosyllactose and lactodifucotetraose, and the CafD of Hepatic Helicobacter hepaticus ATCC51449 for producing LNnFP-III.
[0012] However, it is known in the art that glycosyltransferases (including fucosyltransferases) can vary greatly in kinetics, substrate specificity, affinity for donor substrates and acceptor molecules, stability and solubility. In addition, the choice of fucosyltransferase used to mediate the desired fucosylation reaction significantly affects the final yield of the desired fucosylated oligosaccharides. For example, WO 2014 / 018596 A1 records that WbgL produced by Escherichia coli (E. coli) synthesizes 2'-FL and can also synthesize lactofucine (LDFT), however, WbsJ produced by E. coli or WblA of Vibrio cholerae can promote 2'-FL synthesis but cannot synthesize LDFT.
[0013] Furthermore, more complex fucosylated oligosaccharides, such as fucosylated tetrasaccharides, fucosylated pentoses, fucosylated hexoses or even fucosylated heptoses, are known to be produced only on a small scale.
[0014] In view of these drawbacks, there is a need for additional fucosyltransferases with faster kinetics, stronger affinity for nucleotide sugar donors and / or different specificities for acceptor molecules. In particular, there is a need for fucosyltransferases that can be used for the commercial production of complex fucosylated human milk oligosaccharides, i.e., fucosyltransferases that are able to fucosylate trisaccharides, tetrasaccharides, pentoses or even hexoses and / or that have sufficient activity to obtain commercially valuable quantities of the desired fucosylated oligosaccharides.
[0015] To solve this problem, the present inventors searched the protein database and the nucleotide sequence database for entries representing still unknown fucosyltransferases. For putative fucosyltransferases provided by the hits retrieved from the database search, the fucosyltransferase activity on the corresponding polypeptides was analyzed. Based on this approach, still unknown fucosyltransferases were identified that utilize lactotetraose as an acceptor molecule to be fucosylated. Summary of the invention
[0016] The present application provides a novel fucosyltransferase derived from bacterial cells. The fucosyltransferase utilizes a lactotetraose as an acceptor molecule for its fucosyltransferase activity. The novel fucosyltransferase can be used to synthesize fucosylated oligosaccharides based on LNT and / or LNnT.
[0017] According to a first aspect, a method for producing fucosylated oligosaccharides is provided, wherein a genetically engineered cell is used to produce the fucosylated oligosaccharides. The genetically engineered cell has been genetically engineered to express a heterologous fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule, wherein the acceptor molecule is lactotetraose.
[0018] According to a second aspect, there is provided a genetically engineered cell for use in a method for producing fucosylated oligosaccharides. The genetically engineered cell has been genetically engineered to express a heterologous fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule, wherein the acceptor molecule is lactotetraose.
[0019] According to a third aspect, there is provided a recombinant nucleic acid molecule for expressing a heterologous fucosyltransferase when propagated in a cell, wherein the fucosyltransferase is capable of transferring a fucose residue from a donor substrate to an acceptor molecule, wherein the acceptor molecule is lactotetraose.
[0020] According to a fourth aspect, there is provided a fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule, wherein the acceptor molecule is lactotetraose.
[0021] According to a fifth aspect, there is provided use of a fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule for producing fucosylated oligosaccharides, wherein the acceptor molecule is lactotetraose.
[0022] According to a sixth aspect, there is provided a method for producing fucosylated oligosaccharides by in vitro biocatalysis, wherein a fucosyltransferase is used, which is capable of transferring a fucose residue from a donor substrate to an acceptor molecule.
[0023] According to a seventh aspect, there is provided a fucosylated oligosaccharide produced according to the method of the first aspect or according to the method of the sixth aspect.
[0024] According to an eighth aspect, there is provided use of the fucosylated oligosaccharide according to the seventh aspect for preparing a nutritional composition.
[0025] According to a ninth aspect, there is provided a nutritional composition comprising at least one fucosylated oligosaccharide according to the seventh aspect. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 is a schematic diagram showing the plasmid map of the expression vector pINT-malE-fucT-zeo, which is used for heterologous expression of the nucleotide sequence encoding the putative fucosyltransferase in Escherichia coli.
[0027] FIG. 2 shows chromatograms of LC / MS analysis of fucosylated type 1 (core structure: Gal(β1,3)GlcNAc) and type 2 (core structure: Gal(β1,4)GlcNAc) products.
[0028] Figure 2a Chromatograms of fucosylated derivatives of LNT and LNnT are shown.
[0029] Figure 2b Shown is the chromatogram of a mixture of LNFP-III and LNnFP-V synthesized in an in vitro reaction using a cell extract containing a heterologously expressed fucosyltransferase from Bacteroides fragilis, namely FucT109 (top), compared to the chromatogram of a sugar standard.
[0030] Figure 3 Schematic diagram of the metabolic pathway for the production of fucosylated oligosaccharides based on lacto-N-tetraose and lacto-N-neotetraose in Escherichia coli.
[0031] Figure 4TLC analysis of the culture supernatant of a lacto-N-fucopentose producing E. coli strain containing pINT-malE-fucT109-zeo is described.
[0032] Figure 5 Shown is a bar graph illustrating the extracellular production of LNFP-I by E. coli (strain #993) after chromosomal integration of different fucT genes.
[0033] Figure 6 Shown is a bar graph illustrating LNFP-I production by E. coli (strain #1772) in a 1 L fermentation using glucose as the carbon source.
[0034] Figure 7 A graph illustrating the degradation of LNT-2 and lactose by hydrolases expressed by E. coli strain #1886 is shown.
[0035] Figure 8 Shown is an image of a thin layer chromatography illustrating the time-dependent LNT degradation by β-1,3-galactosidase Bga42A. DETAILED DESCRIPTION
[0036] According to a first aspect, there is provided a method for producing fucosylated oligosaccharides, the method comprising the following steps:
[0037] a) providing at least one genetically engineered cell that has been genetically engineered to express a heterologous fucosyltransferase, wherein the heterologous fucosyltransferase is capable of transferring a fucose residue from a donor substrate to an acceptor molecule, the acceptor molecule being lactotetraose;
[0038] b) culturing the at least one genetically engineered cell in the presence of at least one carbon source and under conditions suitable for the at least one genetically engineered cell to transfer the fucose residues from the donor substrate to the acceptor molecule; and
[0039] c) optionally, recovering the fucosylated oligosaccharides.
[0040] According to the method of the first aspect, a genetically engineered cell is provided. The term "genetic engineering" used herein refers to the modification of the genetic composition of a cell using molecular biological methods. The modification of the genetic composition of a cell may include the transfer, insertion, deletion, replacement and / or modification of nucleotides, triplets, genes, open reading frames, promoters, enhancers, terminators and other nucleotide sequences that mediate and / or control gene expression within a species and / or across species boundaries. The modification of the genetic composition of a cell aims to produce a genetically engineered organism with specific, desired characteristics. The genetically engineered cell may include one or more genes that do not exist in the cell of a natural (non-genetically engineered) form. The techniques for introducing exogenous nucleic acid molecules and / or inserting exogenous nucleic acid molecules (recombination, heterologous) into the genetic information of a cell to insert, delete or change the nucleotide sequence of the cell's genetic information are known to those skilled in the art. The genetically engineered cell may include one or more genes present in a cell of a natural form, wherein the gene is modified and reintroduced into the cell by artificial means. The term "genetic engineering" also includes cells containing such nucleic acid molecules, i.e., the nucleic acid molecules are endogenous to the cell and have been modified without removing the nucleic acid molecules from the cell. These modifications include those obtained by gene replacement, site-specific mutagenesis and related techniques.
[0041] Genetically engineered cells are prokaryotic cells or eukaryotic cells. Suitable cells include yeast cells, bacteria, archaea, fungal cells, insect cells, plant cells and animal cells, including mammalian cells (such as human cells and cell lines).
[0042] In an additional and / or alternative embodiment, the prokaryotic cell is a bacterial cell, preferably selected from Bacillus, Lactobacillus, Lactococcus, Enterococcus, Bifidobacterium, Sporolactobacillus spp., Micromonospora spp., Micrococcus spp., Rhodococcus spp. and Pseudomonas. Suitable bacterial species include Bacillus subtilis, Bacillus licheniformis, Bacillus coagulans, Bacillus thermophilus, Bacillus laterosporus, Bacillus megaterium, Bacillus mycoides, Bacillus pumilus, Bacillus lentus, Bacillus cereus, Bacillus circulans, Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium bifidum, Citrobacter freundii, Clostridium cellulolyticus, and Bacillus spp. cellulolyticum), Clostridium ljungdahlii, Clostridium autoethanogenum, Clostridium acetobutylicum, Corynebacterium glutamicum, Enterococcus faecium, Enterococcus thermophiles, Escherichia coli, Erwinia herbicola (Pantoea agglomerans), Lactobacillus acidophilusacidophilus, Lactobacillus salivarius, Lactobacillus plantarum, Lactobacillus helveticus, Lactobacillus delbrueckii, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus jensenii, Lactococcus lactis, Pantoeacitrea, Pectobacterium carotovorum, Proprionibacterium freudenreichii, Pseudomonas fluorescens, Pseudomonas aeruginosa, Streptococcus thermophiles, and Xanthomonas campestris.
[0043] In an additional and / or alternative embodiment, the eukaryotic cell is a yeast cell, an insect cell, a plant cell or a mammalian cell. The yeast cell is preferably selected from the group consisting of Saccharomyces sp., in particular Saccharomyces cerevisiae, Saccharomycopsis sp., Pichia sp., in particular Pichia pastoris, Hansenulasp., Kluyveromyces sp., Yarrowia sp., Rhodotorula sp. and Schizosaccharomyces sp.
[0044] Genetically engineered cells are genetically engineered to express a heterologous fucosyltransferase. The term "heterologous" as used herein refers to a nucleotide sequence, nucleic acid molecule or polypeptide that is foreign to a cell or organism, i.e., a nucleotide sequence, nucleic acid molecule or polypeptide that is not naturally present in the cell or organism. As used herein, a "heterologous sequence" or "heterologous nucleic acid" or "heterologous polypeptide" is derived from a source other than a specific host cell (e.g., from a different species), or if from the same source, is modified from its original form. Thus, a heterologous nucleic acid operably linked to a promoter is from a source different from the promoter, or, if from the same source, is modified from its original form. The heterologous sequence can be stably introduced into the genome of a host microbial host cell, for example, by transfection, transformation, conjugation or transduction, thereby representing a genetically engineered host cell. Techniques can be applied, which will depend on the host cell into which the sequence is to be introduced. Various techniques are known to those skilled in the art and are described, for example, in Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989). Thus, a "heterologous polypeptide" is a polypeptide that does not naturally occur in a cell, and a "heterologous fucosyltransferase" is a fucosyltransferase that does not naturally occur in a cell.
[0045] The term "fucosyltransferase" as used herein refers to a polypeptide that can catalyze the transfer of a fucose residue from a donor substrate to an acceptor molecule. The donor substrate used to transfer the fucose residue to the acceptor molecule is usually guanosine diphosphate L-fucose (GDP-L-fucose). Suitable acceptor molecules for fucose residues include oligosaccharides, glycopeptides, glycoproteins and glycolipids. Typically, the fucose residue is transferred to, for example, an N-acetylglucosamine residue, an N-acetylgalactosamine residue, a galactose residue, a fucose residue, a sialic acid residue or a glucose residue of an oligosaccharide, or a sugar portion of a glycoprotein or glycolipid. The term "fucosyltransferase" as used herein is also understood to include functional variants of the novel fucosyltransferase, functional fragments of the fucosyltransferase and functional fragments of the functional variant. The term "functional" indicates that the variants and fragments are also capable of catalyzing the transfer of fucose residues from a donor substrate to an acceptor molecule, i.e., they can have fucosyltransferase activity.
[0046] As used herein, the term "functional fragment" refers to a polypeptide that is truncated compared to a naturally occurring fucosyltransferase, and the fragment is capable of having the same fucosyltransferase activity as the naturally occurring polypeptide from which the fragment is derived.
[0047] As used herein, the term "functional variant" refers to a polypeptide capable of having the same fucosyltransferase activity as the naturally occurring polypeptide from which the derivative is derived, but which has an altered amino acid sequence compared to the naturally occurring polypeptide.
[0048] The heterologous fucosyltransferase is capable of transferring fucose residues from a donor substrate to an acceptor molecule. With respect to heterologous fucosyltransferases, the term "capable" refers to the fucosyltransferase activity of the heterologous fucosyltransferase, and stipulates that the heterologous fucosyltransferase requires suitable reaction conditions to have enzymatic activity. In the absence of suitable reaction conditions, the heterologous fucosyltransferase does not have enzymatic activity, but retains enzymatic activity and has enzymatic activity when suitable reaction conditions are restored. Suitable reaction conditions include: the presence of a suitable donor substrate, the presence of a suitable acceptor molecule, the presence of basic cofactors such as monovalent or divalent ions, pH values within an appropriate range, suitable temperature, etc. It is not necessary to meet the optimal value of each factor that affects the enzymatic reaction of the heterologous fucosyltransferase, but the reaction conditions must allow the heterologous fucosyltransferase to exert its enzymatic activity. Therefore, the term "capable" excludes any conditions under which the enzymatic activity of the heterologous fucosyltransferase is irreversibly damaged, and also excludes exposing the heterologous fucosyltransferase to any such conditions. In contrast, "capable of" means that the fucosyltransferase has enzymatic activity, that is, if suitable reaction conditions (all conditions necessary for the fucosyltransferase to carry out its enzymatic activity) are provided, it has its fucosyltransferase activity.
[0049] Fucosyltransferases can form α-1,2-, α-1,3-, α-1,4-, or α-1,6-glycosidic bonds between fucose and the sugar moiety of an acceptor molecule. Thus, the term "α-1,2-fucosyltransferase" refers to a glycosyltransferase that catalyzes the transfer of fucose from a donor substrate to an acceptor molecule to form an α-1,2-bond of a fucose residue and a sugar residue of the acceptor molecule. The term "α-1,3-fucosyltransferase" refers to a glycosyltransferase that catalyzes the transfer of fucose from a donor substrate to an acceptor molecule to form an α-1,3-bond of a fucose residue and a sugar residue of the acceptor molecule. The term "α-1,4-fucosyltransferase" refers to a glycosyltransferase that catalyzes the transfer of fucose from a donor substrate to an acceptor molecule to form an α-1,4-bond between a fucose residue and a sugar residue of the acceptor molecule; and the term "α-1,6-fucosyltransferase" refers to a glycosyltransferase that catalyzes the transfer of fucose from a donor substrate to an acceptor molecule to form an α-1,6-bond between a fucose residue and a sugar residue of the acceptor molecule.
[0050] In the context of transferring a fucose residue from a donor substrate to an acceptor molecule, the term "donor substrate" refers to a molecule comprising a fucose residue that is utilized by a heterologous fucosyltransferase as the sole source of fucose for transfer to a specific acceptor molecule. Typically, the donor substrate is GDP-fucose.
[0051] The term "acceptor molecule" as used herein refers to a molecule that receives a fucose residue from a donor substrate by the enzymatic activity of a heterologous fucosyltransferase. The term "acceptor molecule" as used herein more specifically refers to a molecule consisting of or comprising a sugar moiety. Unless otherwise indicated, the term "acceptor molecule" as used herein refers to lactotetraose.
[0052] Heterologous fucosyltransferases are able to transfer fucose residues to lactotetraose (as acceptor molecule).The term "lactotetraose" as used herein refers to a tetrasaccharide, ie an oligosaccharide composed of 4 monosaccharide residues, wherein the tetrasaccharide includes a lactose motif (Gal(β1,4)Glc) at its reducing end.
[0053] In an embodiment, the lactotetraose is selected from lacto-N-tetraose (LNT; Gal(β1,3)GlcNAc(β1,3)Gal(β1,4)Glc) and lacto-N-neotetraose (LNnT; Gal(β1,3)GlcNAc(β1,4)Gal(β1,4)Glc). The enzymatic activity of the heterologous fucosyltransferase produces a fucosylated oligosaccharide, more specifically a fucosylated lactotetraose, i.e., lactofucopentose. The lactofucopentose is a pentose polysaccharide, preferably selected from lacto-N-fucopentose I (LNFP-I), lacto-N-neofucopentose I (LNnFP-I), lacto-N-fucopentose II (LNFP-II), lacto-N-neofucopentose III (LNnFP-III), lacto-N-fucopentose V (LNFP-V) and lacto-N-neofucopentose V (LNnFP-V).
[0054] In Table 1 are shown polypeptides identified in the genomes of various bacterial species which are capable of having fucosyltransferase activity to transfer fucose residues from a donor substrate to lactotetraose.
[0055]
[0056]
[0057] Table 1: Fucosyltransferases capable of transferring fucose residues from a donor substrate to lactotetraose. The amino acid sequences (aa) of the fucosyltransferases used in the examples and the nucleotide sequences (nt) encoding said amino acid sequences and used for expressing the fucosyltransferases according to the examples are indicated in the last two columns of the table by their SEQ ID NOs identifying them.
[0058] Therefore, in an additional and / or alternative embodiment, the heterologous fucosyltransferase is selected from the polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional variant of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, and a functional variant of a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30.Therefore, the heterologous fucosyltransferase is selected from the group consisting of: a polypeptide represented by any one of SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29 and SEQ ID NO: 30, a functional fragment of a polypeptide represented by any one of SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29 and SEQ ID NO: 30, NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29 and SEQ ID NO:30, and functional variants of functional fragments of the polypeptide represented by any one of SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29 and SEQ ID NO:30.
[0059] In an additional and / or alternative embodiment, the heterologous fucosyltransferase is encoded by a nucleic acid molecule comprising:
[0060] i) a nucleotide sequence represented by any one of SEQ ID NOs: 1 to 15;
[0061] ii) a nucleotide sequence having at least 80% sequence identity with any one of the nucleotide sequences represented by any one of SEQ ID NOs: 1 to 15, preferably having sequence identity over the entire length of the sequence;
[0062] iii) a nucleotide sequence encoding a polypeptide having an amino acid sequence represented by any one of SEQ ID NOs: 16 to 30;
[0063] iv) a nucleotide sequence encoding a polypeptide having an amino acid sequence that is at least 80% identical to any one of the amino acid sequences represented by any one of SEQ ID NOs: 16 to 30;
[0064] v) a nucleotide sequence encoding a functional fragment of a polypeptide according to any one of iii) and iv); or
[0065] vi) a nucleic acid molecule which hybridizes under stringent conditions to the complementary strand of a nucleic acid molecule according to I), II), III), IV) or V).
[0066] The expression “SEQ ID NOs: 1 to 15” refers to the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14 and SEQ ID NO: 15.
[0067] "Hybridization under stringent conditions" refers, for example, to hybridization at 65°C in 4x SSC, followed by multiple washes in 0.1x SSC at 65°C for about 1 hour. Less stringent hybridization conditions are, for example, hybridization at 37°C in 4x SSC, followed by multiple washes in 1x SSC at room temperature. "Stringent hybridization conditions" also refer to hybridization at 68°C in 0.25M sodium phosphate, pH 7.2, 7% (w / v) SDS, 1mM EDTA, and 1% (w / v) BSA for 16 hours, followed by washing twice at 68°C with 2x SSC and 0.1% (w / v) SDS.
[0068] The nucleotide sequence encoding the heterologous fucosyltransferase may be present on a linear nucleic acid molecule or a circular nucleic acid molecule. Additionally and / or alternatively, the nucleotide sequence encoding the heterologous fucosyltransferase may be present on an extrachromosomal nucleic acid molecule, or integrated into a chromosomal nucleic acid molecule of at least one cell, wherein the chromosomal nucleic acid molecule may be a linear or circular (bacterial chromosome) nucleic acid molecule.
[0069] The at least one genetically engineered cell is cultured in the presence of at least one carbon source.
[0070] As used herein, the term "culture" refers to growing cells in a fermentation broth and under conditions that allow and are suitable for the production of the desired fucosylated oligosaccharides. After reading the disclosure of the present invention, those skilled in the art will easily obtain several suitable fermentation broths and conditions for cell culture in combination with their technical and expert background.
[0071] In an additional and / or alternative embodiment, the at least one carbon source is selected from glycerol, sucrose, glucose, galactose, fructose, molasses, lactose, xylose, cellulose, pyruvate, succinate, synthesis gas carbon monoxide and any other carbon source and energy that can be metabolized by genetically engineered cells to produce the desired fucosylated oligosaccharides. In this context, it should be understood that any other (preferably low-cost) fermentation substrate can be used as a carbon source, and those skilled in the art will be able to easily use a carbon source suitable for the present invention to cultivate microorganisms to produce the desired monosaccharides on a large scale. In a preferred embodiment of the production of fucosylated oligosaccharides, lactose is supplemented to the fermentation broth, especially if the genetically engineered cells themselves cannot synthesize lactose. In an additional and / or alternative embodiment of the production of fucosylated oligosaccharides, fucose is supplemented to the fermentation broth, especially if the genetically engineered cells themselves cannot synthesize fucose. Supplementing the fermentation broth with fucose can increase the intracellular synthesis of GDP-fucose using a fucose salvage pathway or a fucose salvage system.
[0072] The at least one genetically engineered cell is cultured under conditions suitable for the at least one genetically engineered cell to transfer fucose residues from a heterologous fucosyltransferase donor substrate to an acceptor molecule. In order to produce fucosylated oligosaccharides, the at least one genetically engineered cell is cultured in a fermentation broth that provides sufficient nutrition for the at least one cell to be metabolically active so as to express a heterologous fucosyltransferase, and to provide the cell with a sufficient amount of donor substrate and acceptor molecules for the heterologous fucosyltransferase with enzymatic activity. For conditions suitable for the at least one genetically engineered cell to transfer fucose residues from a donor substrate to an acceptor molecule through the activity of a heterologous fucosyltransferase, the fermentation broth has a suitable temperature, a suitable pH value, a suitable amount of dissolved oxygen in the fermentation broth, and a suitable osmotic pressure, among other conditions. Suitable values may vary, depending on the type of cultured cells. Suitable values can be easily determined by those skilled in the art.
[0073] In an additional and / or alternative embodiment, culturing the at least one genetically engineered cell under conditions suitable for the at least one genetically engineered cell to transfer fucose residues from a donor substrate of a heterologous fucosyltransferase to an acceptor molecule comprises the step of supplementing the fermentation broth with exogenous lactose while culturing the at least one genetically engineered cell. This allows the at least one genetically engineered cell to take up the exogenously supplemented lactose for endogenous synthesis of lactotetraose. The endogenously synthesized lactotetraose can then serve as an acceptor substrate for the heterologous fucosyltransferase.
[0074] In an additional and / or alternative embodiment, culturing the at least one genetically engineered cell under conditions suitable for the at least one genetically engineered cell to transfer a fucose residue from a heterologous fucosyltransferase donor substrate to an acceptor molecule comprises endogenously synthesizing lactose by the at least one genetically engineered cell. In embodiments, endogenous synthesis of lactose may occur due to the natural ability of the genetically engineered cell to synthesize lactose. Additionally and / or alternatively, endogenous synthesis of lactose is achieved by overexpressing a heterologous β-1,4-galactosyltransferase in the genetically engineered cell. Thus, the genetically engineered cell is also genetically engineered to overexpress the heterologous β-1,4-galactosyltransferase gene compared to the non-genetically engineered progenitor cell. The heterologous β-1,4-galactosyltransferase gene encodes a β-1,4-galactosyltransferase that catalyzes the production of lactose from galactose and glucose. Examples of suitable beta-1,4-galactosyltransferases are selected from Pm1141 of Pasteurella multocida (Accession No. AEC04686) and Lex1 of Aggregatibacter aphrophilus NJ8700 (Accession No. AK965832).
[0075] In an additional and / or alternative embodiment, culturing the at least one genetically engineered cell under conditions suitable for the at least one genetically engineered cell to transfer fucose residues from a heterologous fucosyltransferase donor substrate to an acceptor molecule includes the step of providing lacto-N-triose-2 (LNT-2) to the fermentation broth while culturing the at least one genetically engineered cell, wherein the at least one genetically engineered cell comprises (i) β-1,3-galactosyltransferase or β-1,4-galactosyltransferase and (ii) α-1,2-fucosyltransferase and / or α-1,3-fucosyltransferase as glycosyltransferases. LNT-2 is a trisaccharide that can be produced quite efficiently. Supplementing the fermentation broth with LNT-2 enables the at least one genetically engineered cell to take up the exogenously supplemented LNT-2 as a precursor for endogenous synthesis of LNT or LNnT, which in turn can serve as an acceptor molecule for the heterologous fucosyltransferase.
[0076] According to additional and / or alternative embodiments of the method for producing fucosylated oligosaccharides, the method comprising the step of culturing at least one genetically engineered cell is a continuous fermentation process or a batch fermentation process, preferably a fed-batch fermentation process.
[0077] Therefore, according to this embodiment, wherein the culture is a continuous fermentation process, i.e., a process in which at least one carbon source is continuously added to the fermentation broth during the culture step of the genetically engineered cells, wherein the fermentation broth is continuously recovered from the fermentation process. By continuously adding a carbon source during the culture process, a continuous and effective production of oligosaccharides is achieved.
[0078] According to an embodiment in which the culture is a batch fermentation process, a closed culture system is used with a specific nutrient composition at the beginning of the fermentation, and specific temperature, pressure, aeration and other environmental conditions are used to optimize growth. During the culturing of the cells, no nutrients are added, and no waste products are removed from the fermentation process.
[0079] Batch fermentation is understood to be an operation technique in which one or more nutrients (substrates) are fed (supplemented) into a bioreactor during the cultivation process, wherein the product remains in the bioreactor until the end of the run, or at least a portion of the fermentation broth (including cells and product) is removed from the bioreactor during the fermentation process. The portion of the fermentation broth can be removed from the bioreactor multiple times and / or at different intervals during the fermentation process.
[0080] In an additional and / or alternative embodiment, the method for producing fucosylated oligosaccharides comprises recovering the desired fucosylated oligosaccharides from a culture of producing cells. As used herein, the term "recovery" refers to separating, obtaining, purifying, collecting or otherwise separating the oligosaccharides produced by the host microorganism of the present invention from the host microorganism culture. The term "purification" used herein refers to removing at least a large amount of impurities and unwanted compounds. The impurities and unwanted compounds (unwanted by-products) include cells, ions and salts, other sugars other than the desired lactofucopentose, such as monosaccharides, disaccharides, trisaccharides, tetrasaccharides, in particular lactotetraose and other pentose polysaccharides, and other pentoses other than the desired lactofucopentose.
[0081] In an additional and / or alternative embodiment, the recovery and / or purification of the fucosylated oligosaccharide comprises a step selected from: (i) crystallizing the fucosylated oligosaccharide from a solution of the fucosylated oligosaccharide and (ii) spray drying the fucosylated oligosaccharide. These steps provide fucosylated oligosaccharides crystallized in an amorphous form.
[0082] In an additional and / or alternative embodiment of the recovery or purification of the desired fucosylated oligosaccharides, at least one glycosidase is applied, wherein the at least one glycosidase is used to degrade interfering and / or unwanted impurities or by-products, unused starting substrates and intermediates produced during the production of the desired oligosaccharides. By using at least one glycosidase, it is achieved that, for example, other (oligo)saccharides other than the desired fucosylated oligosaccharides can be metabolized, which other (oligo)saccharides are produced in or by at least one genetically engineered cell during the synthesis of the desired fucosylated oligosaccharides and which interfere with the purification step of the desired oligosaccharides.
[0083] The at least one glycosidase can be added externally to the fermentation broth at the end of the fermentation process, or synthesized endogenously by the at least one genetically engineered cell.
[0084] If the genetically engineered cell is not able to synthesize one or more glycosidases, for example because the endogenous gene encoding the one or more glycosidases of the genetically engineered cell is deleted or the expression of the endogenous gene encoding the one or more glycosidases is impaired, it is advantageous to add at least one glycosidase to the fermentation broth.
[0085] In an embodiment, at least one glycosidase is added to the fermentation broth, the at least one glycosidase being produced by at least one other cell than the genetically engineered cell for producing fucosylated oligosaccharides, and the at least one other cell is additionally added to the fermentation broth for expressing a gene encoding the at least one glycosidase.
[0086] In this embodiment, the at least one glycosidase expressed by at least one other cell is a glycosidase naturally occurring in the other cell or a heterologous glycosidase, wherein the other cell has been stably transformed to express the heterologous glycosidase, and wherein the expression of the heterologous glycosidase in the other cell is inducible. Preferably, the heterologous glycosidase is encoded by a nucleotide sequence that has been stably integrated into the genome of the at least one other cell.
[0087] This embodiment is particularly suitable for continuous fermentation processes for the production of fucosylated oligosaccharides, wherein, for example, two separate fermentation vessels or containers are provided, and one vessel / container is used for the oligosaccharide synthesis reaction, while the second vessel / container is primarily used to cultivate cells expressing a heterologous glycosidase.
[0088] In an additional and / or alternative embodiment, at least one glycosidase expressed by at least one other cell is an intracellular glycosidase. Therefore, at least one glycosidase expressed by at least one cell is present in the at least one cell. Therefore, the at least one other cell takes in unwanted impurities, by-products, unused starting substrates and / or intermediates produced during the production of the required oligosaccharide, thereby making the internalized compound degraded by at least one intracellular glycosidase.
[0089] In an alternative embodiment, at least one glycosidase expressed by at least one other cell is secreted into the fermented liquid from at least one other cell. Then, in the fermented liquid, degraded unwanted impurities, by-products, unused starting substrates and / or intermediate products produced in the production of required oligosaccharides. This embodiment is favourable because the at least one other cell described in this way does not need to be able to internalize unwanted impurities, by-products, unused starting substrates and / or intermediate products produced during the production of required oligosaccharides.
[0090] In a preferred embodiment, the glycosidase degrades lactose. A suitable glycosidase for degrading lactose is the β-1,4-galactosidase LacZ of Escherichia coli. A suitable glycosidase for hydrolyzing LNT-2 (intermediate product) is the β-N-acetylhexosaminidase Bbhl from Bifidobacterium bifidum JCM1254. A suitable glycosidase for hydrolyzing the intermediate LNT is the β-1,3-galactosidase Bga42A from Bifidobacterium longum subsp. infantis.
[0091] In an additional and / or alternative embodiment, the genetically engineered cell (also producing at least one glycosidase) or at least one other cell (producing at least one glycosidase) expresses at least one glycosidase upon external induction, such as by temperature-induced expression or by substrate-induced expression. This means that the expression of at least one glycosidase is downregulated during the synthesis of the desired fucosylated oligosaccharides and may be induced at the end of the fermentation process, such as by temperature or by the addition of an inducer such as IPTG. After sufficient and / or substantially maximum amounts of oligosaccharides have been produced during the culture of the genetically engineered cells, the expression of the glycosidase may be induced. Subsequently, the expressed glycosidase will degrade unwanted carbohydrate intermediates, substrates, etc., rendering the culture medium substantially free of carbohydrate intermediates or substrates that would otherwise hinder or complicate the purification of the desired oligosaccharides. Several suitable inducible expression tools are known in the prior art (see, e.g., Sambrook et al., 1989, supra) and the skilled person will be able to apply a suitable one to the desired oligosaccharides, respectively.
[0092] In the context of the present invention, "regulated" when used in relation to a gene is generally understood to mean a gene whose transcription can be regulated in a controlled manner, e.g. downregulated or upregulated, i.e. the amount of synthesized protein encoded by the regulated gene differs from that from an otherwise unregulated gene, e.g. deregulated / downregulated or upregulated.
[0093] In another embodiment, monosaccharides produced as a result of the degradation of unwanted carbohydrate intermediates, substrates, etc. can be metabolized by genetically engineered cells.
[0094] According to a second aspect, a genetically engineered cell for producing fucosylated oligosaccharides or a method for producing fucosylated oligosaccharides is provided. The genetically engineered cell has been genetically engineered to express a heterologous fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule, wherein the acceptor molecule is lactotetraose.
[0095] With respect to host cells, the term "genetically engineered" as used herein indicates that the host cell replicates heterologous or recombinant nucleic acid molecules and / or expresses peptides or proteins encoded by heterologous nucleotide sequences (i.e., nucleotide sequences "outside the cell"). Genetically engineered cells may contain genes not found in the natural (non-recombinant) form of the cell. Genetically engineered cells may also contain genes found in the natural form of the cell, wherein the genes are artificially altered and reintroduced into the cell. The term also includes cells containing nucleic acid molecules that are endogenous to the cell, which are altered without being removed from the cell; these alterations include those obtained by gene replacement, site-specific mutations, and related techniques. Therefore, a "recombinant polypeptide" is produced by a genetically engineered cell.
[0096] Thus, a "genetically engineered cell" is understood to be a cell that has been transformed or transfected.
[0097] Thus, the nucleotide sequences used in the present invention may, for example, be contained in a vector that is to be stably transformed / transfected or otherwise introduced into a host microbial cell.
[0098] Methods for producing "recombinant DNA" (including isolation, synthesis, purification and amplification of genetic material) for transformation or transfection of selected host cells are known to those skilled in the art. Therefore, it is common sense to transform cells with "hybrid viral or circular plasmid DNA containing selected exogenous (i.e., foreign or "heterologous") nucleotide sequences. These methods known in the art include the production of transformation vectors by enzymatic cleavage of circular viral or plasmid DNA to form linear DNA chains. The selected exogenous DNA chain (usually including the sequence encoding the desired protein product) is prepared in linear form using the same / similar enzymes. The linear viral or plasmid DNA is incubated with the exogenous DNA in the presence of a ligase, which is able to achieve the recovery process and form a "hybrid" vector, which contains the selected exogenous DNA fragment that has been "spliced" into the viral or circular DNA plasmid.
[0099] Genetically engineered cells are prokaryotic cells or eukaryotic cells. Suitable cells include yeast, bacteria, archaea, fungi, insect cells, plant cells and animal cells, including mammalian cells (such as human cells and cell lines).
[0100] In an additional and / or alternative embodiment, the prokaryotic cell is a bacterial cell, preferably selected from the genera Bacillus, Lactobacillus, Lactococcus, Enterococcus, Bifidobacterium, Lactobacillus sporogenes, Micromonospora, Micrococcus, Rhodococcus, and Pseudomonas. Suitable bacterial species are Bacillus subtilis, Bacillus licheniformis, Bacillus coagulans, Bacillus thermophilus, Bacillus laterosporus, Bacillus megaterium, Bacillus mycoides, Bacillus brevis, Bacillus lentus, Bacillus cereus, Bacillus circulans, Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium bifidum, Citrobacter freundii, Clostridium cellulolyticum, Clostridium jundal, Clostridium autoethanogenum, Clostridium acetobutylicum, Corynebacterium glutamicum, Enterococcus faecium, Thermophilic Enterococci, Escherichia coli, Erwinia herbicola (Pantoea agglomerans), Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus germaria, Lactobacillus helveticus, Lactobacillus delbrueckii, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus jensenii, Lactococcus lactis, Pantoea citrifolia, Pectobacterium carotovora, Propionibacterium freudenreichii, Pseudomonas fluorescens, Pseudomonas aeruginosa, Streptococcus thermophilus and Xanthomonas campestris.
[0101] In an additional and / or alternative embodiment, the eukaryotic cell is a yeast cell, an insect cell, a plant cell or a mammalian cell. The yeast cell is preferably selected from the group consisting of Saccharomyces species, in particular Saccharomyces cerevisiae, Saccharomyces pyrenophora, Pichia species, in particular Pichia pastoris, Hansenula species, Kluyveromyces species, Yarrowia species, Rhodotorula species and Schizosaccharomyces species.
[0102] The genetically engineered cells have been genetically engineered to express a heterologous fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule (lactotetraose). In an additional and / or alternative embodiment, the heterologous fucosyltransferase is selected from a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional variant of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, and a functional variant of a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30.
[0103] In an additional and / or alternative embodiment, the heterologous fucosyltransferase is encoded by a nucleic acid molecule comprising:
[0104] i) a nucleotide sequence represented by any one of SEQ ID NOs: 1 to 15;
[0105] ii) a nucleotide sequence having at least 80% sequence identity with any one of the nucleotide sequences represented by any one of SEQ ID NOs: 1 to 15, preferably having sequence identity over the entire length of the sequence;
[0106] iii) a nucleotide sequence encoding a polypeptide having an amino acid sequence represented by any one of SEQ ID NOs: 16 to 30;
[0107] iv) a nucleotide sequence encoding a polypeptide having an amino acid sequence that is at least 80% identical to any one of the amino acid sequences represented by any one of SEQ ID NOs: 16 to 30;
[0108] v) a nucleotide sequence encoding a functional fragment of a polypeptide according to any one of iii) and iv); or
[0109] vi) wherein the nucleic acid molecule hybridizes under stringent conditions to the complementary strand of the nucleic acid molecule of I), II), III), IV) or V).
[0110] The nucleotide sequence encoding the heterologous fucosyltransferase may be present on a linear or circular extrachromosomal nucleic acid molecule or integrated into a chromosomal nucleic acid molecule in the genetically engineered cell, wherein the chromosomal nucleic acid molecule may be a linear or circular (bacterial chromosome) nucleic acid molecule.
[0111] The genetically engineered cells are capable of synthesizing GDP-fucose, which is necessary for the reaction catalyzed by the heterologous polypeptide capable of having fucosyltransferase activity (transferring fucose residues from donor substrates to lactose to produce the desired fucosylated oligosaccharides), because GDP-fucose serves as a donor substrate for the fucose residues, which are transferred to lactotetraose by the heterologous fucosyltransferase. Thus, in embodiments, the genetically engineered cells are also genetically engineered to include an increased production capacity of intracellular GDP-fucose compared to the cells prior to genetic engineering.
[0112] In an additional and / or alternative embodiment, an intracellular pool of GDP-fucose for producing fucosylated oligosaccharides is provided, and the genetically engineered cell is also genetically engineered so that a gene encoding a bifunctional fucokinase / L-fucose-1-phosphate-guanosyltransferase (Fkp), preferably a gene encoding a bifunctional fucokinase / L-fucose-1-phosphate-guanosyltransferase (Fkp) of Bacteroides fragilis (Accession No. AY849806) that is capable of converting L-fucose to GDP-fucose, is expressed or overexpressed by the cell. Preferably, L-fucose is supplied to the genetically engineered cell during cell fermentation for the production of the desired fucosylated oligosaccharides.
[0113] In an additional and / or alternative embodiment, the GDP-fucose used to synthesize the desired fucosylated oligosaccharides can be taken from the cell's own GDP-fucose metabolism by using the "de novo pathway". In order to increase the intracellular GDP-fucose pool by the "de novo pathway", the genetically engineered cells are also genetically engineered to express or overexpress at least one gene encoding phosphomannose mutase, mannose-1-phosphate guanosyltransferase, GDP-mannose-4,6-dehydratase and GDP-L-fucose synthase compared to the cells before genetic engineering. In a preferred embodiment, the cells are genetically modified to overexpress all four of the genes.
[0114] In an additional and / or alternative embodiment, the genetically engineered cell is also genetically engineered to increase the input of exogenous L-fucose across its cell membrane. Preferably, compared to the progenitor cell before genetic engineering, the genetically engineered cell is also genetically engineered to express or overexpress a nucleotide sequence selected from the following: a nucleotide sequence encoding the major facilitating transport protein FucP (accession number AIZ90162) from Escherichia coli MG1655, a nucleotide sequence encoding a functional variant of the major facilitating transport protein FucP from Escherichia coli, a nucleotide sequence encoding a functional fragment of the major facilitating transport protein FucP from Escherichia coli, and a nucleotide sequence encoding a functional variant of the functional fragment of the major facilitating transport protein FucP from Escherichia coli. The expression or overexpression of the major facilitating transport protein FucP in the genetically engineered cell is its functional variant and / or functional fragment, which increases the cell's uptake of exogenous L-fucose across its cell membrane.
[0115] In an additional and / or alternative embodiment, the genetically engineered cell is also genetically engineered to prevent depletion of the intracellular GDP-fucose pool. In one embodiment, the cell is genetically engineered such that expression of the gene encoding WcaJ (which catalyzes the first step in colic acid synthesis) is impaired or inactivated, preferably such that the WcaJ gene is at least partially deleted from the genetic information of the cell, or the nucleotide sequence of the WcaJ gene has been altered such that transcription of the gene encoding WcaJ cannot be performed. In an additional and / or alternative method, the nucleotide sequence of the gene encoding WcaJ has been altered such that the altered WcaJ gene encodes a polypeptide without enzymatic activity, such as a stop codon is introduced into the open reading frame to obtain a truncated variant of WcaJ, which represents a non-functional fragment, or the nucleotide sequence of the WcaJ gene is altered such that one or more amino acid residues of the polypeptide encoded by the altered WcaJ gene differ from wild-type WcaJ, such that the resulting polypeptide has no enzymatic activity.
[0116] In an additional and / or alternative embodiment, the genetically engineered cell is also genetically engineered so that the genes fucl and / or fucK encoding L-fucose isomerase and L-fucokinase (L-fuculose) are deleted, the nucleotide sequence of fucl and / or fucK is changed to irreversibly inactivate the enzymatic activity of the corresponding polypeptide, or the expression of fucl and / or fucK is impaired. Eliminating the intracellular synthesis of fucl and / or fucK eliminates fucose catabolism in the corresponding cell, thereby increasing the amount of fucose available for the production of GDP-fucose.
[0117] In another embodiment, the genetically engineered cell is also genetically engineered so that the cell (i) does not express one or more polypeptides that degrade one or more precursors of the desired fucosylated oligosaccharides produced in the cell, or (ii) expresses one or more polypeptides having an altered amino acid sequence and / or length compared to its naturally occurring homologs to weaken the activity of such enzymes in degrading one or more precursors of the desired fucosylated oligosaccharides produced in the cell.
[0118] The term "precursor" used herein with respect to the desired fucosylated oligosaccharide refers to a compound that is an intermediate in the biosynthetic pathway of the desired fucosylated oligosaccharide produced. These intermediates include endogenous compounds, i.e., compounds produced, and may exist naturally in the host cell, and even their synthesis in the bacterial host cell is increased by genetic modification of the host.
[0119] In an additional and / or alternative embodiment, the genetically engineered cell is also genetically engineered to not comprise enzymatically active β-galactosidase.
[0120] In an additional and / or alternative embodiment, the genetically engineered cell is further genetically modified to lack a functional LacZ or to comprise a functional LacZ gene, the expression of which is tightly regulated and is not expressed during the fermentation process for the production of fucosylated oligosaccharides.
[0121] Additionally and / or alternatively, the genetically engineered cell is also genetically engineered so that the cell does not contain or expresses a polypeptide with an enzymatic activity that hydrolyzes another precursor of the desired fucosylated oligosaccharides other than lactose, such as LNT-2, LNT or LNnT, or larger derivatives of LNT and LNnT. For this purpose, the genetically engineered cell is also genetically engineered so that the genome of the cell does not contain a nucleotide sequence encoding a polypeptide capable of hydrolyzing said another precursor of the desired fucosylated oligosaccharides, or so that the expression of genes encoding such proteins is regulated in such a way that they are not expressed during the fermentation process for producing fucosylated oligosaccharides.
[0122] In an additional and / or alternative embodiment, the genetically engineered cell comprises at least one nucleotide sequence encoding a polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity. The genetically engineered cell of this embodiment is capable of expressing a polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity. Preferably, the genetically engineered cell expresses the polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity. More preferably, the genetically engineered cell comprises a polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity. Preferably, the at least one nucleotide sequence encoding a polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity is a heterologous nucleic acid sequence, i.e., a nucleotide sequence that is not naturally present in the non-genetically engineered initial cell of the genetically engineered cell.
[0123] By expressing a polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity, when the polypeptide has β-1,3-N-acetylglucosamine transferase activity, the host cell can link β-1,3-N-acetylglucosamine to the acceptor substrate lactose, thereby producing LNT-2 in the cell.
[0124] In an additional and / or alternative embodiment, the polypeptide capable of exhibiting β-1,3-N-acetylglucosamine transferase activity for the transfer of N-acetylglucosamine to lactose is a β-1,3-N-acetylglucosamine transferase selected from LgtA from Neisseria meningitidis MC58 (Accession No. NP_274923) and β-1,3-N-acetylglucosamine transferase from Pasteurella multocida subsp. multocida strain HN06 (Accession No. PMCN06_0022).
[0125] In an additional and / or alternative embodiment, the genetically engineered cell comprises at least one nucleotide sequence encoding a polypeptide capable of exhibiting β-1,3-galactosyltransferase activity or β-1,4-galactosyltransferase activity. The genetically engineered cell of this embodiment is capable of expressing a polypeptide capable of exhibiting β-1,3-galactosyltransferase activity or β-1,4-galactosyltransferase activity. Preferably, the genetically engineered cell expresses the polypeptide capable of exhibiting β-1,3-galactosyltransferase activity or β-1,4-galactosyltransferase activity. More preferably, the genetically engineered cell comprises a polypeptide capable of exhibiting β-1,3-galactosyltransferase activity or β-1,4-galactosyltransferase activity. Preferably, the at least one nucleotide sequence encoding a polypeptide capable of exhibiting β-1,3-galactosyltransferase activity or β-1,4-galactosyltransferase activity is a heterologous nucleic acid sequence, i.e., a nucleotide sequence that is not naturally present in the non-genetically engineered initial cell of the genetically engineered cell. By expressing a polypeptide capable of exhibiting β-1,3-galactosyltransferase activity or β-1,4-galactosyltransferase activity, the genetically engineered cells are capable of galactosylating LNT-2 to generate LNT or LNnT, respectively, within the cell.
[0126] In an additional and / or alternative embodiment, the polypeptide capable of exhibiting β-1,3-galactosyltransferase activity for galactosylation of LNT-2 to produce LNT is selected from: β-1,3-galactosyltransferase WbdO from Salmonella enterica (Accession No. AY730594) and a β-1,3-galactosyltransferase encoded by a gene selected from wbgO of Escherichia coli O55:H7 (Accession No. BAG11838), furA of Lutiella nitroferrum (FuraDRAFT_0419), and functional fragments of the β-1,3-galactosyltransferase.
[0127] In an additional and / or alternative embodiment, the polypeptide capable of exhibiting β-1,4-galactosyltransferase activity for galactosylation of LNT-2 to produce LNnT is a β-1,4-galactosyltransferase selected from the group consisting of LgtB from Neisseria meningitidis (Accession No. AAF42257), Lex1 from Aggregatibacter fomentophilus NJ8700 (Accession No. YP_003008647), GalT from Kingella denitrificans ATCC 33394 (Accession No. HMPREF9098_2407), GatD from Pasteurella multocida M1404 (Accession No. GQ444331), GalT from Bacteroides fragilis NCTC9343 (Accession No. BF9343_0585), GatD from Bacteroides fragilis NCTC9343 (Accession No. BF9343_0586), GatD from Bacteroides fragilis NCTC9343 (Accession No. BF9343_0587 ... influenza), IsgD from Pseudomonas influenza (Accession No. AAA24981), GalT from Helicobacter pylori (Accession No. AB035971), and a functional fragment of the β-1,4-galactosyltransferase.
[0128] In genetically engineered cells, UDP-galactose and UDP-N-acetylglucosamine are required for the intracellular synthesis of LNT or LNnT or their larger derivatives.
[0129] Intracellular UDP-galactose can be provided within genetically engineered cells by supplying galactose to the genetically engineered cells as the cells are cultured in a fermentation broth containing galactose. Galactose is taken up by the cells, phosphorylated to galactose-1-phosphate, and then converted to UDP-galactose. Genes encoding polypeptides having the enzymatic activities required for these reactions are well known.
[0130] In an additional and / or alternative embodiment, the intracellular supply of UDP-galactose can also be obtained from the cell's own metabolism, and the cell's own metabolism can be improved by genetic modification of the cell, so that, for example, the cell overexpresses UDP-galactose-4'-epimerase or overexpresses a combination of UDP-galactose-4'-epimerase and glucose-1-phosphate-1-uridyl acyl-transferase.
[0131] Intracellular UDP-N-acetylglucosamine in genetically engineered cells can also be obtained from the UDP-N-acetylglucosamine metabolism of the cell itself. In order to increase the intracellular UDP-N-acetylglucosamine pool in genetically engineered cells, cells can be genetically modified to overexpress one or more genes encoding L-glutamine:D-fructose-6-phosphate transaminase, phosphoglucosamine mutase, phospho-glucose mutase, and N-acetylglucosamine-1-phosphate uridyl transferase / glucosamine-1-phosphate acetyl transferase.
[0132] In an additional and / or alternative embodiment, the cell is genetically modified so that N-acetylglucosamine catabolism is inactivated in the genetically engineered cell. Inactivation of N-acetylglucosamine catabolism in the cell can increase the intracellular level of UDP-N-acetylglucosamine, which can be used for intracellular synthesis of N-acetylglucosamine.
[0133] In an additional and / or alternative embodiment, the genetically engineered cells for synthesizing complex fucosylated HMOs are capable of incorporating lactose across their cell membranes to accumulate lactose as a starting material for the production of the desired fucosylated oligosaccharides. Thus, the cells may express an endogenous gene encoding a lactose permease. In an additional and / or alternative embodiment, the cells are genetically engineered to contain and express a heterologous lactose permease gene, particularly if the cell does not naturally contain and express a gene encoding a lactose permease.
[0134] In an additional and / or alternative embodiment, lactose for producing the desired fucosylated oligosaccharides is provided by intracellular synthesis of lactose. Preferably, this is achieved by the cell expressing an endogenous or recombinant gene encoding a β-1,4-galactosyltransferase, which is capable of transferring the galactosyl group of UDP-galactose to a glucose molecule. This β-1,4-galactosyltransferase can be selected from Pm1141 (Accession No. AEC04686) from Pasteurella multocida or Lex1 (Accession No. YP_003008647) from Aggregatibacter nigrophila NJ8700.
[0135] Thus, in an additional and / or alternative embodiment, the genetically engineered cell comprises:
[0136] (i) β-1,3-N-acetylglucosamine transferase,
[0137] (ii) β-1,3-galactosyltransferase or β-1,4-galactosyltransferase; and
[0138] (iii) α-1,2-fucosyltransferase and / or α-1,3-fucosyltransferase.
[0139] In another embodiment, wherein a genetically engineered cell is cultured for the production of fucosylated oligosaccharides, LNT-2 is added to the fermentation broth as a precursor of the receptor molecule, the genetically engineered cell comprising:
[0140] (i) β-1,3-galactosyltransferase or β-1,4-galactosyltransferase; and
[0141] (ii) α-1,2-fucosyltransferase and / or α-1,3-fucosyltransferase as glycosyltransferase.
[0142] According to a third aspect, a recombinant nucleic acid molecule expressing a heterologous fucosyltransferase in a genetically engineered cell is provided. The term "nucleic acid molecule" refers to a single-stranded or double-stranded deoxyribonucleotide macromolecule or ribonucleotide macromolecule, and includes a strand deoxyribonucleotide macromolecule or ribonucleotide macromolecule containing one or more known analogs or naturally or synthetically produced nucleotides.
[0143] The recombinant nucleic acid molecule comprises a nucleotide sequence encoding a fucosyltransferase, wherein the fucosyltransferase is selected from: a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional variant of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, and a functional variant of a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30.
[0144] In an additional and / or alternative embodiment, the nucleotide sequence encoding the fucosyltransferase is selected from:
[0145] i) a nucleotide sequence represented by any one of SEQ ID NOs: 1 to 15;
[0146] ii) a nucleotide sequence having at least 80% sequence identity with any one of the nucleotide sequences represented by any one of SEQ ID NOs: 1 to 15, preferably having sequence identity over the entire length of the sequence;
[0147] iii) a nucleotide sequence encoding a polypeptide having an amino acid sequence represented by any one of SEQ ID NOs: 16 to 30;
[0148] iv) a nucleotide sequence encoding a polypeptide having an amino acid sequence that is at least 80% identical to any one of the amino acid sequences represented by any one of SEQ ID NOs: 16 to 30;
[0149] v) a nucleotide sequence encoding a functional fragment of any one of the polypeptides iii) and iv); or
[0150] vi) a nucleic acid molecule that hybridizes under stringent conditions to the complementary strand of a nucleic acid molecule in I), II), III), IV) or V).
[0151] Within the scope of the present invention, those terms also include nucleic acid / polynucleotide and polypeptide polymorphic variants, alleles, mutants and interspecies homologs whose amino acid sequences have greater than about 60% amino acid sequence identity, 65%, 70%, 75%, 80%, 85%, 90%, preferably 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% or more amino acid sequence identity to a polypeptide similar to one of the amino acid sequences in SEQ ID NOs: 16 to 30, preferably over a region of at least about 25, 50, 100, 200, 500 or more amino acids.
[0152] The term "variant" as used herein is a polynucleotide or polypeptide that is different from a reference polynucleotide or reference polypeptide, respectively, but retains the basic (enzyme) properties of the reference polynucleotide or polypeptide. A typical variant of a polynucleotide is different from another reference polynucleotide in nucleotide sequence. Changes in the nucleotide sequence of the variant may or may not change the amino acid sequence of the polypeptide encoded by the reference polynucleotide. Nucleotide changes can result in amino acid substitutions, additions, deletions, fusions and truncations in the polypeptide encoded by the reference sequence, as described below. A typical variant of a polypeptide is different from the amino acid sequence of another reference polypeptide. Generally, the difference is limited, so that the sequences of the reference polypeptide and the variant are generally similar and identical in many regions. The amino acid sequences of the variant and the reference polypeptide may differ in any combination of one or more substitutions, additions, deletions. The amino acid residues substituted or inserted may or may not be amino acid residues encoded by the genetic code. A variant of a polynucleotide or polypeptide may be naturally occurring, such as an allelic variant, or it may be a variant that is not yet known whether it occurs naturally. Non-naturally occurring variants of polynucleotides and polypeptides can be prepared by mutagenesis techniques, direct synthesis, and other recombinant methods known to those skilled in the art.
[0153] In the recombinant nucleic acid molecule, the nucleotide sequence encoding the fucosyltransferase, its functional variant, the functional fragment of the fucosyltransferase or the functional variant of the functional fragment is operably linked to at least one nucleotide sequence that mediates and / or controls the expression of the fucosyltransferase, its variant or fragment, provided that the recombinant nucleic acid molecule is present in the cell.
[0154] The term "operably connected" as used herein refers to a functional connection between a nucleic acid expression control sequence (e.g., a promoter, an operator, an enhancer, a regulator, an array of transcription factor binding sites, a transcription terminator, a ribosome binding site) and a second nucleotide sequence, wherein the expression control sequence affects the transcription and / or translation of the nucleic acid corresponding to the second nucleotide sequence. Therefore, the term "promoter" refers to a DNA sequence that is usually located "in front" of a gene in a DNA polymer and provides a start site for transcription into mRNA. A "regulator" DNA sequence is also usually "upstream" (i.e., in front) of a gene in a given DNA polymer, in conjunction with a protein that determines the frequency (or rate) of transcription initiation. These sequences are collectively referred to as "promoter / regulator" or "regulatory" DNA sequences, which cooperate with each other to determine whether the transcription (and final expression) of a gene will occur before a selected gene (or a series of genes) in a functional DNA polymer. A DNA sequence that "follows" a gene in a DNA polymer and provides a termination signal for transcription into mRNA is referred to as a transcription "terminator" sequence.
[0155] A wide variety of expression systems can be used to produce the polypeptides of the present invention. These systems include chromosomal, episomal and viral-derived vectors, for example, vectors derived from bacterial plasmids, bacteriophages, transposons, yeast episomes, insertion elements, yeast chromosomal elements, viruses, and vectors derived from combinations thereof, such as those derived from plasmid and bacteriophage genetic elements, such as cosmids and phagemids. The expression system construct may include control regions for regulating and producing expression. Generally, any system or vector suitable for maintaining, propagating or expressing polynucleotides and synthetic polypeptides in a host can be used for expression in this regard. Appropriate DNA sequences can be inserted into the expression system by any of a variety of well-known and conventional techniques, such as those described in Sambrook et al. above. Therefore, the nucleic acid molecule expressing a heterologous fucosyltransferase in a genetically engineered cell is selected from a plasmid, a phagemid, a cosmid, a bacterial artificial chromosome (BAC) and a yeast artificial chromosome (YAC).
[0156] According to a fourth aspect, there is provided a fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule, wherein the acceptor molecule is lactotetraose.
[0157] Fucosyltransferases are of bacterial origin. Fucosyltransferases can be used to synthesize fucosylated oligosaccharides, preferably complex fucosylated HMOs or other oligosaccharides based on lactose, LNT and / or LNnT. Fucosylated oligosaccharides are lactofucopentose.
[0158] Fucosyltransferases are capable of transferring a fucose residue from a donor substrate, preferably GDP-fucose, to an acceptor molecule. In a preferred embodiment, the acceptor molecule is lactotetraose, preferably LNT and / or LNnT.
[0159] In an additional and / or alternative embodiment, the fucosyltransferase is selected from a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional variant of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30, and a functional variant of a functional fragment of a polypeptide represented by any one of SEQ ID NOs: 16 to 30.
[0160] The fucosyltransferases represented by any one of SEQ ID NOs: 16 to 30 have not been described as fucosyltransferases capable of transferring a fucose residue from a donor substrate to lactotetraose as an acceptor substrate. The novel fucosyltransferases represented by any one of SEQ ID NOs: 16 to 27 themselves have not even been described as fucosyltransferases before, i.e. without regard to their acceptor molecules.
[0161] The fucosyltransferases described herein before can be used to produce complex fucosylated oligosaccharides, by a whole cell fermentation process as described herein before, or by in vitro biocatalysis. Thus, according to a fifth aspect, there is provided the use of at least one fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule for producing fucosylated oligosaccharides, wherein the acceptor molecule is lactotetraose.
[0162] In an additional and / or alternative embodiment, the fucosyltransferase described herein before is used to synthesize complex fucosylated HMOs by in vitro biocatalysis.
[0163] Using at least one novel fucosyltransferase in an in vitro biocatalytic process comprises adding a suitable donor substrate (preferably GDP-fucose) containing a fucosyl residue and a suitable acceptor molecule to at least one novel fucosyltransferase in a solvent under conditions suitable for the fucosyltransferase to transfer the fucosyl residue from the donor substrate to the acceptor molecule, thereby synthesizing fucosylated oligosaccharides. Preferably, the suitable acceptor molecule is lactotetraose, more preferably LNT or LNnT. When lactotetraose is used as the acceptor molecule, the reaction product of the fucosyltransferase in the in vitro biocatalytic reaction is lactofucopentose. The lactofucopentose is preferably a pentose selected from lacto-N-fucopentose I, lacto-N-neofucopentose I, lacto-N-neofucopentose III, lacto-N-fucopentose V and lacto-N-neofucopentose V.
[0164] According to a sixth aspect, there is provided a method for producing fucosylated oligosaccharides, preferably fucosylated human milk oligosaccharides, more preferably complex human milk oligosaccharides, and most preferably milk-fucopentose, by in vitro biocatalysis, wherein a fucosyltransferase is used, which is capable of transferring a fucose residue from a donor substrate to an acceptor molecule.
[0165] In an in vitro biocatalytic embodiment, the method comprises the following steps:
[0166] a) providing in the reaction mixture a fucosyltransferase capable of transferring a fucose residue from a donor substrate to an acceptor molecule;
[0167] b) contacting the fucosyltransferase with a donor substrate comprising a fucose residue and an acceptor molecule, wherein the acceptor molecule is lactotetraose, for synthesizing fucosylated oligosaccharides.
[0168] This embodiment includes providing a fucosyltransferase in the reaction mixture. The term "fucosyltransferase" as used herein also includes functional variants, functional fragments and functional variants of fucosyltransferase fragments of the fucosyltransferase, wherein "functional" means that the variants and fragments are capable of having the fucosyltransferase activity described above.
[0169] The method according to this embodiment further comprises reacting the mixture under conditions suitable for transferring the fucose residue from the donor substrate, preferably GDP-fucose, to the acceptor portion of an acceptor molecule, preferably lactotetraose.
[0170] In another embodiment, the in vitro biocatalytic method further comprises subsequently purifying and / or isolating the fucosyl acceptor molecule from the reaction mixture.
[0171] According to a seventh aspect, there is provided a fucosylated oligosaccharide produced by whole cell fermentation or in vitro biocatalysis as described above.
[0172] In one embodiment, the fucosylated oligosaccharide is a human milk oligosaccharide. The selected human milk oligosaccharides are 2'-fucosyllactose, 3-fucosyllactose, 2',3-difucosyllactose, 3-fucosyl-3'-sialyl lactose, 3-fucosyl-6'-sialyl lactose, lacto-N-fucopentose I, lacto-N-neofucopentose III, lacto-N-fucopentose V, lacto-N-neofucopentose I, lacto-N-neofucopentose V, lacto-N-difucosylhexose I, lacto-N-difucosylhexose II, fucosyl-lacto-N-sialylfucopentose b, fucosyl-lacto-N-sialylfucopentose c, lacto-N-neodifucohexose I, disialyl-lacto-N-fucopentose V and fucosyl-p-lacto-N-hexose IV. The structures of selected human milk oligosaccharides are shown in Table 2.
[0173] In one embodiment, the fucosylated oligosaccharide produced using the fucosyltransferase as described above is selected from pentoses, preferably selected from lacto-N-fucopentose I, lacto-N-neofucopentose I, lacto-N-neofucopentose III, lacto-N-fucopentose V, and lacto-N-neofucopentose V.
[0174] Although the lactofucopentose named in the preceding paragraph is a direct reaction product of the fucosyltransferase enzymatic activity previously described herein, the lactofucopentose may be further processed by the lactofucopentose. For example, the lactofucopentose may be provided as an acceptor molecule to other glycosyltransferases so that the hexoses (e.g., the hexoses in Table 2) and heptoses produced may also be considered fucosylated oligosaccharides that may be produced using the fucosyltransferases disclosed herein. Furthermore, it is contemplated that the fucosyltransferases may also be used to produce trisaccharides and / or tetrasaccharides, such as those identified in Table 2.
[0175]
[0176]
[0177] Table 2: Structures of exemplary HMOs.
[0178] According to an eighth aspect, there is provided a use of a fucosylated oligosaccharide produced by whole cell fermentation or in vitro biocatalysis as described above for preparing a nutritional composition. The nutritional composition comprises at least one fucosylated oligosaccharide produced by the method disclosed above.
[0179] Therefore, according to the ninth aspect, there is provided a nutritional composition containing at least one fucosylated oligosaccharide produced by the method as disclosed above. The at least one fucosylated oligosaccharide is lactofucopentose. The at least one lactofucopentose in the nutritional composition is selected from lacto-N-fucopentose I, lacto-N-neofucopentose I, lacto-N-neofucopentose III, lacto-N-fucopentose V and lacto-N-neofucopentose V.
[0180] In another embodiment, the nutritional composition is selected from the group consisting of a pharmaceutical preparation, an infant formula, and a dietary supplement.
[0181] The nutritional composition may be in liquid form or in solid form including, but not limited to, powders, granules, flakes and pellets.
[0182] The present invention will be described with specific embodiments and accompanying drawings, but the present invention is not limited thereto, but only by the claims. In addition, the terms first, second and similar terms in the specification and claims are used to distinguish similar elements, and are not necessarily used to describe order in time, space, sorting or in any other way. It should be understood that the terms so used are interchangeable where appropriate, and the embodiments of the present invention described herein can be operated in other sequences than those described or illustrated herein.
[0183] It should be noted that the term "comprising" used in the claims should not be interpreted as being limited to the means listed thereafter; it does not exclude other elements or steps. It is therefore interpreted as indicating the presence of the stated features, integers, steps or components, but does not exclude the presence or addition of one or more other features, integers, steps or components or groups thereof. Therefore, the scope of the expression "a device comprising means A and B" should not be limited to devices consisting only of components A and B. This means that, for the purposes of the present invention, the only relevant components of the device are A and B.
[0184] References to "one embodiment" or "an embodiment" in this specification refer to at least one embodiment of the present invention including a particular characteristic, structure, or feature described in connection with the embodiment. Therefore, the phrases "in one embodiment" or "in an embodiment" appearing in various places in this specification do not necessarily refer to the same embodiment, but may. In addition, in one or more embodiments, the particular characteristics, structures, or features may be combined in any appropriate manner, which will be apparent to those skilled in the art to which the present disclosure belongs.
[0185] Similarly, it should be appreciated that in the description of exemplary embodiments of the invention, various features of the invention are sometimes grouped together in a single embodiment, figure, or description thereof in order to simplify the disclosure and aid in understanding one or more aspects of the invention. However, this method of disclosure should not be interpreted as reflecting an intention that the claimed invention requires more features than those expressly stated in each claim. On the contrary, as reflected in the claims below, aspects of the invention are less than all the features of a single preceding disclosed embodiment. Therefore, the claims following the specific description are expressly incorporated into this specific description, with each claim standing on its own as a separate embodiment of the invention.
[0186] In addition, although some embodiments described herein include some features included in other embodiments but not other features, the combination of features of different embodiments should be within the scope of the present invention and form different embodiments, as understood by those skilled in the art. For example, in the following claims, any of the claimed embodiments can be used in any combination.
[0187] In addition, some embodiments are described herein as methods or combinations of method elements that can be implemented by a processor of a computer system or by other means of performing the function. Therefore, a processor having the necessary instructions to perform such a method or method element constitutes a means for performing the method or method element. In addition, the elements of the device embodiments described herein are examples of devices for performing the functions performed by the elements in order to implement the present invention.
[0188] In the description and drawings provided herein, many specific details are listed. However, it is understood that embodiments of the present invention can be implemented without these specific details. In other cases, well-known methods, structures and techniques have not been shown in detail to avoid obscuring the understanding of this specification.
[0189] The present invention will now be described by a detailed description of several embodiments of the present invention. Obviously, other embodiments can be set according to the knowledge of those skilled in the art without departing from the true spirit or technical teaching of the present invention, and the present invention is limited only by the terms of the appended claims.
[0190] Example 1: Identification of fucosyltransferases that fucosylate lacto-N-tetraose and lacto-N-neotetraose
[0191] The GenBank database was examined for putative fucosyltransferases encoded in the genomes of various bacterial species. This approach revealed 125 putative fucosyltransferases that had not been previously annotated as fucosyltransferases.
[0192] The gene encoding the putative fucosyltransferase (fucT) was codon-optimized for expression in E. coli and purchased from GenScript Cooperation (Piscataway, USA). The fucosyltransferase gene was subcloned into the vector pINT-malE-zeo by sequence-independent ligation cloning (SLIC) using primers 2700 and 2702 for amplification of the fucT gene and primers 2701 and 2703 for amplification of pINT-malE-zeo (the oligonucleotide primers used are listed in Table 3), downstream of the malE gene, which encodes maltose binding protein (MBP) and allows the synthesis of the MBP-fusion protein ( Figure 1 ).
[0193] The fucT gene was expressed in E. coli ER 2508 (New England Biolabs, Ipswich, USA). The genes encoding α-1,2-fucosyltransferase wbgL (from E. coli O126) and fucT2Hp (from Helicobacter pylori) were also codon optimized for expression in E. coli, purchased from GenScript Cooperation, and cloned into the NcoI and BamHI sites of the vector pACYC (Novagen, Merck, Darmstadt, Germany) under the transcriptional control of the T7 promoter. WbgL and fucT2Hp were amplified with oligonucleotides 141 and 142 and 143 and 144, respectively. The vector and PCR amplification products were digested with restriction endonucleases NcoI and BamHI and ligated. E. coli transformants were selected on chloramphenicol. WbgL and fucT2HP were expressed in E. coli BL21(DE3)ΔlacZ (the bacterial strains used in this work are listed in Table 4).
[0194]
[0195] Table 3: Oligonucleotides used for polymerase chain reaction
[0196]
[0197]
[0198] Table 4: Bacterial strains used
[0199] E. coli ER 2508 containing pINT-malE-fucT-zeo plasmid was grown in 2YT liquid medium (Sambrook et al., 1989, see above) containing ampicillin 100 μg / ml and bleomycin 40 μg / ml until OD600nm was 0.3, and then 200 μg / ml of anhydrotetracycline was added to induce malE-fucT gene expression. E. coli BL21 (DE3) ΔlacZ carrying pACYC-wbgL or pACYC-fucT2Hp was grown in 2YT medium containing 34 μg / ml chloramphenicol. When OD600nm reached 0.3, expression was induced with 0.3 mM IPTG. After incubation at 30°C for 16 hours, the cells were collected by centrifugation.
[0200] Cells were mechanically disrupted using glass beads. Cell-free extracts of expression clones containing equal protein concentrations were incubated in 100 μl fucosyltransferase activity assays at 37°C for 22 hours. The assay contained 5 mM GDP-L-fucose, 5 mM LNT or LNnT and 1 mM ATP in 20 mM Tris / HCl (pH 7.4), and 200 mM NaCl.
[0201] Use silica gel TCL plate (silica gel 60F 254 (Merck KGaA, Darmstadt, Germany)) was used to determine the formation of fucosylated LNT or LNnT by thin layer chromatography (TLC). A mixture of butanol:acetone:acetic acid:H2O (35 / 35 / 7 / 23 (v / v / v / v)) was used as the mobile phase. To detect the separated substances, the TLC was impregnated with thymol reagent (0.5 g thymol was dissolved in 95 ml ethanol, 5 ml sulfuric acid was added) and heated.
[0202] The formation and identification of the products were additionally determined by mass spectrometry. Using an LC triple quadrupole MS detection system (Shimadzu LC-MS 8050) (Shimadzu Corporation, Kyoto, Japan), mass spectrometry analysis was performed by MRM (multiple reaction monitoring). Precursor ions were selected and analyzed in quadrupole 1, fragmentation occurred in the collision cell using argon as CID gas, and selection of fragment ions was performed in quadrupole 3. Table 5 lists the selective transitions and collision energies (CE) of intermediate and final product metabolites. After diluting the culture supernatant, particle-free biocatalytic reaction or crude extract with H2O (LC / MS grade) at 1:50 or 1:100, respectively, XBridge Amide HPLC column (3.5 μm, 2.1×50 mm (Waters, USA)) was used to chromatographically separate lactose, LNT-II, LNT, and LNFP variants. Samples were prepared by filtration (0.22 μm pore size) and cleanup on an ion exchange matrix (Strata ABW, Phenomenex) using solid phase extraction prior to LC / MS analysis. The HPLC system consisted of a Shimadzu Nexera X2SIL-30AC MPThe instrument was equipped with an autosampler (operated at 8°C), a Shimadzu LC-20AD pump, and a Shimadzu CTO-20AC column oven (operated at 35°C) (Shimadzu Corporation, Kyoto, Japan). The mobile phase consisted of acetonitrile:H2O and 0.1% (v / v) ammonium hydroxide. 1 μl of sample was injected into the instrument and run for 5 minutes at a flow rate of 300 μl / min. All metabolites were analyzed by MRM in ESI negative ionization mode. The mass spectrometer was operated at unit resolution. The collision energy, Q1, and Q3 pre-biases were optimized for each analyte separately. The quantitative method was established using commercial standards (Carbosynth, Compton, UK and Elicityl, Crolles, France).
[0203] By chromatographic separation (LNFP-I - 2.4min and LNFP-V - 2.5min), LNFP variants based on the fucosylation of the intermediate lacto-N-tetraose (LNT) can be identified. The slightly different retention times are caused by differences in the type of LNT fucosylation (LNFP-I: α-1,2-fucosylation of galactose; LNFP-II: α-1,4-fucosylation of N-acetylglucosamine; and LNFP-V: α-1,3-fucosylation of glucose). In addition, due to the specific fragmentation pattern related to the position of fucosylation, they can be identified by their transition pattern (see Table 5).
[0204] LNnFP variants based on differences in the fucosylation position of the intermediate lacto-N-neotetraose (LNnT) (LNnFP-I: α-1,2-fucosylation of galactose; LNnFPIII: α-1,3-fucosylation of N-acetylglucosamine; and LNnFP-V: α-1,3-fucosylation of glucose) can be identified by chromatographic separation ( Figure 2a ). Furthermore, they can be identified by their transition patterns due to the specific fragmentation patterns related to the position of fucosylation (see Table 5).
[0205] The retention time of LNnFP-III and LNnFP-V differed by only 0.1 min. In vitro enzyme reaction analysis using α-1,3-fucosyltransferase FucT109 showed that the mixture of LNnFP-III and LNnFP-V (see Figure 2b ).
[0206] Table 6 summarizes the tested fucosyltransferases for fucopentose production and the products detected in the biocatalytic reactions when LNT and LNnT were used as glycan substrates, respectively.
[0207]
[0208] Table 5: List of transformations of metabolites analyzed for identification and quantification of intermediates and final products.
[0209] Example 2: Development of Escherichia coli lacto-N-triose II production strain
[0210] The lacto-N-triose II (LNT-2) production strain was constructed using Escherichia coli BL21 (DE3). Metabolic modification included mutagenesis and deletion of specific genes, as well as genomic integration of heterologous genes. Genes LacZ and araA were inactivated by using mismatch-oligonucleotide mutagenesis.
[0211] The genome deletion was carried out according to the method of Datsenko and Wanner. In order to prevent the intracellular degradation of N-acetylglucosamine, the genes encoding N-acetyl-glucosamine-6-phosphate deacetylase (nagA) and glucosamine-6-phosphate deaminase (nagB) were deleted from the Escherichia coli BL21 (DE3) strain genome. The genes wzxC-wcaJ were also deleted. WcaJ encodes UDP-glucose: undecyl isopentenyl phosphate glucose-1-phosphotransferase, which catalyzes the first step of colonic acid synthesis. In addition, the genes fucl and fucK encoding L-fucose isomerase and L-fucokinase were removed respectively.
[0212] Genomic integration of heterologous genes by transposition. Using EZ-Tn5 TM Transposase (Epicentre, USA) was used to integrate linear DNA fragments or the hyperactive C9-mutant of the mariner transposase Himar1 was used for transposition. To produce EZ-Tn5 transpososomes, the target gene and the antibiotic resistance marker flanked by FRT sites were amplified with primers 1119 and 1120; the resulting PCR product carried the 19 bp chimeric end recognition sites of the EZ-Tn5 transposase at both sites. For integration using Himar1 transposase, the target expression construct (operator) was cloned together with the antibiotic resistance marker flanked by FRT sites into the pEcomar vector. Under the arabinose-inducible promoter P araB The pEcomar vector encodes a hyperactive C9-mutant of the mariner transposase Himar1 under the control of . The expression fragment was integrated using the EZ-Tn5 transposase <P tet-lacY-FRT-aadA-FRT>(SEQ ID NO:31). After successfully integrating the gene of the lactose import protein LacY (accession number ABN72583) from Escherichia coli K12TG1, the resistance gene was removed from the streptomycin-resistant clone by the FLP recombinase encoded on the plasmid. Strain #534 was obtained by this modification. The N-acetylglucosamine transferase gene IgtA (accession number NP_274923) codon from Neisseria meningitidis MC58 was optimized to be expressed in Escherichia coli and prepared by gene synthesis with a synthetic method. Together with the galactose-1-phosphate uridyltransferase gene galT (accession number NP_415279) (also obtained by gene synthesis) encoding the secondary strain MG1655 of Escherichia coli K-12, lgtA (SEQ ID NO:32) was inserted by transposition using plasmid pEcomar-lgtA-galT. To enhance the de novo synthesis of UDP-N-acetylglucosamine, the gene encoding L-glutamine:D-fructose-6-phosphate aminotransferase (glmS), the gene encoding phosphoglucosamine mutase of Escherichia coli K-12 sub-strain MG1655 (glmM), and the gene encoding N-acetylglucosamine-1-phosphate uridyltransferase / glucosamine-1-phosphate acetyltransferase (glmU) of Escherichia coli K-12 sub-strain MG1655 (accession numbers NP_418185, NP_417643, and NP_418186, respectively) were codon optimized and obtained by gene synthesis. The operon glmUM was cloned into the constitutive tetracycline promoter P tet , and glmS was cloned into the constitutive P T5 The transposon cassette from pEcomar-glmUM-glmS was inserted under the control of the promoter.
[0213] <P tet -glmUM-P T5 -glmS-FRT-dhfr-FRT> (SEQ ID NO: 33), which is flanked by inverted terminal repeats specifically recognized by the mariner-like element Himar1 transposase, showing a lacto-N-triose 2 production strain (#724). The strain Escherichia coli BL21 (DE3) was used as the initial host strain for the development of E. coli production strains.
[0214] Example 3: Engineering E. coli to screen for fucosyltransferases for producing fucosylated LNT in vivo
[0215] The 1,3-galactosyltransferase gene wbdO (accession number AAV34525) of Salmonella salamae was codon-optimized for expression in E. coli and synthesized by GenScript. The galE gene was amplified from E. coli K12 genomic DNA. The two genes were transposed into the plasmid pEcomar-wbdO-galE. <P tet -wbdOco-P T5 -galE-FRT-cat-FRT>(SEQ ID NO:34) transposon was inserted into strain #724. The resulting strain is #753. In order to improve the supply of GDP-fucose, the bifunctional fucokinase / L-fucose-1-phosphate-guanosyltransferase (fkp) (Accession No. AY849806) from Bacteroides fragilis, which converts L-fucose into GDP-fucose, was overexpressed in Escherichia coli BL21 (DE3) strain. Using splicing by overlap extension PCR (SOE-PCR) and primers 1119 and 1120, the fkp gene (originally amplified from genomic DNA of Bacteroides fragilis (ATCC25285D)) was linked to the previous promoter P tet Fused together with the gentamicin resistance gene flanked by lox sites; EZ-Tn5 TM Transposase-mediated, EZ-Tn5 <P tet -fkp-lox-aacC1-lox>(SEQ ID NO:35) transposon was integrated into E. coli BL21(DE3) strain to obtain strain #993. Alternatively, for de novo synthesis of GDP-L-fucose, genes encoding phosphomannose mutase (manB), mannose-1-phosphate guanyltransferase (manC), GDP-mannose-4,6-dehydratase (gmd) and GDP-L-fucose synthase (wcaG) from E. coli K12DH5α were overexpressed in E. coli BL21(DE3) strain; the operon manCB was placed under the constitutive promoter P tet The operons gmd and wcaG are also under the control of the constitutive P T5 The transposon cassette contains the gene aacC1 that confers gentamicin resistance to the bacterial host. <P tet -manCB-P T5-gmd,wcaG-FRT-aacC1-FRT> (SEQ ID NO: 36) is flanked by inverted terminal repeats specifically recognized by the mariner-like element Himar1 transposase. It was inserted from pEcomar C9-manCB-gmd,wcaG-aacC1 into the genome of strain #753 to generate strain #1445.
[0216] Example 4: Transformation of E. coli to screen for fucosyltransferases for producing fucosylated LNnT in vivo
[0217] The β-1,4-galactosyltransferase gene lgtB from Neisseria meningitidis (Accession No. AAF42257) was optimized for expression in E. coli and synthesized by GenScript. The gene was transferred to the plasmid pEcomar-lgtB via transposition along with a tetracycline resistance gene flanked by FRT sites. <P T5 -lgtB-FRT-tetA-FRT> (SEQ ID NO: 37) was inserted into strain #724. The galE gene was amplified from the genomic DNA of Escherichia coli K12 and linked to the promoter P by SOE-PCR. tet The EZ-transposon was constructed using primers that generate a 19 bp chimeric end recognition site for the EZ-Tn5 transposase (primers 2194 and 2235). <P tet -galE-FRT-cat-FRT> was used to integrate it into E. coli BL21 (DE3) strain to obtain strain #1046. In addition, the β-1,4-galactosyltransferase gene lex1 (accession number YP_003008647) from Aggregatibacterium fomentophilum NJ 8700 was synthesized by a synthetic method and codon optimized for use in E. coli, and the gene was integrated into strain #724. The lex1 gene was fused with the malE gene encoding maltose binding protein (MBP) to obtain an N-terminal fusion of MBP and Lex1. At the same time, the malE-lex1 fusion was integrated with galE (SEQ ID NO: 38) by transposition using pEcomar-malE-lex1-galE-cat, which was in P tet Promoter under transcriptional control. Use EZ-Fragment EZ-Tn5 <P tet -fkp-FRT-aacC1-FRT> (see Example 3), the gene encoding fucosekinase / L-Fucose-1-phosphate-guanyltransferase (fkp) from Bacteroides fragilis was chromosomally integrated into strain #1046 to produce strain #1076.
[0218] Example 5: In vivo screening of fucosyltransferases that fucosylate LNT and LNnT
[0219] The mineral salt (MS) medium used to cultivate the strain for synthesizing fucose contains 7g / L NH4H2PO4, 7g / L K2HPO4, 2g / L KOH, 0.3g / L citric acid, 2g / L MgSO4 x7H2O and 0.015g / L CaCl2 x 6H2O, supplemented with 1mL / L trace element solution (54.4g / L ammonium ferric citrate, 9.8g / L MnCl2×4H2O, 1.6g / L COCl2 x 6H2O, 1g / LCuCl2 x2H2O, 1.9g / L H3BO3, 9g / L ZnSO4×7H2O, 1.1g / L Na2MoO4 x 2H2O, 1.5g / L Na2SeO3, 1.5g / L NiSO4×6H2O).
[0220] The plasmid p1NT-malE-fucT-zeo was used to produce fucosylated pentoses in vivo using strains #993 or #1445 for LNT and strain #1076 for LNnT, respectively, as Fuct substrates. The strains containing the plasmids were grown in 20 ml mineral salts (MS) medium containing 100 g / ml of the antibiotic ampicillin, 20 g / ml of bleomycin, 2% glucose as the carbon source, and 200 ng / ml of anhydrotetracycline as the gene expression inducer. The bacteria were cultured in baffled shake flasks at 30°C until OD 600nm to 0.3, followed by the addition of 3 mM lactose and 2 mM L-fucose (for derivatives of strains #993 and #1076) and 3 mM lactose (for derivatives of strain #1445).
[0221] After 24 to 72 hours of cultivation, cells were collected by centrifugation, washed once in saline (0.9% (w / v) NaCl), resuspended in 150 μl to 200 μl of saline (depending on the size of the precipitate), and mechanically disrupted using glass beads. A clear supernatant was obtained by palletising the cell debris. The formation of fucosylated LNTs was detected by TLC analysis of intracellular metabolites, and the results are summarized in Table 6. To analyse LNFP-V formed by FucT109 of Bacteroides fragilis NTCT 9343 secreted into the culture supernatant, intact cells were centrifuged and the supernatant was applied to TLC analysis ( Figure 4 ). Figure 4TLC analysis of culture supernatants of E. coli strains (containing pINT-malE-fucT109-zeo) producing lacto-N-fucopentose is shown. LNFP-V was detected in the supernatant of strains expressing the malE-fucT109 fusion gene by comparing mobility with purified standard sugars. Reference sugars: Lane 1: lactose; Lane 2: LNT-2; Lane 3: LNT+LNFP-V; Lane 4: LNT; Lane 5: supernatant sample of strain #993; Lane 6: supernatant sample of strain #993 pINT-malE-fucT109-zeo; Lane 7: supernatant sample of strain #1445; Lane 8: supernatant sample of strain #1445 pINT-malE-fucT109-zeo.
[0222] Example 6: Synthesis of LNFP-I during fermentation
[0223] Integration of the fucT gene in E. coli BL21(DE3) derivative strains
[0224] Using strain #993 as a host, genes encoding fucosyltransferases fucT41 (Gram viscosa KT0803, accession number WP_011708479), FucT 48 (Franciscoides mirador subsp. mirage ATCC 25015, accession number EET21243.1), FucT49 (Pseudogobingensis ferrooxidans, accession number EEG10438.1), FucT54 (autotrophic iron-oxidizing bacteria ES-11, accession number ADE13114.1), FucT61 (Pseudoalteromonas maritima ANT / 505, accession number EGI74693.1), FucT66 (ISM, accession number EAP78457.1) and FucT69 (Mariospirillum WP0211, accession number EKF09232.1) were integrated into the chromosome. Using the p1NT-malE-fucT-zeo plasmid as a template, primers 1119 and 1120 were used to amplify the malE-fucT fusion gene and the promoter P in front. tet and bleomycin resistance gene; using EZ-Tn5 TM Transposase EZ-Tn5 <P tet -malE-fucT-zeo> was inserted into the Escherichia coli BL21(DE3) strain.
[0225] Strains carrying malE-fucT integration were grown in 96-well plates in 200 μl MS medium containing 2% glucose and 20 μg / ml zeocin at 30°C with shaking. After 24 hours of cultivation, 50 μl of the culture was transferred to 400 μl fresh MS medium containing 2% glucose, 20 μg / ml zeocin, 3 mM lactose and 2 mM L-fucose. After 48 hours of cultivation, the culture supernatant was analyzed by LC / MS. Figure 5 Results for different FucT genes are shown in Figure 1, where error bars show the standard deviation of five different cultures of the same strain. The strain expressing fucT61 (#1197) obtained the highest LNFP-I titer compared to the other integrated strains ( Figure 5 ).
[0226] Modification of fucose import for production of LNFP-I
[0227] Improved LNFP-I production in strain 1197 was achieved by integrating the major facilitator transporter FucP (accession number AIZ90162) of E. coli MG1655. FucP and its preceding P were amplified using primers 1119 and 1120. tet Promoter and streptomycin resistance gene ( <P tet -fucP-FRT-aad1-FRT>, SEQ ID NO:39), and using EZTn5 TM Transposase performs chromosomal integration via transposition. The strain containing fucT61 and fucP was designated strain #1772.
[0228] Strains #1197 and #1772 were grown in MS medium containing 2% glucose (as a carbon source) in the presence of 3 mM lactose and 2 mM L-fucose in 96-well plates, and the concentration of LNFP-I detected in the supernatant of strain #1772 was twice that detected in the supernatant of strain #1197.
[0229] Production of LNFP-I by fermentation
[0230] Pilot fermentation of strain #1772 was carried out in a 3L fermentor containing 1L MS medium at 30°C. 2% glucose and 2.5g / L NH4Cl were added to the medium before inoculation; fermentation was carried out without the addition of antibiotics. The pH was kept constant at 7.0 by titration with 10% ammonia. The fermentor was inoculated with a culture from a shake flask to an OD600nm of 0.1. At an OD600nm of approximately 10, 1mM lactose and 1mM L-fucose were added; these two substrates were repeatedly added in doses of 1-2mM depending on the growth and production rates. When the batch of 2% glucose was exhausted, glucose was continuously supplied from a 50% glucose stock solution. After 87 hours of cultivation, the culture reached an OD600nm of 185. The concentration of LNFP-I in the culture supernatant was determined to be 4.3g / L by LC / MS analysis. Lactose, LNT-2 and LNT were found to be sugar byproducts in the supernatant ( Figure 6 ). Figure 6 The graph of demonstrates the production of LNFP-I by E. coli (strain #1772) in 1 L fermentation using glucose as carbon source. After 87 hours of fermentation, the product concentration in the culture supernatant was determined. In addition to LNFP-I (4.3 g / L), lactose (13.11 g / L), LNT-2 (4.6 g / L) and LNT (1.1 g / L) were detected in the supernatant.
[0231]
[0232]
[0233] Table 6: Fucosyltransferases analyzed in this study. Fucosyltransferase activity was determined using LNT and LNnT as glycan substrates. Formation of fucopentose was determined in vitro and in vivo using whole cell transformation. Fucopentose was identified by LC / MS. + indicates detection of reaction product, - indicates no activity, nt means not detected.
[0234] Degradation of by-products
[0235] To facilitate the separation of the desired product LNFP-I from the byproducts lactose, LNT-2 and LNT, these sugars can be enzymatically digested and the resulting degradation products metabolized by an E. coli strain.
[0236] β-1,4-galactosidases (e.g. LacZ of E. coli) can efficiently degrade lactose into D-glucose and D-galactose. These two monosaccharides are metabolized by E. coli strains expressing a functional gal-operon.
[0237] The β-N-acetylglucosamine and lactose were hydrolyzed into LNT-2 by the β-N-acetylglucosamine enzyme Bbhl from Bifidobacterium bifidum JCM1254 with high specificity and efficiency.
[0238] β-1,3-galactosidase Bga42A from Bifidobacterium longum subsp. infantis specifically hydrolyzes LNT into galactose and LNT-2.
[0239] Engineering E. coli strains to degrade byproducts
[0240] A degradation strain was constructed using E. coli BL21(DE3)#534 to recover LNFP-I without sugar byproducts from the supernatant after fermentation production.
[0241] The functional galETKM operon and its native promoter were amplified from E. coli K12 genomic DNA using oligonucleotides 6473 and 6474, generating a fragment with a 5' 19 bp chimeric end recognition site for the EZ-Tn5 transposase. TM Transposase-mediated <galetkm>(SEQ ID NO: 40) was integrated into the genome of the E. coli strain. Correctly integrated clones were selected on MacConcey agar (Difco, Sparks, USA) containing 1% galactose, which appeared as red colonies after incubation at 37°C for 36 hours.
[0242] The gene encoding β-N-acetylhexosaminidase Bbhl from Bifidobacterium bifidum JCM1254 was synthesized by a synthetic method and codon optimized for expression in Escherichia coli. tet The Bbhl promoter is transcriptionally regulated and confers bleomycin resistance to the host ( <P tet -bbhl-zeo>(SEQ ID NO:41).
[0243] To ensure full β-1,4-galactosidase activity, lacZ (accession number AM946981) from Escherichia coli BL21(DE3) was cloned under the constitutive promoter P tet Together with the gentamicin resistance gene aacC1, the fragment was amplified using primers 1119 and 1120. <P tet -lacZ-FRT-aacC1-FRT>(SEQ ID NO:42), and integrated by EZTn5 transposition to obtain strain #1369.
[0244] β-1,3-galactosidase Bga42A from Bifidobacterium longum subsp. infantis was codon optimized for use in Escherichia coli and synthesized synthetically. Using the EZTn5 transposase, integration was performed at P tet Bga42A under the transcriptional control of the promoter and the cat gene that confers chloramphenicol resistance to the host ( <P tet -bga42A-cat> (SEQ ID NO:43). The strain expressing all three hydrolase genes was designated strain #1886.
[0245] By adding the culture of strain #1886 to the culture of strain #1772 producing LNFP-1, the degradation of lactose and LNT-2 was effectively achieved. To demonstrate the degradation of LNT-2 and lactose by LacZ and Bbhl, the culture of strain #1886 (grown in MS medium with glucose as the carbon source) was added to the culture of strain #1772 (grown in MS medium containing glucose in the presence of lactose and L-fucose for the production of LNFP-1) at a volume ratio of 1:40.
[0246] Figure 7 The degradation of lactose and LNT-2 by the hydrolytic enzyme expressed in Escherichia coli strain #1886 has been demonstrated. The growth culture of Escherichia coli strain #1886 is added to the culture of Escherichia coli strain #1772 producing the main product LNFP-I and the byproducts LNT and LNT-2. LNT-2 and lactose are nearly completely exhausted in the culture supernatant in 10 hours of incubation. Metabolites are marked as circles: lactose, squares: LNT-2, triangles: LNFP-I, crosses: LNT. In 10 hours, LNT-2 and lactose are degraded to near complete exhaustion, while LNFP-I and LNT are not degraded by #1886 cells. Because strain #1886 contains the active galETKM operon, the monosaccharide glucose and galactose produced by the hydrolysis of lactose are completely metabolized.
[0247] The hydrolase Bga42A was not active outside the cells. However, when cells of strain #1886 grown on MS medium with glucose as the carbon source were mechanically disrupted, the hydrolytic activity of Bga42A towards LNT was demonstrated, as shown in Figure 8 (Image showing thin layer chromatogram) Samples containing cell lysate from E. coli strain #1886 (lane 1: no enzyme, lanes 2 to 6: 100 μg protein) and 5 mM LNT in 20 mM sodium phosphate buffer (pH 7) were incubated at 30°C for a period of time up to 120 minutes (lane 1: 120 minutes, lane 2: 0 minutes, lane 3: 15 minutes, lane 4: 30 minutes, lane 5: 60 minutes, lane 6: 120 minutes) and then heated at 95°C for 5 minutes to inactivate the enzyme.
[0248] Figure 8 The hydrolysis of LNT in the cell-free extract of strain #1886 and the resulting degradation products LNT-2 and lactose are shown. Sequence Listing <110> Jennewein Biotechnologie GmbH <120> Novel fucosyltransferases and their application in producing fucosylated human milk oligosaccharides <130> P 1702 WO <160> 57 <170> PatentIn version 3.5 <210> 1 <211> 963 <212> DNA <213> Helicobacter hepaticus <400> 1 atgaaagatg acctggttat cctgcacccg gatggtggta tcgcctcgca gatcgcattt 60 gtcgcactgg gcctggcatt tgacagaag ggtgcgaaag tgaagtatga cctgagctgg 120 ttgcggaag gcgccaaagg ttctggac ccgtctaatg gctacgataa agtttatgac 180 attacctggg atatcagtaa ggcattccg gctctgcata ttgaatcgc aaacgaagaa 240 gaaatcgaac gttacaagtc taagtacctg atcgataacg accgcgtta cgatttagct 300 ccgccgctgt attgctacgg ctataaaggt cgtatctttc attacctgta tgcgccgttt 360 ttcgcccagt cattcgcacc gaaggaagct cagactcgc acacccgtt tgcagcactg 420 ctgcaggaaa ttgaaagctc tccgtcaccg tgcggtgttc atattcgtcg cggcgatctg 480 tcgcagccgc acatcgtcta cggtaacccg acgagcaatg atatttcgc caatctatt 540 gaactgatgt gtctgctgca cccgcagagt tccttttacc tgttcagcga tgacctggca 600 tttgtgaaag aacaaattgt tccgctgctg aaaggcaaga cctatcgcat ctgcgacgtc 660 aacaatccga gccaggggcta cctggatctg tatctgctgt ctcgttgtcg caacattatc 720 gttcacaag gttcgatggg cgaattcgcc aaagtgctga gcccgcataa cccgctgctg 780 attacgccgc gttaccgcaa tatctttaag gaagtggaaa acgttatgtg cgtcaattgg 840 ggtgaatccg tccaccc gccgctggtg tgtagtgcac cgccgccgct ggtgtcccaa 900 ctgaaacgta acgccccgct gatagtcgc ctgtataaag aaaaggataa tgcatccgct 960 there are 963 <210> 2 <211> 1086 <212> DNA <213> Brachyspira pilosicoli (Brachyspira pilosicoli) <400> 2 atggctccga aacacctgat taacctgtat tatattgaca ttagtatcct gtacgtgaag 60 attack agagtagat ttcatcctgt acaacta cgaacatctg 120 atcacaaga tcgtgcgtat tatcccgatt aaaaagcacc gtgataacct gcgcaatatt 180 ctgtatgaca tcgttacag cctgtacaag atcgaataca tctctagga actgaacaa 240 aagcgcaaca ataacgatag tggcattgtc attatcgaat gccaggggcgg tctggccgac 300 caattctgga agtacatcct gggtgaatct atcaaaaagc attacaactt caccgtgaag 360 tacgatatca cgtggttcga ctacaagcac aggattatcg acggcaaaga tgaacgtccg 420 tttgaactga tcaaactgtg cccggatatt gacttcaaga tcgcgagcta cgatgaaatt 480 ttcttttata aggcctgttt cagtgttatc aacgaatcct acttcggtta cgacatcaac 540 aactacctgg aaaacaacaa gaacctgttt ctgtactcat acccgcgtat tctggatatc 600 aatgtctcgg acattaccaa aaacatcgat ctggacaagt atcattactc cacgctgaaa 660 gaagataatc tggtcctgta caacgaactg aagaattcag aatcggtggc cattcacatc 720 cgcctgggcg atagctacgt gatgtcttgt ttcaaagaag ttttcaacag ctcttacgaa 780 aactacgcaa actacttcat cgaatcaatc aacaagctgt cgaatgaact gaagaacccg 840 accttttct ttttcagcga tgacattgat tgggttaaca agaacatcat caaaaagctg 900 aacaaccgta tctcttacaa agtcagttcc tgcaagaatc cgccgtacct ggatatctac 960 ctgatgagta acgcaaagca ttacatcatc tccctgggcg gttttggtga cctggctacg 1020 cgcttcaaca acaacgaaaa caagatcgtg atcaaggcgt gtaagtttca gtatgattac 1080 ctgtaa 1086 <210> 3 <211> 861 <212> DNA <213> Yersinia sp. <400> 3 atgtttatga aaatctcggt cctggtccaa ggtggcctgg gtaatcaact gttccaaatc 60 gcatgggcaa actatctggt tcgtaagtat cagtataacg tcgaaattaa tctgcaactg 120 ctgtacagtc agtcccaaca tgcgtcaatt aacttttcgc agctgatcgg caaagttccg 180 ctgctgtcag tctcgaaaga aaagctgatt atgctggatg accgtctgag ctctaaaatt 240 atccgtaaga gcctgcgcat cctgggtgtt cattctattc cgaatatcct gctgcacgat 300 tatgacgcac tgaccgattt tgaacactgc aacaaaatgg ctaattatcg ttaccagttc 360 ggctactttc aattcattga agcggccatc ttttctcgtg atattttcct gagcaacatg 420 cgctctatcc atggtgaatt catcaaaaag tgtgaaagcg aatttttcga acgccattat 480 gtgggcattc acatccgtcg cggtgatttc attaaaagca ccgacccgct gcacctggca 540 acgggtattg attacatcaa aaagagtatc aaaaagttca acaatcgtaa ctttattgtg 600 ttctccgatg acatcggttg gtgccgcgat aaactgggcg aaagtgacgg tattgtttat 660 tttagtggca attccgccat tgaagatttc atcggtctga tgtgctgtaa ggactttatc 720 ctgagcggct ctaccttctc atggtgggca gctattctgt cgctgaacga aaatacgcgt 780 gtggttatcc cgaacagtaa agcgcagttt atgtccattg aagccaatac gcgcatcggt 840 tgggatttcg aagtcgtgta a 861 <210> 4 <211> 903 <212> DNA <213> Gramella forsetii <400> 4 atgtccaata aaaatccggt tatcgttgaa atcatgggtg gcctgggcaa tcagatgttc 60 caattcgccg tcgcaaaact gctggcagaa aagaacagca gcgtgctgct ggtcgatacg 120 aacttctaca aggaaatcag ccagaacctg aaggattttc cgcgttattt ctcactgggc 180 attttcgaca tctcgtacaa aatgggcacc gaaaacggta tggtcaactt caagaacctg 240 agtttcaaga accgtgtgtc ccgcaaactg ggtctgaact atccgaagat ctttaaagaa 300 aagtcctacc gttttgatgc ggacctgttc aacaaaaaga cgccgattta tctgaaaggc 360 tactttcagt catataagta cttcattggt gttgaatcga aaatccgcca atggtttgaa 420 tttccgtacg aaaatctggg cgtcggtaac gaagaaatca agagtaagat cctggaaaag 480 acctcagtgt cggttcatat ccgtcgcggc gattacgtgg aaaaaaaaa gacgaaggaa 540 tttcacggta attgctctct ggaatattac aaaaacgcga ttacctactt tctggatatt 600 gtgaaggaat ttaacatcgt gtttttcagc gatgacattt cttgggttcg tgatgaattt 660 aaagacctgc cgaacgaaaa ggtcttcgtg accggcaatc tgcatgaaaa cagttggaaa 720 gatatgtatc tgatgtccct gtgtgaccac aattatcg ccaacagttc cttttcttgg 780 tgggcggcct ggctgaacaa taactctgaa aagaacgtga tcgcaccgaa aaagtggttc 840 gctgatattg accaggaaca aaaaagcctg gatctgctgc cgccgtcttg gattcgcatg 900 city 903 <210> 5 <211> 1128 <212> DNA <213> I'm sorry, I'm sorry. (Francisella philomiragia ssp. philomeragia) <400> 5 atgaaaatta tcaaaatcca aggtggcctg ggtaaccaaa tgttccaata cgcattctac 60 aaaagcctga aaaacaactg catcgattgc tacgtggata ttaagaacta cgacacctac 120 aagctgcatt atggcttcga actgaaccgt atcttcaaga acatcgatct gtcatttgca 180 cgcaaatatc acaaaaagga agttctgggt aaactgttca gtattatccc gtccaagttc 240 atcgtcaagt tcaacaagaa ctacatctta cagaaaaact ttgcgttcga taaggcctac 300 tttgaaatcg ataactgcta tctggacggc tactggcaat ccgaaaagta cttcaaaaag 360 attackagg atatttacga cgcttttacg ttcgaaccgc tggatagtat caacttcgaa 420 tttctgaaga acatccagga ctataatctg gtctccattc atgtgcgtcg cggtgattac 480 gttaatcatc cgctgcacgg cggtatttgt gacctggaat actacaacaa ggcaatttca 540 tttatccgtt cgaaagtggc taacgttcat tttctggtgt tcagcaatga tattctgtgg 600 tgcaaagata acctgaagct ggaccgtgtt acgtatattg atcacaatcg ctggatggat 660 agctacaaag acatgcatct gatgtctctg tgtaaacaca acattatcgc gaatagctct 720 ttttcttggt ggggcgcctg gctgaaccag aatgatgaca aaattgtcat cgcaccgtca 780 aagtggttca acgatgacaa gatcaacca aaggatattt gcccgaactc gtgggttcgc atttagcgg ccgcgtcgac acgcaaaaag gccatccgtc aggatggcct tctgcttaat ttgatgcctg gcagtttatg gcgggcgtcc tgcccgccac cctccgggcc gttgcttcgc 960 aacgttcaaa tccgctcccg gcggatttgt cctactcagg agagcgttca ccgacaaaca acagataaaa cgaaaggccc agtctttcga ctgagcctttt cgttttattt gatgcctggc 1080 agttccctac tctcgcatgg ggagacccca cactaccatc atgtatga <210> 6 <211> 885 <212> DNA <213> Fruit-based fertilizer (Pseudogulbenkiania ferrooxidans) <400> 6 atgattattg ttcgcctgat gggtggcatg ggtaaccaac tgtttcaata cgcaacggca ttcgcactgt caaaacgcaa gtcggaaccg ctggtgctgg atacccgctt tttcgaccat father acggcggtta caagctggat cattttaaca ttagcgcacg tatcctgtct aaagaagaag aaagcctgta tccgaactgg caggcgaatc tgctgctgcg ctacccgatt 240 atcgatcgtg cctttaaaaa gtggcacgtt gaacgccagt tcacctatca agaccgtatt 300 taccgcatga aacgtggcca ggcgctgctg ggttattggc agtcggaact gtacttccaa 360 gaataccgta aggaaattag cgcggaattt accctgaaag aacagagctc tgtcacggcg 420 cagcaaattt ccgtggccat gcaaggcggt aactcagtgg cagttcatat ccgtcgcggc 480 gattatctga gtaatccgtc cgctctgcgc acccacggca tttgcagcct gggttattac 540 aaccacgcaa tgagtctgct gaacgaacgt atcaatgatg ctcagtttta cattttcagc 600 gatgacatcg cgtgggccaa ggaaaacatt aaaatcggca agacgtccaa gaacctgatc 660 ttcatcgagg gtgaatcagt cgaaaccgat ttctggctga tgacgcagtc taaacatcac 720 attatcgcca attcaacctt ttcgtggtgg ggtgcatggc tggctaacaa tacggacgaa 780 caactggtta tttgtccgag cccgtggttc gatgacaaaa acctgtcgga aaccgatctg 840 attccgaaga gctggattcg tctgaataaa gacctgccgg tctaa 885 <210> 7 <211> 879 <212> DNA <213> Sideroxydans lithotrophicus <400> 7 atggttatct caaacattat cggtggcctg ggtaatcaaa tgttccaata cgcagcagca 60 cgcgccctgt ccctgaaact ggaagtgccg ctgaaactgg atatttccgg ttttaccaac 120 tatgccctgc atcagggttt tgaactggac cgtatcttcg gctgcaagat tgaaatcgcg 180 agcgaagccg atgtgcacga aattctgggc tggcaaagtg cgtccggtat ccgtcgcgtg 240 gttagccgtc cgggcatgtc tatttttcgt cgcaaaggct tcgtcgtgga accgcatttt 300 tcatattgga atggcattcg caaaatcacg ggtgattgtt atctggcggg ctactggcag 360 tcggaaaagt acttcctgga tgcggccgtg gaaatccgca aagactttag tttcaagctg 420 ccgctggatt cccataacgc agaactggct gaaaaaattg accaagaaaa tgcggttagc 480 ctgcacatcc gtcgcggtga ttatgccaac aatccgctga ccgcagctac gcatggcctg 540 tgctcactgg actattaccg taaatcgatt aagcacatcg ccggtcaggt gcgcaacccg 600 tactttttcg tttttagtga tgacattgct tgggttaaag ataatctgga aatcgaattt 660 ccgtcccaat atgtggatta caaccacggt tcaatgtcgt tcaatgatat gcgtctgatg 720 agcctgtgta aacatcacat tatcgcaaac agctcttttt cttggtgggg cgcttggctg 780 aacccgaatc cggaaaaggt tgtcattgcg ccggaacgtt ggttcgccaa tcgcaccgat 840 gtccaggacc tgctgccgcc gggttgggtg aaactgtaa 879 <210> 8 <211> 912 <212> DNA <213> Providencia alcalifaciens <400> 8 atgaaaatca acggtaaaga aagctcaatg aaaatcaaac aaaagaaaat tatctctcac 60 ctgatcggtg gcctgggtaa ccaactgttt cagtatgcga cgagctacgc gctggccaaa 120 gaaaacaatg ccaagattgt gatcgatgac cgtctgttca aaaagtataa actgcatggc 180 ggttaccgcc tggacaaact gaacatcatc ggcgaaaaaa ttagctctat cgataagctg 240 ctgtttccgc tgattctgtg caaactgagt cagaaggaaa acttcatctt caaatccacc 300 aaaaagttca tcctggaaaaaaaaccagc agctttaagt acctgacgtt cagtgataag 360 gaacacacca agatgctgat tggttactgg cagaacgcga tctacttcca aaagtacttc 420 tctgaactga aggaaatgtt tgttccgctg gatatttcac aggaacaact ggacctgtcg 480 attcagatcc atgcacagca aagcgtggct ctgcacgttc gtcgcggcga ctatatttct 540 aacaaaaatg cactggctat gcatggtatt tgtagcatcg attactacaa aaactctatc 600 cagcacatca atgcaaaact ggaaaagccg tttttctata tttttagcaa cgacaaactg 660 tggtgcgaag aaaatctgac gccgctgttt gatggcaact tccatatcgt cgaaaacaat 720 tcacaggaaa ttgatctgtg gctgatctcg cagtgtcaac atcacattat cgcgaatagc 780 acgttttctt ggtggggtgc gtggctggcc aactcagatt cgcaaattgt catcaccccg 840 gacccgtggt tcaacaaaga aattgatatt ccgagtccgg tgctgtccca ctggctgaaa 900 ctgaaaaagt aa 912 <210> 9 <211> 867 <212> DNA <213> Pseudoalteromonas haloplanktis <400> 9 atgattaagg tcaaagctat cggtggcctg ggtaaccaac tgttccaata cgcaacggcc 60 cgtgcaatcg cagaaaaacg tggtgatggc gtggttgtcg atatgagcga ctttagctct 120 tataaaaccc atccgttttg cctgaataag ttccgttgta aagcaacgta cgaaagcaaa 180 ccgaagctga tcaacaagct gctgtctaat gaaaaaattc gcaacctgct gcagaaactg 240 ggcttcatca aaaagtacta cttcgaaacc caactgccgt ttaatgaaga tgtgctgctg 300 aacaattcca tcaactatct gacgggttac ttccagtcag aaaaatattt tctgtcgatt 360 cgtgaatgcc tgctggatga actgaccctg atcgaagacc tgaatattgc ggaaacggcc 420 gttagtaagg caatcaagaa cgctaagaac tcaatctcga tccatatccg tcgcggtgat 480 tacgtctcta acgaaggcgc aaataagacc cacggtgtgt gtgatagtga ctatttcaaa 540 aaggctctga actacttttc cgaacgcaaa ctgctggatg aacatacgga actgtttatc 600 ttctcagatg acattgaatg gtgccgtaac aacctgtcgt tcgattacaa gatgaacttc 660 gttgacggca gttccgaacg cccggaagtg gatatggttc tgatgagcca gtgtaaacac 720 caagtcatca gcaactctac cttctcttgg tggggtgcgt ggctgaacaa gaatgatgaa 780 aaagtggttg tcgccccgaa ggaatggttt aaaagtaccg atctggactc cacggacatc 840 gtgccgaacc aatggattaa actgtaa 867 <210> 10 <211> 876 <212> DNA <213> Roseovarius nubinhibens <400> 10 atgacggata cgccgccgcc gagccaagtg attacgagcc gcctgttcgg tggtgccggt 60 aaccaactgt tccaatacgc agccggtcgt gccctggcag atcgcctggg ctgcgatctg 120 atgattgacg cacgttatgt ggctggcagc cgtgatcgcg gtgactgttt tacccatttc 180 gctaaagcac gtctgcgtcg cgatgttgca ctgccgccgg caaaaagtga cggtccgctg 240 cgttacgcac tgtggcgtaa gtttggtcgt tccccgcgtt tccatcgtga acgcggcctg 300 ggtgtcgatc cggaattttt caacctgccg cgtggcacct atctgcacgg ttactggcag 360 tcagaacaat attttggtcc ggataccgac gcgctgcgtc gcgatctgac gctgaccacg 420 gctctggacg caccgaatgc agcaatggca gctcagattg atgcggcccc gtgcccggtt 480 tcgttccatg tccgtcgcgg cgattatatc gcagctggtg catacgcggc ctgtaccccg 540 gattattacc gtgcagctgc agaccacctg gcaaccacgc tgggtaaacc gctgacgtgc 600 tttattttca gtaacgatcc ggcctgggca cgcgataatc tggacctggg ccaggaccaa 660 gtcatcgtgg atctgaacga cgaagcgacc ggtcactttg atatggccct gatggcacgc 720 tgtgctcatc acgttattgc aaacagcacg ttctctttggt ggggtgcttg gctgaatccg 780 gatccggaca aactggtggt ggccccgcgt aactggtttg cgacccaggc cctgcataat 840 ccggatctga tcccggaaca atggcaccgc ctgtaa 876 <210> 11 <211> 879 <212> DNA <213> Thalassospira profundimaris <400> 11 atggttattg tgaaactgct gggtggcctg ggtaatcaaa tgttccaata tgctacgggt 60 cgtgccgttg cttctcgcct ggatgttgaa ctgctgctgg acgttagcgc atttgctcat 120 tatgatctgc gtcgctacga actggatgac tggaacatta ccgcacgtct ggcaacgagc 180 gaagaactgg cacgttctgg cgttaccgca gcaccgccga gctttttcga ccgtattgcg 240 cgcttcctgc gtatcgatct gccggtcaat tgctttcgcg aagcctcctt cacgtatgat 300 ccgcgtattc tggaagtcag ctctccggtg tatctggacg gttactggca gtctgaacgc 360 tactttctgg atatcgaaaa gaaactgcgt caggaattcc aactgaaggc atcaatcgac 420 gctaacaacc attcgttcaa aaagaaaatc gatggcctgg gtaaacaggc agttagtctg 480 catgtccgtc gcggcgatta tgtcaccaac ccgcaaacgg ctagttacca cggtgtgtgc 540 tccctggact attaccgcgc agctgtcgat tatatcgccg aacacgtgag cgatccgtgc 600 tttttcgtgt ttagcgatga cctggaatgg gttcagacca acctgaatat taaacaaccg 660 atcgtgctgg ttgatgcaaa cggcccggac aatggtgcgg ccgatatggc gctgatgatg 720 gcctgtcgtc atcacattat cgccaacagt tccttttcat ggtggggctc gtggctgaac 780 ccgctgaatg ataaaattat cgtggcaccg aagaaatggt tcggtcgcgc taatcacgat 840 accacggacc tggtgccgga tagctgggtt cgtctgtaa 879 <210> 12 <211> 879 <212> DNA <213> Desulfovibrio alaskensis <400> 12 atgaagttcg tgggtgtgtg gatcctgggt ggcctgggta atcaaatgtt ccaattcgca 60 gcagcctatg cactggcaaa acgtatgggc ggtgaactgc gtctggatct gtctggcttt 120 aaaaagtacc cgctgcgcag ttattccctg gacctgttta ccgttgacac gccgctgtgg 180 catggtctgc cgatgagcca gcgtcgcttt cgtattccga tggatgcttg gacccgtggt 240 agtcgtctgc cgctggtgcc gtccccgccg ttcgttatgg cgaaagaaaa gaactttgcc 300 ttctcaccga ttgtttatga actgcagcaa tcgtgctatc tgtacggcta ttggcagagc 360 taccgctatt ttcaagatgt cgaagatgac atccgtaccc tgttttcact gtcgcgtttc 420 gcaacgctgg aactggcacc ggtggttgca cagctgaacg aagtggaatc tgtcgccgtg 480 catctgcgtc gcggtgatta cattaccgac gcggccagta atgcagttca cggcgtctgt 540 ggtatcgatt attaccaacg tagcatgtct ctggtccgtc gctctaccac gaaaccgatc 600 ttttatatct tcagtgacga accggaagtg gcaaaaaagc tgtttgctac ggaagatgac 660 gtcgtggtta tgccgtcccg tcgccaggaa gaagatctgc tgctgatgtc acgttgcaaa 720 catcacatta tcgcgaatag ctctttctcg tggtgggcag cttggctggg caaacgcgca 780 agcggtctgt gtattgctcc gcgttactgg tttgcgcgcc cgaagctgga atccacctac 840 ctgtttgatc tgatcccgga cgaatggctg ctgctgtaa 879 <210> 13 <211> 882 <212> DNA <213> Thermosynechococcus elongates <400> 13 atgattattg tccatctgtg tggtggcctg ggtaaccaaa tgttccaata tgcagcgggc 60 ctggcagcag ctcaccgtat cggtagcgaa gttaaatttg acacccattg gttcgatgca 120 acgtgcctgc accagggtct ggaactgcgt cgcgtgtttg gtctggaact gccggaaccg 180 agctctaaag atctgcgtaa ggttctgggc gcatgtgttc atccggctgt ccgtcgcctg 240 ctggcaggtc atttcctgca cggtctgcgt ccgaagtcac tggtcattca gccgcatttt 300 cactattgga ccggcttcga acacctgccg gacaacgtgt atctggaagg ttactggcaa 360 agcgaacgtt acttttctaa tatcgccgat attatccgtc agcaatttcg cttcgttgaa 420 ccgctggacc cgcataacgc ggccctgatg gatgaaatgc agagcggcgt tagtgtctcc 480 ctgcatattc gtcgcggtga ctatttcaac aatccgcaaa tgcgtcgcgt ccacggtgtg 540 gatctgtctg aatattaccc ggcagctgtg gcaaccatga tcgaaaaaac gaacgctgaa 600 cgcttttacg tgttctcaga tgacccgcag tgggttctgg aacatctgaa gctgccggtc 660 tcgtataccg tggttgacca caatcgtggc gcggccagtt accgcgatat gcaactgatg 720 tccgcgtgcc gtcatcacat tatcgccaac tcaacgtttt cgtggtgggg tgcatggctg 780 aatccgcgtc cggataaagt cgtgattgcc ccgcgccatt ggtttaatgt ggatgttttc 840 gacacgcgcg atctgtattg tccgggctgg atcgtgctgt aa 882 <210> 14 <211> 996 <212> DNA <213> Bacteroides fragilis <400> 14 atgtgtgatt gcctgtctat tatcctgctg gtgaaaatga aaaagatcta cctgaaattc 60 gtggacttct gggacggctt tgataccatc agtaacttta ttgtggatgc actgtccatc 120 cagtatgaag tggttctgtc aaatgaaccg gactacctgt tttatagctg cttcggcacc 180 tctcatctgg aatacgattg tatcaaaatc atgttcatcg gtgaaaacat cgtgccggat 240 ttcaatgttt gcgactatgc gattggcttt aactacatcg atttcggtga ccgttatctg 300 cgcctgccgc tgtatgccat ttacgatggc ttctccaacc tgcaaaacaa gaaaattgat 360 gtcaacaaag cactggaccg caaattctgt tcaattgtcg tgtcgaacaa taaatgggct 420 gatccgatcc gtgaaacgtt tttcaaactg ctgagctctt acaaaaaagt tgattctggc 480 ggtcgcgcat ggaacaatat tggcggtccg gtcgataaca aactggactt catctctcag 540 tacaaattca acatcgcttt cgaaaacagt cgtgttctgg gttacaccac ggaaaaaatt 600 atggaaccga tgcaagtcaa cagcatcccg gtgtattggg gcaacccgct ggttggcaaa 660 gattttaacg ttgactcgtt cgtcaatgcc catgattttg acagcctgga acgcctggtt 720 gaatatatta tcgaactgga tagttccaaa gacaaatacc tggaaatgct ggaaaaaccg 780 tggctgctgg ataaaaccta tctggactgg aaacagctgc tgctgaactt catcaacaac 840 atcatgatga aaagttacaa agatgcgaaa tacctggtta actacggcca cgccggtaaa 900 taccgtaatg aaacgctt ctggggccgt tgcgaacgta aattcaaact gcaacgcatt 960 atcgaatact actcccaact gtttgatcgt aaataa 996 <210> 15 <211> 550 <212> DNA <213> Escherichia coli <400> 15 atgagcatta ttcgtctgca gggtggtctg ggtaatcagc tgtttcagtt tagctttggt 60 tatgccctga gcaaaattaa tggtacaccg ctgtatttcg acattagcca ttatgccgaa 120 aacgatgatc atggtggtta tcgtctgaat aatctgcaga ttccggaaga atatctgcag 180 tattataccc cgaaaattaa tatatttat aaactgctgg tgcgtggcag ccgtctgtat 240 ccggatattt ttctgtttct gggctttgc aacgaatttc atgcctatgg ctacgatttt 300 gaatatattg cccagaaatg gaaaagcaaa aaatacattg gctactggca gagcgaacac 360 ttttttcata aacatattct ggacctgaaa gaattttta ttccgaaaaa tgtgagcgaa 420 caggcaaatc tgctggcagc aaaaattctg gaaagccaga gcagcctgag cattcatatt 480 cgtcgtggcg attatattaa aaacaaaacc gcaaccctga cacatggtgt ttgtagcctg 540 gaatattata 550 <210> 16 <211> 320 <212> PRT <213> Helicobacter hepaticus <400> 16 Met Lys Asp Asp Leu Val Ile Leu His Pro Asp Gly Gly Ile Ala Ser 1 5 10 15 Gln Ile Ala Phe Val Ala Leu Gly Leu Ala Phe Glu Gln Lys Gly Ala 20 25 30 Lys Val Lys Tyr Asp Leu Ser Trp Phe Ala Glu Gly Ala Lys Gly Phe 35 40 45 Trp Asn Pro Ser Asn Gly Tyr Asp Lys Val Tyr Asp Ile Thr Trp Asp 50 55 60 Ile Ser Lys Ala Phe Pro Ala Leu His Ile Glu Ile Ala Asn Glu Glu 65 70 75 80 Glu Ile Glu Arg Tyr Lys Ser Lys Tyr Leu Ile Asp Asn Asp Arg Val 85 90 95 Ile Asp Tyr Ala Pro Pro Leu Tyr Cys Tyr Gly Tyr Lys Gly Arg Ile 100 105 110 Phe His Tyr Leu Tyr Ala Pro Phe Phe Ala Gln Ser Phe Ala Pro Lys 115 120 125 Glu Ala Gln Asp Ser His Thr Pro Phe Ala Ala Leu Leu Gln Glu Ile 130 135 140 Glu Ser Ser Pro Ser Pro Cys Gly Val His Ile Arg Arg Gly Asp Leu 145 150 155 160 Ser Gln Pro His Ile Val Tyr Gly Asn Pro Thr Ser Asn Glu Tyr Phe 165 170 175 Ala Lys Ser Ile Glu Leu Met Cys Leu Leu His Pro Gln Ser Ser Phe 180 185 190 Tyr Leu Phe Ser Asp Asp Leu Ala Phe Val Lys Glu Gln Ile Val Pro 195 200 205 Leu Leu Lys Gly Lys Thr Tyr Arg Ile Cys Asp Val Asn Asn Pro Ser 210 215 220 Gln Gly Tyr Leu Asp Leu Tyr Leu Leu Ser Arg Cys Arg Asn Ile Ile 225 230 235 240 Gly Ser Gln Gly Ser Met Gly Glu Phe Ala Lys Val Leu Ser Pro His 245 250 255 Asn Pro Leu Leu Ile Thr Pro Arg Tyr Arg Asn Ile Phe Lys Glu Val 260 265 270 Glu Asn Val Met Cys Val Asn Trp Gly Glu Ser Val Gln His Pro Pro 275 280 285 Leu Val Cys Ser Ala Pro Pro Pro Leu Val Ser Gln Leu Lys Arg Asn 290 295 300 Ala Pro Leu Asn Ser Arg Leu Tyr Lys Glu Lys Asp Asn Ala Ser Ala 305 310 315 320 <210> 17 <211> 361 <212> PRT <213> Brachyspira pilosicoli <400> 17 Met Ala Pro Lys His Leu Ile Asn Leu Tyr Tyr Ile Asp Ile Ser Ile 1 5 10 15 Leu Tyr Val Lys Ile Lys Gln Lys Ser Lys Ile Phe Ile Asn Phe Met 20 25 30 Leu Tyr Asn Asn Tyr Glu His Leu Ile Asn Lys Ile Val Arg Ile Ile 35 40 45 Pro Ile Lys Lys His Arg Asp Asn Leu Arg Asn Ile Leu Tyr Asp Ile 50 55 60 Val Asn Ser Leu Tyr Lys Ile Glu Tyr Ile Ser Lys Glu Leu Asn Lys 65 70 75 80 Lys Arg Asn Asn Asn Asp Ser Gly Ile Val Ile Ile Glu Cys Gln Gly 85 90 95 Gly Leu Ala Asp Gln Phe Trp Lys Tyr Ile Leu Gly Glu Ser Ile Lys 100 105 110 Lys His Tyr Asn Phe Thr Val Lys Tyr Asp Ile Thr Trp Phe Asp Tyr 115 120 125 Lys His Lys Asp Ile Asp Gly Lys Asp Glu Arg Pro Phe Glu Leu Ile 130 135 140 Lys Leu Cys Pro Asp Ile Asp Phe Lys Ile Ala Ser Tyr Asp Glu Ile 145 150 155 160 Phe Phe Tyr Lys Ala Cys Phe Ser Val Ile Asn Glu Ser Tyr Phe Gly 165 170 175 Tyr Asp With Asn Asn Tyr To Glue Asn To Lys Asn To Phe Lead Tyr 180 185 190 Be Tyr Pro Arg With Leu Asp With Asn Val Be Asp With Thr Lys Asn 195 200 205 Ile Asp Leu Asp Lys Tyr His Tyr Ser Thr Leu Lys Glu Asp Asn Leu 210 215 220 Will Tyr Asn Glu Leu Lys Asn Ser Glu Ser Val Ala Ile His Ile 225 230 235 240 Arg Leu Gly Asp Ser Tyr Val Met Ser Cys Phe Lys Glu Val Phe Asn 245 250 255 Ser Ser Tyr Glu Asn Tyr Ala Asn Tyr Phe Ile Glu Ser Ile Asn Lys 260 265 270 Leu Ser Asn Glu Leu Lys Asn Pro Thr Phe Phe Phe Phe Ser Asp Asp 275 280 285 Ile Asp Trp Val Asn Lys Asn Ile Ile Lys Lys Leu Asn Asn Arg Ile 290 295 300 Ser Tyr Lys Val Ser Ser Cys Lys Asn Pro Pro Tyr Leu Asp Ile Tyr 305 310 315 320 Leu Met Ser Asn Ala Lys His Tyr Ile Ile Ser Leu Gly Gly Phe Gly 325 330 335 Asp Leu Ala Thr Arg Phe Asn Asn Asn Glu Asn Lys Ile Val Ile Lys 340 345 350 Ala Cys Lys Phe Gln Tyr Asp Tyr Leu 355 360 <210> 18 <211> 286 <212> PRT <213> Yersinia species <400> 18 Met Phe Met Lys Ile Ser Val Leu Val Gln Gly Gly Leu Gly Asn Gln 1 5 10 15 Leu Phe Gln Ile Ala Trp Ala Asn Tyr Leu Val Arg Lys Tyr Gln Tyr 20 25 30 Asn Val Glu Ile Asn Leu Gln Leu Leu Tyr Ser Gln Ser Gln His Ala 35 40 45 Ser Ile Asn Phe Ser Gln Leu Ile Gly Lys Val Pro Leu Leu Ser Val 50 55 60 Ser Lys Glu Lys Ile Met Leu Asp Asp Arg Leu Ser Lys Ile 65 70 75 80 Ile Arg Lys Ser Leu Arg Ile Leu Gly Val His Ser Ile Pro Asn Ile 85 90 95 Leu Leu His Asp Tyr Asp Ala Leu Thr Asp Phe Glu His Cys Asn Lys 100 105 110 Met Ala Asn Tyr Arg Tyr Gln Phe Gly Tyr Phe Gln Phe Ile Glu Ala 115 120 125 Ala I'm Not Arg Asp I'm Not Leu I'm Not Met Arg I'm His 130 135 140 Gly Glu Phe Ile Lys Lys Cys Glu Ser Glu Phe Phe Glu Arg His Tyr 145 150 155 160 Val Gly Ile His Ile Arg Arg Gly Asp Phe Ile Lys Ser Thr Asp Pro 165 170 175 His Leu Ala Thr Gly Ile Asp Tyr Ile Lys Ser Ile Lys Lys 180 185 190 Phe Asn Asn Arg Asn Phe Ile Val Phe Ser Asp Asp Ile Gly Trp Cys 195 200 205 Arg Asp Lys Leu Gly Glu Ser Asp Gly Ile Val Tyr Phe Ser Gly Asn 210 215 220 Ser Ala Ile Glu Asp Phe Ile Gly Leu Met Cys Cys Lys Asp Phe Ile 225 230 235 240 Leu Ser Gly Ser Thr Phe Ser Trp Trp Ala Ala Ile Leu Ser Leu Asn 245 250 255 Glu Asn Thr Arg Val Val Ile Pro Asn Ser Lys Ala Gln Phe Met Ser 260 265 270 Ile Glu Ala Asn Thr Arg Ile Gly Trp Asp Phe Glu Val Val 275 280 285 <210> 19 <211> 300 <212> PRT <213> Fusobacterium <400> 19 Met Ser Asn Lys Asn Pro Val Ile Val Glu Ile Met Gly Gly Leu Gly 1 5 10 15 Asn Gln Met Phe Gln Phe Ala Val Ala Lys Leu Leu Ala Glu Lys Asn 20 25 30 Ser Ser Val Leu Leu Val Asp Thr Asn Phe Tyr Lys Glu Ile Ser Gln 35 40 45 Asn Leu Lys Asp Phe Pro Arg Tyr Phe Ser Leu Gly Ile Phe Asp Ile 50 55 60 Ser Tyr Lys Met Gly Thr Glu Asn Gly Met Val Asn Phe Lys Asn Leu 65 70 75 80 Ser Phe Lys Asn Arg Val Ser Arg Lys Leu Gly Leu Asn Tyr Pro Lys 85 90 95 Ile Phe Lys Glu Lys Ser Tyr Arg Phe Asp Ala Asp Leu Phe Asn Lys 100 105 110 Lys Thr Pro With Tyr Leu Lys Gly Tyr Phe Gln Ser Tyr Lys Tyr Phe 115 120 125 Ile Gly Val Glu Ser Lys Ile Arg Gln Trp Phe Glu Phe Pro Tyr Glu 130 135 140 Asn Leu Gly Val Gly Asn Glu Glu Ile Lys Ser Lys Ile Leu Glu Lys 145 150 155 160 His Ile Arg Arg Gly Asp Tyr Val Glu Asn Lys 165 170 175 Lys Thr Lys Glu Phe His Gly Asn Cys Served By Leu Glu Tyr Lys Asn 180 185 190 Ala Ile Thr Tyr Phe Leu Asp Ile Val Lys Glu Phe Asn Ile Val Phe 195 200 205 Phe Ser Asp Asp Ile Ser Trp Val Arg Asp Glu Phe Lys Asp Leu Pro 210 215 220 Asn Glu Lys Val Phe Val Thr Gly Asn Leu His Glu Asn Ser Trp Lys 225 230 235 240 Asp Met Tyr Leu Met Ser Leu Cys Asp His Asn Ile Ile Ala Asn Ser 245 250 255 Ser Phe Ser Trp Trp Ala Ala Trp Leu Asn Asn Asn Ser Glu Lys Asn 260 265 270 Val Ile Ala Pro Lys Lys Trp Phe Ala Asp Ile Asp Gln Glu Gln Lys 275 280 285 Ser Leu Asp Leu Leu Pro Pro Ser Trp Ile Arg Met 290 295 300 <210> 20 <211> 281 <212> PRT <213> Francisella mirabilis subsp. mirabilis <400> 20 Met Lys Ile Ile Lys Ile Gln Gly Gly Leu Gly Asn Gln Met Phe Gln 1 5 10 15 Tyr Ala Phe Tyr Lys Ser Leu Lys Asn Asn Cys Ile Asp Cys Tyr Val 20 25 30 Asp Ile Lys Asn Tyr Asp Thr Tyr Lys Leu His Tyr Gly Phe Glu Leu 35 40 45 Asn Arg Ile Phe Lys Asn Ile Asp Leu Ser Phe Ala Arg Lys Tyr His 50 55 60 Lys Lys Glu Val Leu Gly Lys Leu Phe Ser Ile Ile Pro Ser Lys Phe 65 70 75 80 Ile Val Lys Phe Asn Lys Asn Tyr Ile Leu Gln Lys Asn Phe Ala Phe 85 90 95 Asp Lys Ala Tyr Phe Glu With Asp Asn Cys Tyr Leu Asp Gly Tyr Trp 100 105 110 Gln Ser Glu Lys Tyr Phe Lys With Thr Lys Asp And Tyr Asp Ala 115 120 125 Phe Thr Phe Glu Pro Leu Asp Ser Ile Asn Phe Glu Phe Leu Lys Asn 130 135 140 With Gln Asp Tyr Asn Leu Will Be With His Val Arg Arg Gly Asp Tyr 145 150 155 160 Val Asn His Pro Leu His Gly Gly Ile Cys Asp Leu Glu Tyr Tyr Asn 165 170 175 Lys Ala Ile Ser Phe Ile Arg Ser Lys Val Ala Asn Val His Phe Leu 180 185 190 Val Phe Ser Asn Asp With Trp Cys Lys Asp With Lys Lys With Asp 195 200 205 Arg Val Thr Tyr Ile Asp His Asn Arg Trp Met Asp Ser Tyr Lys Asp 210 215 220 Met His Leu Met Ser Leu Cys Lys His Asn Ile Ile Ala Asn Ser Ser 225 230 235 240 Phe Ser Trp Trp Gly Ala Trp Leu Asn Gln Asn Asp Asp Lys Ile Val 245 250 255 Ile Ala Pro Ser Lys Trp Phe Asn Asp Asp Lys Ile Asn Gln Lys Asp 260 265 270 Ile Cys Pro Asn Ser Trp Val Arg Ile 275 280 <210> 21 <211> 294 <212> PRT <213> Ferrimonas pseudoglobulescens <400> 21 Met Ile Ile Val Arg Leu Met Gly Gly Met Gly Asn Gln Leu Phe Gln 1 5 10 15 Tyr Ala Thr Ala Phe Ala Leu Ser Lys Arg Lys Ser Glu Pro Leu Val 20 25 30 Leu Asp Thr Arg Phe Phe Asp His Tyr Thr Leu His Gly Gly Tyr Lys 35 40 45 Leu Asp His Phe Asn Ile Ser Ala Arg Ile Leu Ser Lys Glu Glu Glu 50 55 60 Ser Leu Tyr Pro Asn Trp Gln Ala Asn Leu Leu Leu Arg Tyr Pro Ile 65 70 75 80 Ile Asp Arg Ala Phe Lys Lys Trp His Val Glu Arg Gln Phe Thr Tyr 85 90 95 Gln Asp Arg Ile Tyr Arg Met Lys Arg Gly Gln Ala Leu Leu Gly Tyr 100 105 110 Trp Gln Ser Glu Leu Tyr Phe Gln Glu Tyr Arg Lys Glu Ile Ser Ala 115 120 125 Glu Phe Thr Leu Lys Glu Gln Ser Ser Val Thr Ala Gln Gln Ile Ser 130 135 140 Val Ala Met Gln Gly Gly Asn Ser Val Ala Val His Ile Arg Arg Gly 145 150 155 160 Asp Tyr Leu Ser Asn Pro Ser Ala Leu Arg Thr His Gly Ile Cys Ser 165 170 175 Leu Gly Tyr Tyr Asn His Ala Met Ser Leu Leu Asn Glu Arg Ile Asn 180 185 190 Asp Ala Gln Phe Tyr Ile Phe Ser Asp Asp Ile Ala Trp Ala Lys Glu 195 200 205 Asn Ile Lys Ile Gly Lys Thr Ser Lys Asn Leu Ile Phe Ile Glu Gly 210 215 220 Glu Ser Val Glu Thr Asp Phe Trp Leu Met Thr Gln Ser Lys His His 225 230 235 240 Ile Ile Ala Asn Ser Thr Phe Ser Trp Trp Gly Ala Trp Leu Ala Asn 245 250 255 Asn Thr Asp Glu Gln Leu Val Ile Cys Pro Ser Pro Trp Phe Asp Asp 260 265 270 Lys Asn Leu Ser Glu Thr Asp Leu Ile Pro Lys Ser Trp Ile Arg Leu 275 280 285 Asn Lys Asp Leu Pro Val 290 <210> 22 <211> 292 <212> PRT <213> Self-sustaining iron oxide bacteria <400> 22 Met Val Ile Ser Asn Ile Ile Gly Gly Leu Gly Asn Gln Met Phe Gln 1 5 10 15 Tyr Ala Ala Ala Arg Ala Leu Ser Leu Lys Leu Glu Val Pro Leu Lys 20 25 30 Leu Asp Ile Ser Gly Phe Thr Asn Tyr Ala Leu His Gln Gly Phe Glu 35 40 45 Leu Asp Arg Ile Phe Gly Cys Lys Ile Glu Ile Ala Ser Glu Ala Asp 50 55 60 Val His Glu Ile Leu Gly Trp Gln Ser Ala Ser Gly Ile Arg Arg Val 65 70 75 80 Val Ser Arg Pro Gly Met Ser Ile Phe Arg Arg Lys Gly Phe Val Val 85 90 95 Glu Pro His Phe Ser Tyr Trp Asn Gly Ile Arg Lys Ile Thr Gly Asp 100 105 110 Cys Tyr Leu Ala Gly Tyr Trp Gln Ser Glu Lys Tyr Phe Leu Asp Ala 115 120 125 Ala Val Glu Ile Arg Lys Asp Phe Ser Phe Lys Leu Pro Leu Asp Ser 130 135 140 His Asn Ala Glu Leu Ala Glu Lys Ile Asp Gln Glu Asn Ala Val Ser 145 150 155 160 Leu His Ile Arg Arg Gly Asp Tyr Ala Asn Asn Pro Leu Thr Ala Ala 165 170 175 Thr His Gly Leu Cys Ser Leu Asp Tyr Tyr Arg Lys Ser Ile Lys His 180 185 190 Ile Ala Gly Gln Val Arg Asn Pro Tyr Phe Phe Val Phe Ser Asp Asp 195 200 205 Ile Ala Trp Val Lys Asp Asn Leu Glu Ile Glu Phe Pro Ser Gln Tyr 210 215 220 Val Asp Tyr Asn His Gly Ser Met Ser Phe Asn Asp Met Arg Leu Met 225 230 235 240 Ser Leu Cys Lys His His Ile Ile Ala Asn Ser Ser Phe Ser Trp Trp 245 250 255 Gly Ala Trp Leu Asn Pro Asn Pro Glu Lys Val Val Ile Ala Pro Glu 260 265 270 Arg Trp Phe Ala Asn Arg Thr Asp Val Gln Asp Leu Leu Pro Pro Gly 275 280 285 Trp Val Lys Leu 290 <210> 23 <211> 303 <212> PRT <213> Providencia alcalifaciens <400> 23 Met Lys Ile Asn Gly Lys Glu Ser Ser Met Lys Ile Lys Gln Lys Lys 1 5 10 15 Ile Ile Ser His Leu Ile Gly Gly Leu Gly Asn Gln Leu Phe Gln Tyr 20 25 30 Ala Thr Ser Tyr Ala Leu Ala Lys Glu Asn Asn Ala Lys Ile Val Ile 35 40 45 Asp Asp Arg Leu Phe Lys Lys Tyr Lys Leu His Gly Gly Tyr Arg Leu 50 55 60 Asp Lys Leu Asn Ile Ile Gly Glu Lys Ile Ser Ser Ile Asp Lys Leu 65 70 75 80 Leu Phe Pro Leu Ile Leu Cys Lys Leu Ser Gln Lys Glu Asn Phe Ile 85 90 95 Phe Lys Ser Thr Lys Lys Phe Ile Leu Glu Lys Lys Thr Ser Ser Phe 100 105 110 Lys Tyr Leu Thr Phe Ser Asp Lys Glu His Thr Lys Met Leu Ile Gly 115 120 125 Tyr Trp Gln Asn Ala Ile Tyr Phe Gln Lys Tyr Phe Ser Glu Leu Lys 130 135 140 Glu Met Phe Val Pro Leu Asp Ile Ser Gln Glu Gln Leu Asp Leu Ser 145 150 155 160 Gln Isolated Only Gln Gln Ser Val Only Leu His Valid Arg Arg Gly 165 170 175 Asp Tyr Ile Server Asn Lys Asn Ala Leu Ala Met His Gly Ile Cys Server 180 185 190 With Asp Tyr Tyr Lys Asn Ser Ile Gln His Ile Asn Ala Lys Leu Glu 195 200 205 Lys Pro Phe Phe Tyr Ile Phe Ser Asn Asp Lys Leu Trp Cys Glu Glu 210 215 220 Asn Leu Thr Pro Leu Phe Asp Gly Asn Phe His Ile Val Glu Asn Asn 225 230 235 240 Ser Gln Glu Ile Asp Leu Trp Leu Ile Ser Gln Cys Gln His His Ile 245 250 255 Ile Ala Asn Ser Thr Phe Ser Trp Trp Gly Ala Trp Leu Ala Asn Ser 260 265 270 Asp Ser Gln Ile Val Ile Thr Pro Asp Pro Trp Phe Asn Lys Glu Ile 275 280 285 Asp Ile Pro Ser Pro Val Leu Ser His Trp Leu Lys Leu Lys Lys 290 295 300 <210> 24 <211> 288 <212> PRT <213> Pseudoalteromonas haloplanktis <400> 24 Met Ile Lys Val Lys Ala Ile Gly Gly Leu Gly Asn Gln Leu Phe Gln 1 5 10 15 Tyr Ala Thr Ala Arg Ala Ile Ala Glu Lys Arg Gly Asp Gly Val Val 20 25 30 Val Asp Met Ser Asp Phe Ser Ser Tyr Lys Thr His Pro Phe Cys Leu 35 40 45 Asn Lys Phe Arg Cys Lys Ala Thr Tyr Glu Ser Lys Pro Lys Leu Ile 50 55 60 Asn Lys Leu Leu Ser Asn Glu Lys Ile Arg Asn Leu Leu Gln Lys Leu 65 70 75 80 Gly Phe Ile Lys Lys Tyr Tyr Phe Glu Thr Gln Leu Pro Phe Asn Glu 85 90 95 Asp Val Leu Leu Asn Asn Ser Ile Asn Tyr Leu Thr Gly Tyr Phe Gln 100 105 110 Ser Glu Lys Tyr Phe Leu Ser Ile Arg Glu Cys Leu Leu Asp Glu Leu 115 120 125 Thr Leu Ile Glu Asp Leu Asn Ile Ala Glu Thr Ala Val Ser Lys Ala 130 135 140 Ile Lys Asn Ala Lys Asn Ser Ile Ser Ile His Ile Arg Arg Gly Asp 145 150 155 160 Tyr Val Ser Asn Glu Gly Ala Asn Lys Thr His Gly Val Cys Asp Ser 165 170 175 Asp Tyr Phe Lys Lys Ala Leu Asn Tyr Phe Ser Glu Arg Lys Leu Leu 180 185 190 Asp Glu His Thr Glu Leu Phe Ile Phe Ser Asp Asp Ile Glu Trp Cys 195 200 205 Arg Asn Asn Leu Ser Phe Asp Tyr Lys Met Asn Phe Val Asp Gly Ser 210 215 220 Ser Glu Arg Pro Glu Val Asp Met Val Leu Met Ser Gln Cys Lys His 225 230 235 240 Gln Val Ile Ser Asn Ser Thr Phe Ser Trp Trp Gly Ala Trp Leu Asn 245 250 255 Lys Asn Asp Glu Lys Val Val Val Ala Pro Lys Glu Trp Phe Lys Ser 260 265 270 Thr Asp Leu Asp Ser Thr Asp Ile Val Pro Asn Gln Trp Ile Lys Leu 275 280 285 <210> 25 <211> 291 <212> PRT <213> Roseobacter denitrificans <400> 25 Met Thr Asp Thr Pro Pro Pro Ser Gln Val Ile Thr Ser Arg Leu Phe 1 5 10 15 Gly Gly Ala Gly Asn Gln Leu Phe Gln Tyr Ala Ala Gly Arg Ala Leu 20 25 30 Ala Asp Arg Leu Gly Cys Asp Leu Met Ile Asp Ala Arg Tyr Val Ala 35 40 45 Gly Ser Arg Asp Arg Gly Asp Cys Phe Thr His Phe Ala Lys Ala Arg 50 55 60 Leu Arg Arg Asp Val Ala Leu Pro Pro Ala Lys Ser Asp Gly Pro Leu 65 70 75 80 Arg Tyr Ala Leu Trp Arg Lys Phe Gly Arg Ser Pro Arg Phe His Arg 85 90 95 Glu Arg Gly Leu Gly Val Asp Pro Glu Phe Phe Asn Leu Pro Arg Gly 100 105 110 Thr Tyr Leu His Gly Tyr Trp Gln Ser Glu Gln Tyr Phe Gly Pro Asp 115 120 125 Thr Asp Ala Leu Arg Arg Asp Leu Thr Leu Thr Thr Ala Leu Asp Ala 130 135 140 Pro Asn Ala Ala Met Ala Ala Gln Ile Asp Ala Ala Pro Cys Pro Val 145 150 155 160 Ser Phe His Val Arg Arg Gly Asp Tyr Ile Ala Ala Gly Ala Tyr Ala 165 170 175 Ala Cys Thr Pro Asp Tyr Tyr Arg Ala Ala Ala Asp His Leu Ala Thr 180 185 190 Thr Leu Gly Lys Pro Leu Thr Cys Phe Ile Phe Ser Asn Asp Pro Ala 195 200 205 Trp Ala Arg Asp Asn Leu Asp Leu Gly Gln Asp Gln Val Ile Val Asp 210 215 220 Leu Asn Asp Glu Ala Thr Gly His Phe Asp Met Ala Leu Met Ala Arg 225 230 235 240 Cys Ala His His Val Ile Ala Asn Ser Thr Phe Ser Trp Trp Gly Ala 245 250 255 Trp Leu Asn Pro Asp Pro Asp Lys Leu Val Val Ala Pro Arg Asn Trp 260 265 270 Phe Ala Thr Gln Ala Leu His Asn Pro Asp Leu Ile Pro Glu Gln Trp 275 280 285 His Arg Leo 290 <210> 26 <211> 292 <212> PRT <213> Maori <400> 26 Met Lys Phe Val Gly Val Trp Ile Leu Gly Gly Leu Gly Asn Gln Met 1 5 10 15 Phe Gln Phe Ala Ala Ala Tyr Ala Leu Ala Lys Arg Met Gly Gly Glu 20 25 30 Leu Arg Leu Asp Leu Ser Gly Phe Lys Lys Tyr Pro Leu Arg Ser Tyr 35 40 45 Ser Leu Asp Leu Phe Thr Val Asp Thr Pro Leu Trp His Gly Leu Pro 50 55 60 Met Ser Gln Arg Arg Phe Arg Ile Pro Met Asp Ala Trp Thr Arg Gly 65 70 75 80 Ser Arg Leu Pro Leu Val Pro Ser Pro Pro Phe Val Met Ala Lys Glu 85 90 95 Lys Asn Phe Ala Phe Ser Pro Ile Val Tyr Glu Leu Gln Gln Ser Cys 100 105 110 Tyr Leu Tyr Gly Tyr Trp Gln Ser Tyr Arg Tyr Phe Gln Asp Val Glu 115 120 125 Asp Asp Ile Arg Thr Leu Phe Ser Leu Ser Arg Phe Ala Thr Leu Glu 130 135 140 Leu Ala Pro Val Val Ala Gln Leu Asn Glu Val Glu Ser Val Ala Val 145 150 155 160 His Leu Arg Arg Gly Asp Tyr Ile Thr Asp Ala Ala Ser Asn Ala Val 165 170 175 His Gly Val Cys Gly Ile Asp Tyr Tyr Gln Arg Ser Met Ser Leu Val 180 185 190 Arg Arg Ser Thr Thr Lys Pro Ile Phe Tyr Ile Phe Ser Asp Glu Pro 195 200 205 Glu Val Ala Lys Lys Leu Phe Ala Thr Glu Asp Asp Val Val Val Met 210 215 220 Pro Ser Arg Arg Gln Glu Glu Asp Leu Leu Leu Met Ser Arg Cys Lys 225 230 235 240 His His Ile Ile Ala Asn Ser Ser Phe Ser Trp Trp Ala Ala Trp Leu 245 250 255 Gly Lys Arg Ala Ser Gly Leu Cys Ile Ala Pro Arg Tyr Trp Phe Ala 260 265 270 Arg Pro Lys Leu Glu Ser Thr Tyr Leu Phe Asp Leu Ile Pro Asp Glu 275 280 285 Trp Leu Leu Leu 290 <210> 27 <211> 293 <212> PRT <213> Synechococcus elongatus <400> 27 Met Ile Ile Val His Leu Cys Gly Gly Leu Gly Asn Gln Met Phe Gln 1 5 10 15 Tyr Ala Ala Gly Leu Ala Ala Ala His Arg Ile Gly Ser Glu Val Lys 20 25 30 Phe Asp Thr His Trp Phe Asp Ala Thr Cys Leu His Gln Gly Leu Glu 35 40 45 Leu Arg Arg Val Phe Gly Leu Glu Leu Pro Glu Pro Ser Ser Lys Asp 50 55 60 Leu Arg Lys Val Leu Gly Ala Cys Val His Pro Ala Val Arg Arg Leu 65 70 75 80 Leu Ala Gly His Phe Leu His Gly Leu Arg Pro Lys Ser Leu Val Ile 85 90 95 Gln Pro His Phe His Tyr Trp Thr Gly Phe Glu His Leu Pro Asp Asn 100 105 110 Val Tyr Leu Glu Gly Tyr Trp Gln Ser Glu Arg Tyr Phe Ser Asn Ile 115 120 125 Ala Asp Ile Ile Arg Gln Gln Phe Arg Phe Val Glu Pro Leu Asp Pro 130 135 140 His Asn Ala Ala Leu Met Asp Glu Met Gln Ser Gly Val Ser Val Ser 145 150 155 160 Leu His Ile Arg Arg Gly Asp Tyr Phe Asn Asn Pro Gln Met Arg Arg 165 170 175 Val His Gly Val Asp Leu Ser Glu Tyr Tyr Pro Ala Ala Val Ala Thr 180 185 190 Met Ile Glu Lys Thr Asn Ala Glu Arg Phe Tyr Val Phe Ser Asp Asp 195 200 205 Pro Gln Trp Val Leu Glu His Leu Lys Leu Pro Val Ser Tyr Thr Val 210 215 220 Val Asp His Asn Arg Gly Ala Ala Ser Tyr Arg Asp Met Gln Leu Met 225 230 235 240 Ser Ala Cys Arg His His Ile Ile Ala Asn Ser Thr Phe Ser Trp Trp 245 250 255 Gly Ala Trp Leu Asn Pro Arg Pro Asp Lys Val Val Ile Ala Pro Arg 260 265 270 His Trp Phe Asn Val Asp Val Phe Asp Thr Arg Asp Leu Tyr Cys Pro 275 280 285 Gly Trp Ile Val Leu 290 <210> 28 <211> 331 <212> PRT <213> Bacteroides fragilis <400> 28 Met Cys Asp Cys Leu Ser Ile Ile Leu Leu Val Lys Met Lys Lys Ile 1 5 10 15 Tyr Leu Lys Phe Val Asp Phe Trp Asp Gly Phe Asp Thr Ile Ser Asn 20 25 30 Phe Ile Val Asp Ala Leu Ser Ile Gln Tyr Glu Val Val Leu Ser Asn 35 40 45 Glu Pro Asp Tyr Leu Phe Tyr Ser Cys Phe Gly Thr Ser His Leu Glu 50 55 60 Tyr Asp Cys Ile Lys Ile Met Phe Ile Gly Glu Asn Ile Val Pro Asp 65 70 75 80 Phe Asn Val Cys Asp Tyr Ala Ile Gly Phe Asn Tyr Ile Asp Phe Gly 85 90 95 Asp Arg Tyr Leu Arg Leu Pro Leu Tyr Ala Ile Tyr Asp Gly Phe Ser 100 105 110 Asn Leu Gln Asn Lys Lys Ile Asp Val Asn Lys Ala Leu Asp Arg Lys 115 120 125 Phe Cys Ser Ile Val Val Ser Asn Asn Lys Trp Ala Asp Pro Ile Arg 130 135 140 Glu Thr Phe Phe Lys Leu Leu Ser Ser Tyr Lys Lys Val Asp Ser Gly 145 150 155 160 Gly Arg Ala Trp Asn Asn Ile Gly Gly Pro Val Asp Asn Lys Leu Asp 165 170 175 Phe Ile Ser Gln Tyr Lys Phe Asn Ile Ala Phe Glu Asn Ser Arg Val 180 185 190 Leu Gly Tyr Thr Thr Glu Lys Ile Met Glu Pro Met Gln Val Asn Ser 195 200 205 Ile Pro Val Tyr Trp Gly Asn Pro Leu Val Gly Lys Asp Phe Asn Val 210 215 220 Asp Ser Phe Val Asn Ala His Asp Phe Asp Ser Leu Glu Arg Leu Val 225 230 235 240 Glu Tyr Ile Ile Glu Leu Asp Ser Ser Lys Asp Lys Tyr Leu Glu Met 245 250 255 Leu Glu Lys Pro Trp Leu Leu Asp Lys Thr Tyr Leu Asp Trp Lys Gln 260 265 270 Leu Leu Leu Asn Phe Ile Asn Asn Ile Met Met Lys Ser Tyr Lys Asp 275 280 285 Ala Lys Tyr Leu Val Asn Tyr Gly His Ala Gly Lys Tyr Arg Asn Glu 290 295 300 Gln Arg Phe Trp Gly Arg Cys Glu Arg Lys Phe Lys Leu Gln Arg Ile 305 310 315 320 Ile Glu Tyr Tyr Ser Gln Leu Phe Asp Arg Lys 325 330 <210> 29 <211> 297 <212> PRT <213> Escherichia coli <400> 29 Met Ser Ile Ile Arg Leu Gln Gly Gly Leu Gly Asn Gln Leu Phe Gln 1 5 10 15 Phe Ser Phe Gly Tyr Ala Leu Ser Lys Ile Asn Gly Thr Pro Leu Tyr 20 25 30 Phe Asp Ile Ser His Tyr Ala Glu Asn Asp Asp His Gly Gly Tyr Arg 35 40 45 Lemon Asn Asn Lemon Gluten Ile Pro Glu Glu Tyr Lemon Glun Tyre Thr Pro 50 55 60 Lys Ile Asn Asn Ile Tyr Lys Leu Leu Val Arg Gly Ser Arg Leu Tyr 65 70 75 80 Pro Asp Ile Phe Leu Phe Leu Gly Phe Cys Asn Glu Phe His Ala Tyr 85 90 95 Gly Tyr Asp Phe Glu Tyr Ile Ala Gln Lys Trp Lys Ser Lys Lys Tyr 100 105 110 Ile Gly Tyr Trp Gln Ser Glu His Phe Phe His Lys His Ile Leu Asp 115 120 125 Leu Lys Glu Phe Phe Ile Pro Lys Asn Val Ser Glu Gln Ala Asn Leu 130 135 140 Leu Wing Wing Lys Ile Leu Glu Ser Gln Ser Ser Leu Ser Ile His Ile 145 150 155 160 Arg Arg Gly Asp Tyr Ile Lys Asn Lys Thr Ala Thr Leu Thr His Gly 165 170 175 Val Cys Ser Leu Glu Tyr Tyr Lys Ala Leu Asn Lys Ile Arg Asp 180 185 190 Leu Ala Met Ile Arg Asp Val Phe Ile Phe Ser Asp Asp Ile Phe Trp 195 200 205 Cys Lys Glu Asn Ile Glu Thr Leu Leu Ser Lys Lys Tyr Asn Ile Tyr 210 215 220 Tyr Ser Glu Asp Leu Ser Gln Glu Glu Asp Leu Trp Leu Met Ser Leu 225 230 235 240 Ala Asn His His Ile Ile Ala Asn Ser Ser Phe Ser Trp Trp Gly Ala 245 250 255 Tyr Leu Gly Ser Ser Ala Ser Gln Ile Val Ile Tyr Pro Thr Pro Trp 260 265 270 Tyr Asp Ile Thr Pro Lys Asn Thr Tyr Ile Pro Ile Val Asn His Trp 275 280 285 Ile Asn Val Asp Lys His Ser Ser Cys 290 295 <210> 30 <211> 292 <212> PRT <213> Deep-sea Oceanospirillum <400> 30 Met Val Ile Val Lys Leu Leu Gly Gly Leu Gly Asn Gln Met Phe Gln 1 5 10 15 Tyr Ala Thr Gly Arg Ala Val Ala Ser Arg Leu Asp Val Glu Leu Leu 20 25 30 Leu Asp Val Ser Ala Phe Ala His Tyr Asp Leu Arg Arg Tyr Glu Leu 35 40 45 Asp Asp Trp Asn Ile Thr Ala Arg Leu Ala Thr Ser Glu Glu Leu Ala 50 55 60 Arg Ser Gly Val Thr Ala Ala Pro Pro Ser Phe Phe Asp Arg Ile Ala 65 70 75 80 Arg Phe Leu Arg Ile Asp Leu Pro Val Asn Cys Phe Arg Glu Ala Ser 85 90 95 Phe Thr Tyr Asp Pro Arg Ile Leu Glu Val Ser Ser Pro Val Tyr Leu 100 105 110 Asp Gly Tyr Trp Gln Ser Glu Arg Phe Tyr With Asp With Glu Lys Lys 115 120 125 Leu Arg Gln Glu Phe Gln Leu Lys With Ser Ile Asp With Asn Asn His 130 135 140 Ser Phe Lys Lys Ile Asp Gly Leu Gly Lys Gln Ala Val Ser Leu 145 150 155 160 His Val Arg Arg Gly Asp Tyr Val Thr Asn Pro Gln Thr Ala Ser Tyr 165 170 175 His Gly Val Cys Ser Leu Asp Tyr Tyr Arg Ala Ala Val Asp Tyr Ile 180 185 190 Ala Glu His Val Ser Asp Pro Cys Phe Phe Val Phe Ser Asp Asp Leu 195 200 205 Glu Trp Val Gln Thr Asn Leu Asn Ile Lys Gln Pro Ile Val Leu Val 210 215 220 Asp Ala Asn Gly Pro Asp Asn Gly Ala Ala Asp Met Ala Leu Met Met 225 230 235 240 Ala Cys Arg His His Ile Ile Ala Asn Ser Ser Phe Ser Trp Trp Gly 245 250 255 Ser Trp Leu Asn Pro Leu Asn Asp Lys Ile Ile Val Ala Pro Lys Lys 260 265 270 Trp Phe Gly Arg Ala Asn His Asp Thr Thr Asp Leu Val Pro Asp Ser 275 280 285 Trp Val Arg Leu 290 <210> 31 <211> 2851 <212> DNA <213> unknown <220> <223> Expression fragment for integration into the E. coli genome <400> 31 tggccagatg attaattcct aatttttgtt gacactctat cattgataga gttatttac 60 cactccctat cagtgataga gaaaagtgaa atgaatagtt cgacaaaaat ctagaaataa 120 ttttgtttaa ctttaagaag gagatataca aatgtactat ttaaaaaaca caaacttttg 180 gatgttcggt ttattctttt tcttttactt ttttatcatg ggagcctact tcccgttttt 240 cccgatttgg ctacatgaca tcaaccatat cagcaaaagt gatacgggta ttatttttgc 300 cgctatttct ctgttctcgc tattattcca accgctgttt ggtctgcttt ctgacaaact 360 cgggctgcgc aaatacctgc tgtggattat taccggcatg ttagtgatgt ttgcgccgtt 420 ctttattttt atcttcgggc cactgttaca atacaacatt ttagtaggat cgattgttgg 480 tggtatttat ctaggctttt gttttaacgc cggtgcgcca gcagtagagg catttattga 540 gaaagtcagc cgtcgcagta atttcgaatt tggtcgcgcg cggatgtttg gctgtgttgg 600 ctgggcgctg tgtgcctcga ttgtcggcat catgttcacc atcaataatc agtttgtttt 660 ctggctgggc tctggctgtg cactcatcct cgccgtttta ctctttttcg ccaaaacgga 720 tgcgccctct tctgccacgg ttgccaatgc ggtaggtgcc aaccattcgg catttagcct 780 taagctggca ctggaactgt tcagacagcc aaaactgtgg tttttgtcac tgtatgttat 840 tggcgtttcc tgcacctacg atgtttttga ccaacagttt gctaatttct ttacttcgtt 900 ctttgctacc ggtgaacagg gtacgcgggt atttggctac gtaacgacaa tgggcgaatt 960 acttaacgcc tcgattatgt tctttgcgcc actgatcatt aatcgcatcg gtgggaaaaa 1020 cgccctgctg ctggctggca ctattatgtc tgtacgtatt attggctcat cgttcgccac 1080 ctcagcgctg gaagtggtta ttctgaaaac gctgcatatg tttgaagtac cgttcctgct 1140 ggtgggctgc tttaaatata ttaccagcca gtttgaagtg cgtttttcag cgacgattta 1200 tctggtctgt ttctgcttct ttaagcaact ggcgatgatt tttatgtctg tactggcggg 1260 caatatgtat gaaagcatcg gtttccaggg cgcttatctg gtgctgggtc tggtggcgct 1320 gggcttcacc ttaatttccg tgttcacgct tagcggcccc ggcccgcttt ccctgctgcg 1380 tcgtcaggtg aatgaagtcg ctgggagcta agcggccgcg tcgacacgca aaaaggccat 1440 ccgtcaggat ggccttctgc ttaatttgat gcctggcagt ttatggcggg cgtcctgccc 1500 gccaccctcc gggccgttgc ttcgcaacgt tcaaatccgc tcccggcgga tttgtcctac 1560 tcaggagagc gttcaccgac aaacaacaga taaaacgaaa ggcccagtct ttcgactgag 1620 cctttcgttt tatttgatgc ctggcagttc cctactctcg catggggaga ccccacacta 1680 ccatcatgta tgaatatcct ccttagttcc tattccgaag ttcctattct ctagaagga 1740 taggaacttc ggcgcgtcct acctgtgaca cgcgtgccgc agtctcacgc ccggagcgta 1800 gcgaccgagt gagctagcta tttgtttatt tttctaaata cattcaaata tgtatccgct 1860 catgagacaa taaccctgat aaatgcttca ataaattga aaaaggaa gtatgaggga 1920 agcggtgatc gccgaagtt cgactcaact atcagaggta gttggcgtca tcgagcgcca 1980 tctcgaaccg acgttgctgg ccgtacattt gtacggctcc gcagtggatg gcggcctgaa 2040 gccacacagt gatatgatt tgctggttac ggtgaccgta aggcttgatg aaacaacgcg 2100 gcgagctttg atcaacgacc ttttggaaac ttcggcttcc cctggagaga gcgagattct 2160 ccgcgctgta gaagtcacca ttgttgtgca cgacgacatc attccgtggc gttatccagc 2220 2280 gccagccacg atcgacattg atctggctat cttgctgaca aaagcaagag aacatagcgt 2340 tgccttggta ggtccagcgg cggaggaact ctttgatccg gttcctgaac aggatctatt 2400 tgaggcgcta aatgaaacct taacgctatg gaactcgccg cccgactggg ctggcgatga 2460 gcgaaatgta gtgcttacgt tgtcccgcat ttggtacagc gcagtaaccg gcaaaatcgc 2520 gccgaaggat gtcgctgccg actgggcaat ggagcgcctg ccggcccagt atcagcccgt 2580 catacttgaa gctagacagg cttatcttgg acaagaagaa gatcgcttgg cctcgcgcgc 2640 agatcagttg gaagaatttg tccactacgt gaaaggcgag atcaccaagg tagtcggcaa 2700 ataatgtcta acaattcgtt caagccgagg ggccgcaaga tccggccacg atgacccggt 2760 cgtcgggtac cggcagggcg gggcgtaagg cgcgccattt aaatgaagtt cctattccga 2820 agttcctatt ctctagaaag tataggaact t 2851 <210> 32 <211> 4568 <212> DNA <213> unknown <220> <223> Expression constructs for integration into the E. coli genome <400> 32 acaggttggc tgataagtcc ccggtctagc ttgcatgcag attgcagcat tacacgtctt 60 gagcgattgt gtaggctgga gctgcttcga agttcctata ctttctagag aataggaact 120 tcggaatagg aacttcattt aaatggcgcg ccttacgccc cgccctgccg gtaccgagag 180 cgcttttgaa gctggggtgg gcgaagaact ccagcatgag atccccgcgc tggaggatca 240 tccagccggc gtcccggaaa acgattccga agcccaacct ttcatagaag gcggcggtgg 300 aatcgaaatc tcgtgatggc aggttgggcg tcgcttggtc ggtcatttcg aaccccagag 360 tcccgctcag aagaactcgt caagaaggcg atagaaggcg atgcgctgcg aatcgggagc 420 ggcgataccg taaagcacga ggaagcggtc agcccattcg ccgccaagct cttcagcaat 480 atcacgggta gccaacgcta tgtcctgata gcggtccgcc acacccagcc ggccacagtc 540 gatgaatcca gaaaagcggc cattttccac catgatattc ggcaagcagg catcgccatg 600 ggtcacgacg agatcctcgc cgtcgggcat gcgcgccttg agcctggcga acagttcggc 660 tggcgcgagc ccctgatgct cttcgtccag atcatcctga tcgacaagac cggcttccat 720 ccgagtacgt gctcgctcga tgcgatgttt cgcttggtgg tcgaatgggc aggtagccgg 780 atcaagcgta tgcagccgcc gcattgcatc agccatgatg gatactttct cggcaggagc 840 aaggtgagat gacaggagat cctgccccgg cacttcgccc aatagcagcc agtcccttcc 900 cgcttcagtg acaacgtcga gcacagctgc gcaaggaacg cccgtcgtgg ccagccacga 960 tagccgcgct gcctcgtcct gcagttcatt cagggcaccg gacaggtcgg tcttgacaaa 1020 aagaaccggg cgcccctgcg ctgacagccg gaacacggcg gcatcagagc agccgattgt 1080 ctgttgtgcc cagtcatagc cgaatagcct ctccacccaa gcggccggag aacctgcgtg 1140 caatccatct tgttcaatca tgcgaaacga tcctcatcct gtctcttgat cagatcttga 1200 tcccctgcgc catcagatcc ttggcggcaa gaaagccatc cagtttactt tgcagggctt 1260 cccaacctta ccagagggcg ccccagctgg caattccggt tcgcttgctg tccataaaac 1320 cgcccagtct agctatcgcc atgtaagccc actgcaagct acctgctttc tctttgcgct 1380 tgcgttttcc cttgtccaga tagcccagta gctgacattc atccggggtc agcaccgttt 1440 ctgcggactg gctttctacg tgttccgctt cctttagcag cccttgcgcc ctgagtgctt 1500 gcggcagcgt gaggggatct tgacgcgtgt cacaggtagg acgcgccgaa gttcctatac 1560 tttctagaga ataggaactt cggaatagga actaaggagg atattcatac atgatggtag 1620 tgttcgaaat taatacgact cactataggg gaattgattc tggtaccaaa tgagtcgacc 1680 ggccagatga ttaattccta atttttgttg acactctatc attgatagag ttattttacc 1740 actccctatc agtgatagag aaaagtgaaa tgaatagttc gacaaaaatc tagaaataat 1800 tttgtttaac tttaagaagg agatatacaa atgccgtccg aagcattccg tcgtcaccgt 1860 gcttatcgcg aaaacaaact gcagccactg gtctctgtcc tgatctgcgc atacaacgtt 1920 gagaaatact tcgcacagtc tctggcagct gtagttaacc agacctggcg taacctggat 1980 atcctgatcg tagatgacgg ctctacggat ggtacgctgg cgatcgcaca gcgtttccag 2040 gaacaggacg gtcgtatccg cattctcgct cagccgcgta actctggtct gatcccgtct 2100 ctgaacatcg gtctggacga actggccaaa tctggtggtg gtggcgaata catcgcccgt 2160 actgacgccg acgacattgc ggccccggat tggatcgaaa aaatcgtagg tgaaatggag 2220 aaagaccgct ctatcatcgc gatgggtgct tggctggaag ttctgtccga agaaagac 2280 ggtaaccgtc tggcccgtca ccatgaacac ggcaaaatct ggaaaaaacc gacccgtcac 2340 gaagatatcg cggacttctt cccgttcggt aacccgatcc ataacaacac catgatcatg 2400 cgtcgtagcg taatcgacgg tggtctgcgt tacaacaccg aacgtgattg ggcagaagaac 2460 taccagtttt ggtatgacgt gtctaaactg ggtcgtctgg cttactaccc agaagcgctg 2520 gttaaatacc gtctgcacgc caaccaggtt agctccaaat actccatccg tcagcacgaa 2580 atcgcacagg gtatccagaa aacggctcgt aacgacttcc tgcagtccat gggtttcaaa 2640 acccgtttcg actctctgga gtaccgtcag atcaaagcgg ttgcgtatga gctgctgggag 2700 aaacacctgc cggaagagga ctttgaacgt gcgcgtcgtt tcctgtacca gtgcttcaaa 2760 cgtaccgaca ctctgccggc gggtgcatgg ctcgactttg cagcggatgg tcgtatgcgt 2820 cgtctgttta ccctgcgtca gtacttcggt atcctgcatc gtctcctgaa aaccgctaa 2880 tgatttcgtc gacacagg aaacatatta aaaattaaaa cctgcaggag tttaaacgcg 2940 gccgcgatat cgttgtaaaa cgacggccag tgcaagaatc ataaaaaatt tatttgcttt 3000 caggaaaatt tttctgtata atagattcat aaatttgaga gaggagtttt tgtgagcgga 3060 taacaattcc ccatcttagt atattagtta agtataaata cacaaggaga tataccatga 3120 cgcaatttaa tcccgttgat catccacatc gccgctacaa cccgctcacc gggcaatgga 3180 ttctggtttc accgcaccgc gctaagcgcc cctggcaggg ggcgcaggaa acgccagcca 3240 aacaggtgtt acctgcgcac gatccagatt gcttcctctg cgcaggtaat gtgcgggtga 3300 caggcgataa aaaccccgat tacaccggga cttacgtttt cactaatgac tttgcggctt 3360 tgatgtctga cacgccagat gcgccagaaa gtcacgatcc gctgatgcgt tgccagagcg 3420 cgcgcggcac cagccgggtg atctgctttt caccggatca cagtaaaacg ctgccagagc 3480 tcagcgttgc agcattgacg gaaatcgtca aaacctggca ggagcaaacc gcagaactgg 3540 ggaaaacgta cccatgggtg caggtttttg aaaacaaagg cgcggcgatg ggctgctcta 3600 acccgcatcc gcacggtcag atttgggcaa atagcttcct gcctaacgaa gctgagcgcg 3660 aagaccgcct gcaaaaagaa tattttgccg aacagaaatc accaatgctg gtggattatg 3720 ttcagcgcga gctggcagac ggtagccgta ccgttgtcga aaccgaacac tggttagccg 3780 tcgtgcctta ctgggctgcc tggccgttcg aaacgctact gctgcccaaa gcccacgttt 3840 tacggatcac cgatttgacc gacgcccagc gcagcgatct ggcgctggcg ttgaaaaagc 3900 tgaccagtcg ttatgacaac ctcttccagt gctccttccc ctactctatg ggctggcacg 3960 gcgcgccatt taatggcgaa gagaatcaac actggcagct gcacgcgcac ttttatccgc 4020 ctctgctgcg ctccgccacc gtacgtaaat ttatggttgg ttatgaaatg ctggcagaga 4080 cccagcgaga cctgaccgca gaacaggcag cagagcgttt gcgcgcagtc agcgatatcc 4140 attttcgcga atccggagtg taacgcggag gcgcgccatt taaatcaacc tcagcggtca 4200 tagctgtttc ctgtgactga gcaataacta gcataacccc ttggggcctc taaacgggtc 4260 ttgaggggtt ttttgctgaa accaatttgc ctggcggcag tagcgcggtg gtcccacctg 4320 accccatgcc gaactcagaa gtgaaacgcc gtagcgccga tggtagtgtg gggtctcccc 4380 atgcgagagt agggaactgc caggcatcaa ataaaacgaa aggctcagtc gaaagactgg 4440 gcctttcggg atccaggccg gcctgttaac gaattaatct tccgcggcaa caaaaattag 4500 gaattaatca tctggccaat ttcaggtggc acttttcggg cagaccgggg acttatcagc 4560 caacctgt 4568 <210> 33 <211> 6521 <212> DNA <213> Unknown <220> <223> Transposon cassette <400> 33 acaggttggc tgataagtcc ccggtctagc ttgcatgcag attgcagcat tacacgtctt 60 gagcgattgt gtaggctgga gctgcttcga aattaatacg actcactata ggggaattga 120 ttctggtacc aaatgagtcg accggccaga tgattaattc ctaatttttg ttgacactct 180 atcattgata gagttatttt accactccct atcagtgata gagaaaagtg aaatgaatag 240 ttcgacaaaa atctagaaat aattttgttt aactttaaga aggagatata caaatgctga 300 acaacgcgat gtctgttgtt atcctggcgg cgggtaaagg tacccgtatg tactctgacc 360 tgccgaaagt tctgcacacc ctggcgggta aagcgatggt tcagcacgtt atcgacgcgg 420 cgaacgaact gggtgcggcg cacgttcacc tggtttacgg tcacggtggt gacctgctga 480 aacaggcgct gaaagacgac aacctgaact gggttctgca ggcggaacag ctgggtaccg 540 gtcacgcgat gcagcaggcg gcgccgttct tcgcggacga cgaagacatc ctgatgctgt 600 acggtgacgt tccgctgatc tctgttgaaa ccctgcagcg tctgcgtgac gcgaaaccgc 660 agggtggtat cggtctgctg accgttaaac tggacgaccc gaccggttac ggtcgtatca 720 cccgtgaaaa cggtaaagta accggtatcg ttgaacacaa agacgcgacc gacgaacagc 780 gtcagatcca ggagatcaac accggtatcc tgatcgcgaa cggtgcagac atgaaacgtt 840 ggctggcgaa actgaccaac aacaacgcgc agggtgaata ctacatcacc gacatcatcg 900 cgctggcgta ccaggaaggt cgtgaaatcg ttgcggttca cccgcagcgt ctgtctgaag 960 ttgaaggtgt taacaaccgt ctgcagctgt ctcgtctgga acgtgtttac cagtctgaac 1020 aggcggaaaa actgctgctg gcgggtgtta tgctgcgtga cccggcgcgt ttcgacctgc 1080 gtggtaccct gacccacggt cgtgacgttg aaatcgacac caacgttatc atcgaaggta 1140 acgttaccct gggtcaccgt gtaaaaatcg gcaccggttg cgttatcaaa aactctgtta 1200 tcggtgacga ctgcgaaatc tctccgtaca ccgttgttga agacgcgaac ctggcggcgg 1260 cgtgcaccat cggtccgttc gcgcgtctgc gtccgggtgc ggaactgctg gaaggtgcgc 1320 acgttggtaa cttcgttgaa atgaaaaaag cgcgtctggg taaaggttct aaagcgggtc 1380 acctgaccta cctgggtgac gcggaaatcg gtgacaacgt taacatcggt gcgggtacca 1440 tcacctgcaa ctacgacggt gcgaacaaat tcaaaaccat catcggtgac gacgttttcg 1500 ttggttctga cacccagctg gttgcgccgg ttaccgttgg taaaggtgcg accatcgcgg 1560 cgggtaccac cgttacccgt aacgttggtg aaaacgcgct ggcgatctct cgtgttccgc 1620 agacccagaa agaaggttgg cgtcgtccgg ttaaaaaaaa ataacgaagg agatagaacc 1680 atgtccaacc gtaaatactt cggtacggac ggtatccgtg gtcgtgtagg tgatgctccg 1740 attacgccgg atttcgtcct gaaactcggt tgggcagcgg gtaaagttct cgcacgtcac 1800 ggctctcgta aaatcatcat cggtaaagac acccgtatct ctggttacat gctcgaatct 1860 gcactggaag cgggtctggc tgcagctggt ctgtctgcac tgttcacggg tccgatgcca 1920 accccagctg tagcgtacct gactcgcact ttccgtgcag aagcaggtat cgtgatctct 1980 gcctctcaca acccgttcta cgacaacggt atcaaattct tcagcatcga tggtaccaaa 2040 ctcccagacg cggttgaaga ggctatcgaa gcggaaatgg agaaagaaat ctcttgtgta 2100 gactctgccg aactcggtaa agcgtctcgt atcgttgatg cagcgggtcg ttacatcgag 2160 ttctgcaaag ccacctttcc gaacgaactg agcctgtctg agctgaaaat cgtcgtagac 2220 tgtgccaacg gtgcgactta ccacattgcc ccaaacgtac tgcgtgagct gggtgctaac 2280 gtcatcgcga tcggttgtga accgaacggt gtcaacatca acgcggaagt aggtgcgacc 2340 gatgttcgtg cactgcaggc tcgtgtactc gcggagaaag cggatctcgg tatcgccttt 2400 gacggtgatg gtgaccgtgt tatcatggtt gaccacgaag gtaacaaagt ggatggtgac 2460 cagatcatgt acatcattgc ccgtgaaggt ctgcgtcagg gtcagctgcg tggtggtgca 2520 gtaggtaccc tcatgagcaa catgggtctg gaactggccc tgaaacagct gggtatccca 2580 ttcgctcgtg ctaaagtagg cgaccgttac gttctggaga aaatgcagga gaaggttgg cgtatcggtg ccgaaaactc tggtcacgtc atcctgctgg acaaaaccac taccggtgac ggtatcgtag caggtctgca ggtactcgcc gctatggccc gtaaccacat gtccctccat 2760 gacctctgct ctggtatgaa aatgttcccg cagatcctgg ttaacgttcg ttacaccgca ggttctggtg atccgctgga acacgagtct gtgaaagccg ttaccgcaga agtggaagcg gccctgggta accgtggtcg tgtactgctg cgtaaatccg gtactgagcc actgatccgt 2940 gttatggttg agggcgaaga tgaagcccag gtcaccgaat ttgcgcaccg tattgccgac gcagtcaaag cggtttaatt tcgtcgacac acaggaaaca tattaaaaat taaacctgc aggagtttaa acgcggccgc gatatcgttg taaacgacg gccagtgcaa gaatcataaa aaatttattt gctttcagga aaatttttct gtaataga ttcataaatt tgagagagga gtttttgtga gcggataaca attccccatc ttagtatatt agttaagtat aaatacacaa ggagatatac atatgtgcgg tatcgttggt gctatcgcac agcgtgatgt agcggagatc 3300. ctcctggaag gtctgcgtcg tctcgaatac cgtggttacg actctgccgg tctggcagta 3360 gtggatgcag aaggtcacat gactcgtctg cgtcgtctgg gtaaagtgca gatgctcgcg 3420 caggcggcgg aagaacaccc actccacggt ggtacgggta tcgcacacac tcgttgggca 3480 acccacggtg aaccgtctga ggtcaacgca cacccgcatg ttagcgagca catcgtagtc 3540 gttcacaacg gtatcatcga gaaccacgaa ccactccgtg aggaactcaa agcccgtggt 3600 tacaccttcg taagcgaaac cgacacggaa gttatcgccc acctcgttaa ctgggaactc 3660 aaacagggtg gtactctgcg tgaagcagtt ctgcgtgcca ttccacagct gcgtggtgca 3720 tacggtaccg tgatcatgga ctctcgtcat ccggataccc tgctcgccgc acgttctggt 3780 tctccactcg ttatcggtct gggtatgggt gagaacttca tcgcctctga tcagctggcc 3840 ctgctcccag ttacccgtcg cttcatcttc ctggaagagg gtgacatcgc cgaaatcacc 3900 cgtcgttccg ttaacatctt cgacaaaacg ggtgcggaag ttaaacgtca ggacatcgag 3960 tctaacctgc agtatgacgc tggtgacaaa ggcatctacc gtcactacat gcagaaagag 4020 atctacgaac agccgaacgc gatcaaaaac accctgaccg gtcgtatctc tcacggtcag 4080 gttgacctgt ctgagctggg tccaaacgcg gacgaactcc tgtccaaagt cgagcacatc 4140 cagatcctgg cttgtggtac ctcttacaac tccggtatgg tttctcgtta ctggttcgaa 4200 tctctggcag gtatcccatg cgacgttgaa atcgcctccg aattccgtta tcgtaaatct 4260 gcggtacgtc gtaactccct catgatcacc ctgtctcagt ctggtgaaac cgctgatact 4320 ctggcaggtc tgcgtctcag caaagaactg ggttacctgg gttctctggc catctgcaac 4380 gttccgggtt ctagcctggt tcgtgagtct gacctggctc tgatgaccaa cgcgggtacg 4440 gagatcggtg ttgcctctac caaagcgttc actacccagc tcactgtcct gctgatgctg 4500 gttgccaaac tgtctcgtct caaaggcctc gacgctagca tcgaacacga catcgtacac 4560 ggtctgcagg ccctcccatc tcgtatcgag cagatgctgt ctcaggacaa acgtatcgaa 4620 gcactggcag aagacttcag cgacaaacac cacgcgctgt ttctgggtcg tggtgaccag 4680 tacccaattg cgctggaagg tgccctgaaa ctgaaagaga tcagctacat ccatgcagag 4740 gcatacgcag cgggtgagct gaaacatggt ccactggccc tgatcgacgc agatatgccg 4800 gttattgtgg ttgctccgaa caacgaactg ctggagaaac tgaaatccaa catcgaggaa 4860 gtacgtgcgc gtggtggtca gctgtacgtg tttgctgacc aggacgcggg ttcgtttcc 4920 agcgacaaca tgcacatcat cgaaatgccg catgttgaag aggtaatcgc gccaatcttc 4980 tacaccgtac cgctgcagct gctggcgtac catgtagccc tgatcaaagg tacggacgtt 5040 gaccagccgc gtaacctggc gaaatccgtg accgtggaat aacgcggagg cgcgccattt 5100 aaatcaacct cagcggtcat agctgtttcc tgtgactgag caataactag cataacccct 5160 tggggcctct aaacgggtct tgaggggttt ttgctgaaa ccaatttgcc tggcggcagt 5220 agcgcggtgg tcccacctga ccccatgccg aactcagaag tgaaacgccg tagcgccgat 5280 ggtagtgtgg ggtctcccca tgcgagagta gggaactgcc aggcatcaaa taaaacgaaa 5340 ggctcagtcg aaagactggg cctttcggga tccaggccgg cctgttaacg aattaatctt 5400 ccgcggcggt atcgataagc ttgatatcga attccgaagt tcctattctc tagaaagtat 5460 aggaacttca ggtctgaaga ggagtttacg tccagccaag ctagcttggc tgcaggtcgt 5520 cgaaattcta ccgggtaggg gaggcgcttt tcccaaggca gtctggagca tgcgctttag 5580 cagccccgct gggcacttgg cgctacacaa gtggcctctg gcctcgcaca cattccacat 5640 ccaccggtag gcgccaaccg gctccgttct ttggtggccc cttcgcgcca ccttctactc 5700 ctcccctagt caggaagttc ccccccgccc cgcagctcgc gtcgtgcagg acgtgacaaa 5760 tggaagtagc acgtctcact agtctcgtgc agatggacag caccgctgag caatggaagc 5820 gggtaggcct ttggggcagc ggccaatagc agctttgctc cttcgctttc tgggctcaga 5880 ggctgggaag gggtgggtcc gggggcgggc tcaggggcgg gctcaggggc ggggcgggcg 5940 cccgaaggtc ctccggaggc ccggcattct gcacgcttca aaagcgcacg tctgccgcgc 6000 tgttctcctc ttcctcatct ccgggccttt cgacctgcag cctgttgaca attaatcatc 6060 ggcatagtat atcggcatag tataatacga caaggtgagg aactaaacca tgggtcaaag 6120 tagcgatgaa gccaacgctc ccgttgcagg gcagtttgcg cttcccctga gtgccacctt 6180 tggcttaggg gatcgcgtac gcaagaaatc tggtgccgct tggcagggtc aagtcgtcgg 6240 ttggtattgc acaaaactca ctcctgaagg ctatgcggtc gagtccgaat cccacccagg 6300 ctcagtgcaa atttatcctg tggctgcact tgaacgtgtg gcctaatgag gggatcaatt 6360 ctctagagct cgctgatcag aagttcctat tctctagaaa gtataggaac ttcgatggcg 6420 cctcatccct gaagccaata caacaaaaat taggaattaa tcatctggcc aatttcaggt 6480 ggcacttttc gggcagaccg gggacttatc agccaacctg t 6521 <210> 34 <211> 3856 <212> DNA <213> Unknown <220> <223> Transposon cassette <400> 34 acaggttggc tgataagtcc ccggtctgcc cgaaaagtgc cacctgaaat tggccagatg 60 attaattcct aatttttgtt gattctggta ccaaatgagt cgaccggcca gatgattaat 120 tcctaatttt tgttgacact ctatcattga tagagttatt ttaccactcc ctatcagtga 180 tagagaaaag tgaaatgaat agttcgacaa aaatctagaa ataattttgt ttaactttaa 240 gaaggagata tacaaatgct gacggaagtg cgcccggtct ctacgacgaa accgctggtg 300 tctgtgattc tgccggtgaa caaattcaac ccgtatctgg atcgtgcaat tcattcaatc 360 ctgagtcagt cctatccgtc gattgaactg attatcattg caaacaattg caccaatgac 420 tttttcgatg ctctgaaaaa acgtgaatgt gaaaccatta aagtgctgcg cacgaacatc 480 gcgtatctgc cgtactgcct gaataaaggc ctggatctgt gtaacggtga ctttgttgcc 540 cgcatggatt cagatgacat ttcgcacccg gaacgtatcg atcgccaggt cgacttcctg 600 attaacaatc cggacatcga tgtggttggc accaatgcag tctatattga tgaagatgac 660 atcgaactgg aaaaaagcaa cctgccggtg aacaataacg ctattcgtaa aatgctgccg 720 tataaatgct gtctggtgca tccgtctgtt atgtttcgca aaaatgtcgt gatcaccagc 780 ggcggttaca tgttcgcgaa ttattctgaa gattacgaac tgtggaaccg tctggccgtt 840 gaaggccgca atttttataa cctgagcgaa tacctgctgt attaccgtct gcacaataac 900 caatcaacgt cgaaaaataa cctgtttatg gtgatggcga acgatgtcgc cattaaagtg 960 aaatatttcc tgctgaccaa gaaaattagc tacctgctgg gtatcattcg cacggtcttt 1020 tctgtgttct attgcaaata catcaaatga tttcgtcgac acacaggaaa catattaaaa 1080 attaaaacct gcaggagttt aaacgcggcc gcgatatcgt tgtaaaacga cggccagtgc 1140 aagaatcata aaaaatttat ttgctttcag gaaaattttt ctgtataata gattcataaa 1200 tttgagagag gagtttttgt gagcggataa caattcccca tcttagtata ttagttaagt 1260 ataaatacac cgcggaggcg tcgaaggaga tacaaccatg agagttctgg ttaccggtgg 1320 tagcggttac attggaagtc atacctgtgt gcaattactg caaaacggtc atgatgtcat 1380 cattcttgat aacctctgta acagtaagcg cagcgtactg cctgttatcg agcgtttagg 1440 cggcaaacat ccaacgtttg ttgaaggcga tattcgtaac gaagcgttga tgaccgagat 1500 cctgcacgat cacgctatcg acaccgtgat ccacttcgcc gggctgaaag ccgtgggcga 1560 atcggtacaa aaaccgctgg aatattacga caacaatgtc aacggcactc tgcgcctgat 1620 tagcgccatg cgcgccgcta acgtcaaaaa ctttattttt agctcctccg ccaccgttta 1680 tggcgatcag cccaaaattc catacgttga aagcttcccg accggcacac cgcaaagccc 1740 ttacggcaaa agcaagctga tggtggaaca gatcctcacc gatctgcaaa aagcccagcc 1800 ggactggagc attgccctgc tgcgctactt caacccggtt ggcgcgcatc cgtcgggcga 1860 tatgggcgaa gatccgcaag gcattccgaa taacctgatg ccatacatcg cccaggttgc 1920 tgtaggccgt cgcgactcgc tggcgatttt tggtaacgat tatccgaccg aagatggtac 1980 tggcgtacgc gattacatcc acgtaatgga tctggcggac ggtcacgtcg tggcgatgga 2040 aaaactggcg aacaagccag gcgtacacat ctacaacctc ggcgctggcg taggcaacag 2100 cgtgctggac gtggttaatg ccttcagcaa agcctgcggc aaaccggtta attatcattt 2160 tgcaccgcgt cgcgagggcg accttccggc ctactgggcg gacgccagca aagccgaccg 2220 tgaactgaac tggcgcgtaa cgcgcacact cgatgaaatg gcgcaggaca cctggcactg 2280 gcagtcacgc catccacagg gatatcccga ttaacgccat ttaaatcaac ctcagcggtc 2340 atagctgttt cctgtgactg agcaataact agcataaccc cttggggcct ctaaacgggt 2400 cttgaggggt tttttgctga aaccaatttg cctggcggca gtagcgcggt ggtcccacct 2460 gaccccatgc cgaactcaga agtgaaacgc cgtagcgccg atggtagtgt ggggtctccc 2520 catgcgagag tagggaactg ccaggcatca aataaaacga aaggctcagt cgaaagactg 2580 ggcctttcgg gatccaggcc ggcctgttaa cgaattaatc ttccgcggcg gtatcgataa 2640 gcttgatatc gaggctgaca tgggaattag ccatggtcca tatgaatatc ctccttagtt 2700 cctattccga agttcctatt ctctagaaag tataggaact tcggcgcgcc tacctgtgac 2760 ggaagatcac ttcgcagaat aaataaatcc tggtgtccct gttgataccg ggaagccctg 2820 ggccaacttt tggcgaaaat gagacgttga tcggcacgta agaggttcca actttcacca 2880 taatgaaata agatcactac cgggcgtatt ttttgagttg tcgagatttt caggagctaa 2940 ggaagctaaa atggagaaaa aaatcactgg atataccacc gttgatatat cccaatggca 3000 tcgtaaagaa cattttgagg catttcagtc agttgctcaa tgtacctata accagaccgt 3060 tcagctggat attacggcct ttttaaagac cgtaaagaaa aataagcaca agttttatcc 3120 ggcctttatt cacattcttg cccgcctgat gaatgctcat ccggaattac gtatggcaat 3180 gaaagacggt gagctggtga tatgggatag tgttcaccct tgttacaccg ttttccatga 3240 gcaaactgaa acgttttcat cgctctggag tgaataccac gacgatttcc ggcagtttct 3300 acacatatat tcgcaagatg tggcgtgtta cggtgaaaac ctggcctatt tccctaaagg 3360 gtttattgag aatatgtttt tcgtctcagc caatccctgg gtgagtttca ccagttttga 3420 tttaaacgtg gccaatatgg acaacttctt cgcccccgtt ttcaccatgg gcaaatatta 3480 tacgcaaggc gacaaggtgc tgatgccgct ggcgattcag gttcatcatg ccgtttgtga 3540 tggcttccat gtcggcagat gcttaatgaa tacaacagta ctgcgatgag tggcagggcg 3600 gggcgtaagg cgcgccattt aaatgaagtt cctattccga agttcctatt ctctagaaag 3660 tataggaact tcgaagcagc tccagcctac acaatcgctc aagacgtgta atgctgcaat 3720 ctgcatgcaa gcttggcact ggcgatggcg cctcatccct gaagccaata agcagctcca 3780 gcctacacaa tcgctcaaga cgtgtaatgc tgcaatctgc atgcaagcta gaccggggac 3840 ttatcagcca acctgt 3856 <210> 35 <211> 3955 <212> DNA <213> Unknown <220> <223> EZ-Tn5 transposon <400> 35 tggccagatg attaattcct aatttttgtt gacactctat cattgataga gttattttac 60 cactccctat cagtgataga gaaaagtgaa atgaatagtt cgacaaaaat ctagaaataa 120 ttttgtttaa ctttaagaag gagatataca acatgcaaaa actactatct ttaccgtcca 180 atctggttca gtcttttcat gaactggaga gggtgaatcg taccgattgg ttttgtactt 240 ccgacccggt aggtaagaaa cttggttccg gtggtggaac atcctggctg cttgaagaat 300 gttataatga atattcagat ggtgctactt ttggagagtg gcttgaaaaa gaaaaaagaa 360 ttcttcttca tgcgggtggg caaagccgtc gtttacccgg ctatgcacct tctggaaaga 420 ttctcactcc ggttcctgtg ttccggtggg agagagggca acatctggga caaaatctgc 480 tttctctgca acttccccta tatgaaaaaa tcatgtcttt ggctccggat aaactccata 540 cactgattgc gagtggtgat gtctatattc gttcggagaa acctttgcag agtattcccg 600 aagcggatgt ggtttgttat ggactgtggg tagatccgtc tctggctacc catcatggcg 660 tgtttgcttc cgatcgcaaa catcccgaac aactcgactt tatgcttcag aagccttcgt 720 tggcagaatt ggaatcttta tcgaagaccc atttgttcct gatggacatc ggtatatggc 780 ttttgagtga ccgtgccgta gaaatcttga tgaaacgttc tcataaagaa agctctgaag 840 aactaaagta ttatgatctt tattccgatt ttggattagc tttgggaact catccccgta 900 ttgaagacga agaggtcaat acgctatccg ttgctattct gcctttgccg ggaggagagt 960 tctatcatta cgggaccagt aaagaactga tttcttcaac tctttccgta cagaataagg 1020 tttacgatca gcgtcgtatc atgcaccgta aagtaaagcc caatccggct atgtttgtcc 1080 aaaatgctgt cgtgcggata cctctttgtg ccgagaatgc tgatttatgg atcgagaaca 1140 gtcatatcgg accaaagtgg aagattgctt cacgacatat tattaccggg gttccggaaa 1200 atgactggtc attggctgtg cctgccggag tgtgtgtaga tgtggttccg atgggtgata 1260 agggctttgt tgcccgtcca tacggtctgg acgatgtttt caaaggagat ttgagagatt 1320 ccaaaacaac cctgacgggt attccttttg gtgaatggat gtccaaacgc ggtttgtcat 1380 atacagattt gaaaggacgt acggacgatt tacaggcagt ttccgtattc cctatggtta 1440 attctgtaga agagttggga ttggtgttga ggtggatgtt gtccgaaccc gaactggagg 1500 aaggaaagaa tatctggtta cgttccgaac atttttctgc ggacgaaatt tcggcaggtg 1560 ccaatctgaa gcgtttgtat gcacaacgtg aagagttcag aaaaggaaac tggaaagcat 1620 tggccgttaa tcatgaaaaa agtgtttttt atcaacttga tttggccgat gcagctgaag 1680 attttgtacg tcttggtttg gatatgcctg aattattgcc tgaggatgct ctgcagatgt 1740 cacgcatcca taaccggatg ttgcgtgcgc gtattttgaa attagacggg aaagattatc 1800 gtccggaaga acaggctgct tttgatttgc ttcgtgacgg cttgctggac gggatcagta 1860 atcgtaagag taccccaaaa ttggatgtat attccgatca gattgtttgg ggacgtagcc 1920 ccgtgcgcat cgatatggca ggtggatgga ccgatactcc tccttattca ctttattcgg 1980 gaggaaatgt ggtgaatcta gccattgagt tgaacggaca acctccctta caggtctatg 2040 tgaagccgtg taaagacttc catatcgtcc tgcgttctat cgatatgggt gctatggaaa 2100 tagtatctac gtttgatgaa ttgcaagatt ataagaagat cggttcacct ttctctattc 2160 cgaaagccgc tctgtcattg gcaggctttg cacctgcgtt ttctgctgta tcttatgctt 2220 cattagagga acagcttaaa gatttcggtg caggtattga agtgacttta ttggctgcta 2280 ttcctgccgg ttccggtttg ggcaccagtt ccattctggc ttctaccgta cttggtgcca 2340 ttaacgattt ctgtggttta gcctgggata aaaatgagat ttgtcaacgt actcttgttc 2400 ttgaacaatt gctgactacc ggaggtggat ggcaggatca gtatggaggt gtgttgcagg 2460 gtgtgaagct tcttcagacc gaggccggct ttgctcaaag tccattggtg cgttggctac 2520 ccgatcattt atttacgcat cctgaataca aagactgtca cttgctttat tataccggta 2580 taactcgtac ggcaaaaggg atcttggcag aaatagtcag ttccatgttc ctcaattcat 2640 cgttgcatct caatttactt tcggaaatga aggcgcatgc attggatatg aatgaagcta 2700 tacagcgtgg aagttttgtt gagtttggcc gtttggtagg aaaaacctgg gaacaaaaca 2760 aagcattgga tagcggaaca aatcctccgg ctgtggaggc aattatcgat ctgataaaag 2820 attatacctt gggatataaa ttgccgggag ccggtggtgg cgggtactta tatatggtag 2880 cgaaagatcc gcaagctgct gttcgtattc gtaagatact gacagaaaac gctccgaatc 2940 cgcgggcacg ttttgtcgaa atgacgttat ctgataaggg attccaagta tcacgatcat 3000 aataccgttc gtataatgta tgctatacga agttatcgag ctctagagaa tgatcccctc 3060 attaggccac acgttcaagt gcagcgcaca ccgtggaaac ggatgaaggc acgaacccag 3120 ttgacataag cctgttcggt tcgtaaactg taatgcaagt agcgtatgcg ctcacgcaac 3180 tggtccagaa ccttgaccga acgcagcggt ggtaacggcg cagtggcggt tttcatggct 3240 tgttatgact gtttttttgt acagtctatg cctcgggcat ccaagcagca agcgcgttac 3300 gccgtgggtc gatgtttgat gttatggagc agcaacgatg ttacgcagca gcaacgatgt 3360 tacgcagcag ggcagtcgcc ctaaaacaaa gttaggtggc tcaagtatgg gcatcattcg 3420 cacatgtagg ctcggccctg accaagtcaa atccatgcgg gctgctcttg atcttttcgg 3480 tcgtgagttc ggagacgtag ccacctactc ccaacatcag ccggactccg attacctcgg 3540 gaacttgctc cgtagtaaga cattcatcgc gcttgctgcc ttcgaccaag aagcggttgt 3600 tggcgctctc gcggcttacg ttctgcccag gtttgagcag ccgcgtagtg agatctatat 3660 ctatgatctc gcagtctccg gcgagcaccg gaggcagggc attgccaccg cgctcatcaa 3720 tctcctcaag catgaggcca acgcgcttgg tgcttatgtg atctacgtgc aagcagatta 3780 cggtgacgat cccgcagtgg ctctctatac aaagttgggc atacgggaag aagtgatgca 3840 ctttgatatc gacccaagta ccgccaccta acaattcgtt caagccgaga tcgtagaatt 3900 tcgacgacct gcagccaagc ataacttcgt ataatgtatg ctatacgaac ggtag 3955 <210> 36 <211> 7061 <212> DNA <213> Unknown <220> <223> Transposon cassette <400> 36 ggccagatga ttaattccta atttttgttg acactctatc attgatagag ttattttacc 60 actccctatc agtgatagag aaaagtgaaa tgaatagttc gacaaaaatc tagaaataat 120 tttgttaac tttaagaagg agatatacaa tttcgtcgac acacaggaaa catattaaaa 180 attaaaacct gcaggagttt gaaggagata gaaccatggc gcagtcgaaa ctctatccag 240 ttgtgatggc aggtggctcc ggtagccgct tatggccgct ttcccgcgta ctttatccca 300 agcagtttt atgcctgaaa ggcgatctca ccatgctgca aaccaccatc tgccgcctga 360 acggcgtgga gtgcgaaagc ccggtggtga tttgcaatga gcagcaccgc tttattgtcg 420 cggaacagct gcgtcaactg aacaaactta ccgagaacat tattctcgaa ccggcagggc 480 gaaacggc acctgccatt gcgctggcgg cgctggcggc aaaacgtcat agcccggaga 540 gcgaccgtt aatgctggta ttggcggcgg atcatgtgat tgccgatgaa gacgcgttcc 600 gtgccgccgt gcgtaatgcc atgccatatg ccgaagcggg caagctggtg accttcggca 660 ttgtgccgga tctaccagaa accggttatg gctatattcg tcgcggtgaa gtgtctgcgg 720 gtgagcagga tatggtggcc tttgaagtgg cgcagtttgt cgaaaaaccg aatctggaaa 780 ccgctcaggc ctatgtggca agcggcgaat attactggaa cagcggtatg ttcctgttcc 840 gcgccggacg ctatctcgaa gaactgaaaa aatatcgccc ggatatcctc gatgcctgtg 900 aaaaagcgat gagcgccgtc gatccggatc tcaattttat tcgcgtggat gaagagcgt 960 ttctcgcctg cccggagaag tcggtggatt acgcggtcat ggaacgtacg gcagatgctg 1020 ttgtggtgcc gatggatgcg ggctggagcg atgttggctc ctggtcttca ttatgggaga 1080 tcagcgccca caccgccgag ggcaacgttt gccacggcga tgtgattaat caaaaactg 1140 aaaacagcta tgtgtatgct gaatctggcc tggtcaccac cgtcggggtg aaagatctgg 1200 tagtggtgca gaccaaagat gcggtgctga ttgccgaccg taacgcggta caggatgtga 1260 aaaaagtggt cgagcagatc aaagccgatg gtcgccatga gcatcgggtg catcgcgaag 1320 tgtatcgtcc gtggggcaaa tatgactcta tcgacgcggg cgaccgctac caggtgaaac 1380 gcatcaccgt gaaaccgggc gagggcttgt cggtacagat gcaccatcac cgcgcggaac 1440 actgggtggt tgtcgcggga acggcaaaag tcaccattga tggtgatatc aaactgcttg 1500 gtgaaaacga gtccatttat attccgctgg gggcgacgca ttgcctggaa aacccggggga 1560 aaattccgct cgatttaatt gaagtgcgct ccggctctta tctcgaagag gatgatgtgg 1620 tgcgtttcgc ggatcgctac ggacgggtgt aaacgtcgca tcaggcaatg aatgcgaaac 1680 cgcggtgtaa ataacgacaa aaataaaatt ggccgcttcg gtcagggcca actattgcct 1740 gaaaaagggt aacgatatga aaaaattaac ctgctttaaa gcctatgata ttcgcgggaa 1800 attaggcgaa gaactgaatg aagatatcgc ctggcgcatt ggtcgcgcct atggcgaatt 1860 tctcaaaccg aaaaccattg tgttaggcgg tgatgtccgc ctcaccagcg aaaccttaaa 1920 actggcgctg gcgaaaggtt tacaggatgc gggcgttgac gtgctggata ttggtatgtc 1980 cggcaccgaa gagatctatt tcgccacgtt ccatctcggc gtggatggcg gcattgaagt 2040 taccgccagc cataatccga tggattataa cggcatgaag ctggttcgcg agggggctcg 2100 cccgatcagc ggagataccg gactgcgcga cgtccagcgt ctggctgaag ccaacgactt 2160 tcctcccgtc gatgaaacca aacgcggtcg ctatcagcaa atcaacctgc gtgacgctta 2220 cgttgatcac ctgttcggtt atatcaatgt caaaaacctc acgccgctca agctggtgat 2280 caactccggg aacggcgcag cgggtccggt ggtggacgcc attgaagccc gctttaaagc 2340 cctcggcgcg cccgtggaat taatcaaagt gcacaacacg ccggacggca atttccccaa 2400 cggtattcct aacccactac tgccggaatg ccgcgacgac acccgcaatg cggtcatcaa 2460 acacggcgcg gatatgggca ttgcttttga tggcgatttt gaccgctgtt tcctgtttga 2520 cgaaaaaggg cagtttattg agggctacta cattgtcggc ctgttggcag aagcattcct 2580 cgaaaaaaat cccggcgcga agatcatcca cgatccacgt ctctcctgga acaccgttga 2640 tgtggtgact gccgcaggtg gcacgccggt aatgtcgaaa accggacacg cctttattaa 2700 agaacgtatg cgcaaggaag acgccatcta tggtggcgaa atgagcgccc accattactt 2760 ccgtgatttc gcttactgcg acagcggcat gatcccgtgg ctgctggtcg ccgaactggt 2820 gtgcctgaaa gataaaacgc tgggcgaact ggtacgcgac cggatggcgg cgtttccggc 2880 aagcggtgag atcaacagca aactggcgca acccgttgag gcgattaacc gcgtggaaca 2940 gcattttagc cgtgaggcgc tggcggtgga tcgcaccgat ggcatcagca tgacctttgc 3000 ggactggcgc tttaacctgc gcacctccaa taccgaccg gtggtgcgcc tgaatgtgga 3060 atcgcgcggt gatgtgccgc tgatggaagc gcgaacgcga actctgctga cgttgctgaa 3120 cgagtaaaa cgcggccgcg atcgttgt aaacgacgg ccagtgcaag atcataaaa 3180 aatttattg ctttcaggaa aatttctg tataatagat tcataaattt gagagaggag 3240 tttttgtgag cggataacaa ttccccatct tagtatatta gttaagtata atacaccgc 3300 ggaggacgaa ggagatagaa ccatgtcaa agtcgctc atcaccggtg taaccggaca 3360 agacggttct tacctggcag agttctgct ggaaaaggt tacgaggtgc atgtattaa 3420 gcgtcgcgca tcgtcattca acaccgagcg cgtggatcac atttatcagg atccgcacac 3480 ctgcaacccg aaattccatc tgcattatgg cgacctgagt gataccta acctgaccg 3540 cattttgcgt gaagtacagc cggatgaagt gtacaacctg ggcgcaatga gccacgttgc 3600 ggtctctttt gagtcaccag atataccgc tgacgtcgac gcgatgggta cgctgcgcct 3660 gctggaggcg atccgcttcc tcggtctgga aagaaaact cgtttctatc aggcttccac 3720 ctctgaactg tatggtctgg tgcaggaaat tccgcagaaa gagaccacgc cgttctaccc 3780 gcgatctccg tatgcggtcg ccaaactgta cgcctactgg atcaccgtta actaccgtga 3840 atcctacggc atgtacgcct gtaacggaat tctcttcaac catgaatccc cgcgccgcgg 3900 cgaaaccttc gttacccgca aaatcacccg cgcaatcgcc aacatcgccc aggggctgga 3960 gtcgtgcctg tacctcggca atatggattc cctgcgtgac tggggccacg ccaaagacta 4020 cgtaaaaatg cagtggatga tgctgcagca ggaacagccg gaagatttcg ttatcgcgac 4080 cggcgttcag tactccgtgc gtcagttcgt ggaaatggcg gcagcacagc tgggcatcaa 4140 actgcgcttt gaaggcacgg gcgttgaaga gaagggcatt gtggtttccg tcaccgggca 4200 tgacgcgccg ggcgttaaac cgggtgatgt gattatcgct gttgacccgc gttacttccg 4260 tccggctgaa gttgaaacgc tgctcggcga cccgaccaaa gcgcacgaaa aactgggctg 4320 gaaaccggaa atcaccctca gagagatggt gtctgaaatg gtggctaatg acctcgaagc 4380 ggcgaaaaaa cactctctgc tgaaatctca cggctacgac gtggcgatcg cgctggagtc 4440 ataagcatga gtaaacaacg agtttttat gctggtcatc gcgggatggt cggttccgcc 4500 atcaggcggc agctcgaaca gcgcggtgat gtggaactgg tattacgcac ccgcgacgag 4560 ctgaacctgc tggacagccg cgccgtgcat gatttctttg ccagcgaacg tattgaccag 4620 gtctatctgg cggcggcgaa agtgggcggc attgttgcca acaacaccta tccggcggat 4680 ttcatctacc agaacatgat gattgagagc aacatcattc acgccgcgca tcagaacgac 4740 gtgaacaaac tgctgtttct cggatcgtcc tgcatctacc cgaaactggc aaaacagccg 4800 atggcagaaa gcgagttgtt gcagggcacg ctggagccga ctaacgagcc ttatgctatt 4860 gccaaaatcg ccgggatcaa actgtgcgaa tcatacaacc gccagtacgg acgcgattac 4920 cgctcagtca tgccgaccaa cctgtacggg ccacacgaca acttccaccc gagtaattcg 4980 catgtgatcc cagcattgct gcgtcgcttc cacgaggcga cggcacagaa tgcgccggac 5040 gtggtggtat ggggcagcgg tacaccgatg cgcgaatttc tgcacgtcga tgatatggcg 5100 gcggcgagca ttcatgtcat ggagctggcg catgaagtct ggctggagaa cacccagccg 5160 atgttgtcgc acattaacgt cggcacgggc gttgactgca ctatccgcga gctggcgcaa 5220 accatcgcca aagtggtggg ttacaaaggc cgggtggttt ttgatgccag caaaccggat 5280 ggcacgccgc gcaaactgct ggatgtgacg cgcctgcatc agcttggctg gtatcacgaa 5340 atctcactgg aagcggggct tgccagcact taccagtggt tccttgagaa tcaagaccgc 5400 tttcgggggg ggagctaacg cgccatttaa atcaacctca gcggtcatag ctgtttcctg 5460 tgactgagca ataactagca taaccccttg gggcctctaa acgggtcttg aggggttttt 5520 tgctgaaacc aatttgcctg gcggcagtag cgcggtggtc ccacctgacc ccatgccgaa 5580 ctcagaagtg aaacgccgta gcgccgatgg tagtgtgggg tctccccatg cgagagtagg 5640 gaactgccag gcatcaaata aaacgaaagg ctcagtcgaa agactgggcc tttcgggatc 5700 caggccggcc tgttaacgaa ttaatcttcc gcggcgctga aaccaatttg cctggcggca 5760 gtagcgcggt ggtcccacct gaccccatgc cgaactcaga agtgaaacgc cgtagcgccg 5820 atggtagtgt ggggtctccc catgcgagag tagggaactg ccaggcatca aataaaacga 5880 aaggctcagt cgaaagactg ggcctttcgg gatccaggcc ggcctgttaa cgaattaatc 5940 ttccgcggcg gtatcgataa gcttgatatc gaattccgaa gttcctattc tctagaaagt 6000 ataggaactt caggtctgaa gaggagttta cgtccagcca agctagcttg gctgcaggtc 6060 gtcgaaattc tacgatctcg gcttgaacga attgttaggt ggcggtactt gggtcgatat 6120 caaagtgcat cacttcttcc cgtatgccca actttgtata gagagccact gcgggatcgt 6180 caccgtaatc tgcttgcacg tagatcacat aagcaccaag cgcgttggcc tcatgcttga 6240 ggagattgat gagcgcggtg gcaatgccct gcctccggtg ctcgccggag actgcgagat 6300 catagatata gatctcacta cgcggctgct caaacctggg cagaacgtaa gccgcgagag 6360 cgccaacaac cgcttcttgg tcgaaggcag caagcgcgat gaatgtctta ctacggagca 6420 agttcccgag gtaatcggag tccggctgat gttgggagta ggtggctacg tctccgaact 6480 cacgaccgaa aagatcaaga gcagcccgca tggatttgac ttggtcaggg ccgagcctac 6540 atgtgcgaat gatgcccata cttgagccac ctaactttgt tttagggcga ctgccctgct 6600 gcgtaacatc gttgctgctg cgtaacatcg ttgctgctcc ataacatcaa acatcgaccc 6660 acggcgtaac gcgcttgctg cttggatgcc cgaggcatag actgtacaaa aaaacagtca 6720 taacaagcca tgaaaaccgc cactgcgccg ttaccaccgc tgcgttcggt caaggttctg 6780 gaccagttgc gtgagcgcat acgctacttg cattacagtt tacgaaccga acaggcttat 6840 gtcaactggg ttcgtgcctt catccgtttc cacggtgtgc gctgcacttg aacgtgtggc 6900 ctaatgaggg gatcaattct ctagagctcg ctgatcagaa gttcctattc tctagaaagt 6960 ataggaactt cgatggcgcc tcatccctga agccaatagg gataacaggg taatgatcgg 7020 atcccgggcc cgtcgactgc agaggcctgc atgcaagctt g 7061 <210> 37 <211> 4187 <212> DNA <213> Unknown <220> <223> Transposon <400> 37 cacaggttgg ctgataagtc cccggtctag cttgcatgca gattgcagca ttacacgtct 60 tgagcgattg tgtaggctgg agctgctcaa gcccgtcagg gcgcgtcagc gggtgttggc 120 gggtgtcggg gctggcttaa ctatgcggca tcagagcaga ttgtactgag agtgcaccat 180 atgcggtgtg aaataccgca cagatgcgta aggagaaaat accgcatcag gcgccattcg 240 ccattcaggc tgcgcaactg ttgggaaggg cgatcggtgc gggcctcttc gctattacgc 300 cagctggcga aagggggatg tgctgcaagg cgattaagtt gggtaacgcc agggttttcc 360 cagtcacgac gttgtaaaac gacggccagt gaattcgagc tcggtacctc gcgaatgcat 420 ctagattgta aaacgacggc cagtgaattc ccttagggat aacagggtaa ttacggcccc 480 aaggtccaaa cggtgaaggt accgggcccc ccctcgaggt cgaggtaccc aaatatgcat 540 aatcgaaatt aatacgactc actatagggg aattgattct ggtaccaaat gagtcgaccg 600 gccagatgat taattcctaa tttttgttga cactctatca ttgatagagt tattttacca 660 ctccctatca gtgatagaga aaagtgaaat gaatagttcg acaaaaatct agaaataatt 720 ttgtttaact ttaagaagga gatatacaat ttcgtcgaca cacaggaaac atattaaaaa 780 ttaaaacctg caggagttta aacgcggccg cgatatcgtt gtaaaacgac ggccagtgca 840 agaatcataa aaaatttatt tgctttcagg aaaatttttc tgtataatag attcataaat 900 ttgagagagg agtttttgtg agcggataac aattccccat cttagtatat tagttaagta 960 taaatacacc gcggaggcgt cgaaggagat acaaccatgc aaaaccacgt tatcagctta 1020 gcttccgccg cagaacgcag ggcgcacatt gccgatacct tcggcaggca cggcatcccg 1080 tttcagtttt tcgacgcact gatgccgtct gaaaggctgg aacaggcaat ggcggaactc 1140 gtccccggct tgtcggcgca cccctatttg agcggagtgg aaaaagcctg ctttatgagc 1200 cacgccgtat tgtggaagca ggcattggac gaaggtctgc cgtatatcac cgtatttgag 1260 gacgacgttt tactcggcga aggtgcggaa aaattccttg ccgaagacgc ttggctgcaa 1320 gaacgctttg acccggatac cgcctttatc gtccgcttgg aaacgatgtt tatgcacgtc 1380 ctgacctcgc cctccggcgt ggcggattac tgcgggcgcg cctttccgct gttggaaagc 1440 gaacactggg ggacggcggg ctatatcatt tcccgaaaag cgatgcggtt tttcctggac 1500 aggtttgccg ccctgccgcc cgaagggctg caccccgtcg atctgatgat gttcagcgat 1560 tttttcgaca gggaaggaat gccggtttgc cagctcaatc ccgccttgtg cgcccaagag 1620 ctgcattatg ccaagtttca cgaccaaaac agcgcattgg gcagcctgat cgaacacgac 1680 cgcctcctga accgcaaaca gcaaaggcgc gattcccccg ccaacacatt caaacaccgc 1740 ctgatccgcg ccttgaccga tatcagcagg gaaagggaaa aacgccggca aaggcgcgaa 1800 cagttcattg tgcctttcca ataacgccat ttaaatcaac ctcagcggtc atagctgttt 1860 cctgtgactg agcaataact agcataaccc cttggggcct ctaaacgggt cttgaggggt 1920 tttttgctga aaccaatttg cctggcggca gtagcgcggt ggtcccacct gaccccatgc 1980 cgaactcaga agtgaaacgc cgtagcgccg atggtagtgt ggggtctccc catgcgagag 2040 tagggaactg ccaggcatca aataaaacga aaggctcagt cgaaagactg ggcctttcgg 2100 gatccaggcc ggcctgttaa cgaattaatc ttccgcggcg gtatcgataa gcttgatatc 2160 gacactacca tcatgtatga atatcctcct tagttcctat tccgaagttc ctattctcta 2220 gaaagtatag gaacttcggc gacgtctaag aaaccattat tatcatgaca ttaacctata 2280 aaaataggcg tatcacgagg ccctttcgtc ttcaagaatt ctcatgtttg acagcttatc 2340 atcgataagc tttaatgcgg tagtttatca cagttaaatt gctaacgcag tcaggcaccg 2400 tgtatgaaat ctaacaatgc gctcatcgtc atcctcggca ccgtcaccct ggatgctgta 2460 ggcataggct tggttatgcc ggtactgccg ggcctcttgc gggatatcgt ccattccgac 2520 agcatcgcca gtcactatgg cgtgctgcta gcgctatatg cgttgatgca atttctatgc 2580 gcacccgttc tcggagcact gtccgaccgc tttggccgcc gcccagtcct gctcgcttcg 2640 ctacttggag ccactatcga ctacgcgatc atggcgacca cacccgtcct gtggatcctc 2700 tacgccggac gcatcgtggc cggcatcacc ggcgccacag gtgcggttgc tggcgcctat 2760 atcgccgaca tcaccgatgg ggaagatcgg gctcgccact tcgggctcat gagcgcttgt 2820 ttcggcgtgg gtatggtggc aggccccgtg gccgggggac tgttgggcgc catctccttg 2880 catgcaccat tccttgcggc ggcggtgctc aacggcctca acctactact gggctgcttc 2940 ctaatgcagg agtcgcataa gggagagcgt cgaccgatgc ccttgagagc cttcaaccca 3000 gtcagctcct tccggtgggc gcggggcatg actatcgtcg ccgcacttat gactgtcttc 3060 tttatcatgc aactcgtagg acaggtgccg gcagcgctct gggtcatttt cggcgaggac 3120 cgctttcgct ggagcgcgac gatgatcggc ctgtcgcttg cggtattcgg aatcttgcac 3180 gccctcgctc aagccttcgt cactggtccc gccaccaaac gtttcggcga gaagcaggcc 3240 attatcgccg gcatggcggc cgacgcgctg ggctacgtct tgctggcgtt cgcgacgcga 3300 ggctggatgg ccttccccat tatgattctt ctcgcttccg gcggcatcgg gatgcccgcg 3360 ttgcaggcca tgctgtccag gcaggtagat gacgaccatc agggacagct tcaaggatcg ctcgcggctc ttaccagcct aacttcgatc attggaccgc tgatcgtcac ggcgatttat 3480. gccgcctcgg cgagcacatg gaacggggttg gcatggattg taggcgccgc cctatacctt 3540 gtctgcctcc ccgcgttgcg tcgcggtgca tggagccggg ccacctcgac ctgagtggca 3600 gggcggggcg taaggcgcgc catttaaatg aagttcctat tccgaagttc ctattctcta 3720. gtgtaatgct cctacacaat cgctcaagac gtgtaatgct gcaatctgca tgcaagcttg gcactgggat ggcgcctcat ccctgaagcc aatagggata 3780 acagggtaat aagcttggcg taatcatgtc atgatcggat cccgggcccg tcgactgcag 3840 aggcctgcat gcaagcttgg cgtaatcatg gtcatagctg tttcctgtgt gaaattgtta 3900 tccgctcaca attccacaca acatacgagc cggaagcata aagtgtaaag cctggggtgc 3960 ctaatgagtg agctaactca cattaattgc gttgcgctca ctgcccgctt tccagtcggg 4020 aaacctgtcg tgccagctgc attaatgaat cggccaacgc gcggggagag gcggtttgcg 4080 tattgggcgc tcttccgctt cctcgccaac aaaaattagg aattaatcat ctggccaatt 4140 tcaggtggca cttttcgggc agaccgggga cttatcagcc aacctgt 4187 <210> 38 <211> 5011 <212> DNA <213> Unknown <220> <223> Transposon <400> 38 acaggttggc tgataagtcc ccggtctgcc cgaaaagtgc cacctgaaat tggccagatg 60 attaattcct aatttttgtt gattctggta ccaaatgagt cgaccggcca gatgattaat 120 tcctaatttt tgttgacact ctatcattga tagagttatt ttaccactcc ctatcagtga 240. scientist agttcgacaa scientist scientist gaggagata tacaatga aatcgaga ggtaactgg taatctggat taacggcgat aaaggctata acggtctcgc tgaagtcggt aagaaattcg agaagatac cggaattaaa gtcaccgttg agcatccgga taactgga gagaattcc cacaggttgc ggcaactggc gatggccctg acattatctt ctgggcacac gaccgctttg gtggctacgc tcaatctggc 480 ctgttggctg aaatcacccc ggacaaagcg ttccaggaca agctgtatcc gtttacctgg 540 gatgccgtac gttacaacgg caagctgatt gcttacccga tcgctgttga agcgttatcg ctgatttata acaaagatct gctgccgaac ccgccaaaaa cctgggaaga gatccccggcg ctggataag aactgaaagc gaaggtaag agcgcgctga tgttcaacct gcaagaaccg tacttcacct ggccgctgat tgctgctgac gggggttatg cgttcaagta tgaaaacggc 780 aagtacgaca ttaaagacgt gggcgtggat aacgctggcg cgaaagcggg tctgaccttc ctggttgacc tgattaaaaa caaacacatg aatgcagaca ccgattactc catcgcagaa 900 gctgccttta ataaaggcga aacagcgatg accatcaacg gcccgtgggc atggtccaac 960 atcgacacca gcaaagtgaa ttatggtgta acggtactgc cgaccttcaa gggtcaacca 1020 tccaaaccgt tcgttggcgt gctgagcgca ggtattaacg ccgccagtcc gaacaaagag 1080 ctggcaaaag agttcctcga aaactatctg ctgactgatg aaggtctgga agcggttaat 1140 aaagacaaac cgctgggtgc cgtagcgctg aagtcttacg aggaagagtt ggcgaaagat 1200 ccacgtattg ccgccactat ggaaaacgcc cagaaaggtg aaatcatgcc gaacatcccg 1260 cagatgtccg ctttctggta tgccgtgcgt actgcggtga tcaacgccgc cagcggtcgt 1320 cagactgtcg atgaagccct gaaagacgcg cagactatgc acttcattga aaacaaaaac 1380 ttcgtcatct ccattccgac cgcagacaaa cgccgtaatc acatcatcca acagttcggc 1440 caaaagaaaa ttccgtttga atttttcgat gccttcaccc cgagcgaacg tctgaacgac 1500 catctgcagc gctatctgcc gaatgtcgca gcaaccccgc gtctgacgat gggtgaaaaa 1560 ggttgcctga tgtctcactt tatgctgtgg aaaaaatgtg ttgatgacgg cctggattac 1620 attaccctgt ttgaagatga catcctgctg ggtgaaaacg cggaacaatt cctggccgaa 1680 gacgaatggc tgaaagtgcg ttttaatttc caggaaatct ttgttctgcg cctggaaacc 1740 ttcctgatgc cggtgaaaat tgaaaaacag caaggcatcc tgccgtttca gcaacgcgaa 1800 atcgatatcc tgaaatcaaa acatttcggc acggcaggtt atgttatttc gcacggtgca 1860 gctaaatacc tgatcgaagt cttcgaaaaa ttcagctctg aagaagtgaa accgattgat 1920 gaaatcatgt ttaaccagct gattgacatc tccggctatc aggtttacca actgaatccg 1980 gctatttgcg tccaggaact gcaactgaac caggaaaata gtgtgctgga atccggtctg 2040 cagaaagagc gtaagaaaaa caccgttagc cataccaaga aaaccctgaa atatcgtctg 2100 acgcgcatga aagaaaacat cctgcgcgca ctgaataaaa agaaatggga agaacgccaa 2160 tacatcaaag gtctgcaagg caaaaatatc atcctgttta tctagtttcg tcgacacaca 2220 ggaaacatat taaaaattaa aacctgcagg agtttaaacg cggccgcgat atcgttgtaa 2280 aacgacggcc agtgcaagaa tcataaaaaa tttatttgct ttcaggaaaa tttttctgta 2340 taataagattc ataaatttga gagaggtt tttgtgagcg gataacaatt ccccatctta 2400 gtatattagt tagtataaa tacaccgcgg aggcgtcgaa ggagatacaa ccatgagagt 2460 tctggttacc ggtggtagcg gttacattgg aagtcatacc tgtgtgcaat tactgcaaaa 2520 cggtcatgat gtcatcattc ttgataacct ctgtaacagt aagcgcagcg tactgcctgt 2580 tatcgagcgt ttaggcggca aacatccaac gtttgttgaa ggcgatattc gtaacgaagc 2640 gttgatgacc gagatcctgc acgatcacgc tatcgacacc gtgatccact tcgccgggct 2700 gaaagccgtg ggcgaatcgg tacaaaaacc gctggaatat tacgacaaca atgtcaacgg 2760 cactctgcgc ctgattagcg ccatgcgcgc cgctaacgtc aaaaacttta tttttagctc 2820 ctccgccacc gtttatggcg atcagcccaa aattccatac gttgaaagct tcccgaccgg 2880 cacaccgcaa agcccttacg gcaaaagcaa gctgatggtg gaacagatcc tcaccgatct 2940 gcaaaaagcc cagccggact ggagcattgc cctgctgcgc tacttcaacc cggttggcgc 3000 gcatccgtcg ggcgatatgg gcgaagatcc gcaaggcatt ccgaataacc tgatgccata 3060 catcgcccag gttgctgtag gccgtcgcga ctcgctggcg atttttggta acgattatcc 3120 gaccgaagat ggtactggcg tacgcgatta catccacgta atggatctgg cggacggtca 3180 cgtcgtggcg atggaaaaac tggcgaacaa gccaggcgta cacatctaca acctcggcgc 3240 tggcgtaggc aacagcgtgc tggacgtggt taatgccttc agcaaagcct gcggcaaacc 3300 ggttaattat cattttgcac cgcgtcgcga gggcgacctt ccggcctact gggcggacgc 3360 cagcaaagcc gaccgtgaac tgaactggcg cgtaacgcgc acactcgatg aaatggcgca 3420 ggacacctgg cactggcagt cacgccatcc acagggatat cccgattaac gccatttaaa 3480 tcaacctcag cggtcatagc tgtttcctgt gactgagcaa taactagcat aaccccttgg 3540 ggcctctaaa cgggtcttga ggggtttttt gctgaaacca atttgcctgg cggcagtagc 3600 gcggtggtcc cacctgaccc catgccgaac tcagaagtga aacgccgtag cgccgatggt 3660 agtgtggggt ctccccatgc gagagtaggg aactgccagg catcaaataa aacgaaaggc 3720 tcagtcgaaa gactgggcct ttcgggatcc aggccggcct gttaacgaat taatcttccg 3780 cggcggtatc gataagcttg atatcgaggc tgacatggga attagccatg gtccatatga 3840 atatcctcct tagttcctat tccgaagttc ctattctcta gaaagtatag gaacttcggc 3900 gcgcctacct gtgacggaag atcacttcgc agaataaata aatcctggtg tccctgttga 3960 taccgggaag ccctgggcca acttttggcg aaaatgagac gttgatcggc acgtaagagg 4020 ttccaacttt caccataatg aaataagatc actaccgggc gtattttttg agttgtcgag 4080 attttcagga gctaaggaag ctaaaatgga gaaaaaaatc actggatata ccaccgttga 4140 tatatcccaa tggcatcgta aagaacattt tgaggcattt cagtcagttg ctcaatgtac 4200 ctataaccag accgttcagc tggatattac ggccttttta aagaccgtaa agaaaaataa 4260 gcacaagttt tatccggcct ttattcacat tcttgcccgc ctgatgaatg ctcatccgga 4320 attacgtatg gcaatgaaag acggtgagct ggtgatatgg gatagtgttc acccttgtta 4380 caccgttttc catgagcaaa ctgaaacgtt ttcatcgctc tggagtgaat accacgacga 4440 tttccggcag tttctacaca tatattcgca agatgtggcg tgttacggtg aaaacctggc 4500 ctatttccct aaagggttta ttgagaatat gtttttcgtc tcagccaatc cctgggtgag 4560 tttcaccagt tttgatttaa acgtggccaa tatggacaac ttcttcgccc ccgttttcac 4620 catgggcaaa tattatacgc aaggcgacaa ggtgctgatg ccgctggcga ttcaggttca 4680 tcatgccgtt tgtgatggct tccatgtcgg cagatgctta atgaatacaa cagtactgcg 4740 atgagtggca gggcggggcg taaggcgcgc catttaaatg aagttcctat tccgaagttc 4800 ctattctcta gaaagtatag gaacttcgaa gcagctccag cctacacaat cgctcaagac 4860 gtgtaatgct gcaatctgca tgcaagcttg gcactggcga tggcgcctca tccctgaagc 4920 caataagcag ctccagccta cacaatcgct caagacgtgt aatgctgcaa tctgcatgca 4980 agctagaccg gggacttatc agccaacctg t 5011 <210> 39 <211> 2984 <212> DNA <213> Unknown <220> <223> Transposon <400> 39 tggccagatg attaattcct aatttttgtt gacactctat cattgataga gttattttac 60 cactccctat cagtgataga gaaaagtgaa atgaatagtt cgacaaaaat ctagaaataa 120 ttttgtttaa cttaagaag gagatataca agagctcgag tcgaaggaga tagaaccatg 180 ggaaacacat caatacaaac gcagagttac cgtgcggtag ataaagatgc agggcaaagc 240 agaagttaca ttattccatt cgcgctgctg tgctcactgt ttttctttg ggcggtagcc 300 aataacctta acgacatttt attacctcaa ttccagcagg cttttacgct gacaaatttc 360 caggctggcc tgatccaatc ggccttttac tttggttatt tcattatccc aatccctgct 420 gggatattga tgaaaaaact cagttataaa gcagggatta ttaccgggtt atttttatat 480 gccttgggtg ctgcattatt ctggcccgcc gcagaaataa tgaactacac cttgttttta 540 gttggcctat ttattattgc agccggatta ggttgtctgg aaactgccgc aaaccctttt 600 gttacggtat tagggccgga aagtagtggt cacttccgct taaatcttgc gcaaacattt 660 aactcgtttg gcgcaattat cgcggttgtc tttgggcaaa gtcttatttt gtctaacgtg 720 ccacatcaat cgcaagacgt tctcgataaa atgtctccag agcaattgag tgcgtataaa 780 cacagcctgg tattatcggt acagacacct tatatgatca tcgtggctat cgtgttactg 840 gtcgccctgc tgatcatgct gacgaaattc ccggcattgc agagtgataa tcacagtgac 900 gccaaacaag gatcgttctc cgcatcgctt tctcgcctgg cgcgtattcg ccactggcgc 960 tgggcggtat tagcgcaatt ctgctatgtc ggcgcacaaa cggcctgctg gagctatttg 1020 attcgctacg ctgtagaaga aattccaggt atgactgcag gctttgccgc taactattta 1080 accggaacca tggtgtgctt ctttattggt cgtttcaccg gtacctggct catcagtcgc 1140 ttcgcaccac acaaagtcct ggccgcctac gcattaatcg ctatggcact gtgcctgatc 1200 tcagccttcg ctggcggtca tgtgggctta atagccctga ctttatgcag cgcctttatg 1260 tcgattcagt acccaacaat cttctcgctg ggcattaaga atctcggcca ggacaccaaa 1320 tatggttcgt ccttcatcgt tatgaccatt attggcggcg gtattgtcac tccggtcatg 1380 ggttttgtca gtgacgcggc gggcaacatc cccactgctg aactgatccc cgcactctgc 1440 ttcgcggtca tctttatctt tgcccgtttc cgttctcaaa cggcaactaa ctgataaatc 1500 gatactagca taaccccttg gggcctctaa acgcgtcgac acgcaaaaag gccatccgtc 1560 aggatggcct tctgcttaat ttgatgcctg gcagtttatg gcgggcgtcc tgcccgccac 1620 cctccgggcc gttgcttcgc aacgttcaaa tccgctcccg gcggatttgt cctactcagg 1680 agagcgttca ccgacaaaca acagataaaa cgaaaggccc agtctttcga ctgagccttt 1740 cgttttattt gatgcctggc agttccctac tctcgcatgg ggagacccca cactaccatc 1800 ggatccaggc cggcctgtta acgaattaat cttccgcggc ggtatcgata agcttgatgg 1860 cgaaaggggg atgtgctgca aggcgattaa gttgggtaac gccagggttt tcccagtcac 1920 gacgttgtaa aacgacggcc agtgaattcg agctcggtac ctaccgttcg tataatgtat 1980 gctatacgaa gttatcgagc tctagagaat gatccctaaa tgcttcaata atattgaaaa 2040 aggaagagta tgagggaagc ggtgatcgcc gaagtatcga ctcaactatc agaggtagtt 2100 ggcgtcatcg agcgccatct cgaaccgacg ttgctggccg tacatttgta cggctccgca 2160 gtggatggcg gcctgaagcc acacagtgat attgatttgc tggttacggt gaccgtaagg 2220 cttgatgaaa caacgcggcg agctttgatc aacgaccttt tggaaacttc ggcttcccct 2280 ggagagagcg agattctccg cgctgtagaa gtcaccattg ttgtgcacga cgacatcatt 2340 ccgtggcgtt atccagctaa gcgcgaactg caatttggag aatggcagcg caatgacatt 2400 cttgcaggta tcttcgagcc agccacgatc gacattgatc tggctatctt gctgacaaaa 2460 gcaagagaac atagcgttgc cttggtaggt ccagcggcgg aggaactctt tgatccggtt 2520 cctgaacagg atctatttga ggcgctaaat gaaaccttaa cgctatggaa ctcgccgccc 2580 gactgggctg gcgatgagcg aaatgtagtg cttacgttgt cccgcatttg gtacagcgca 2640 gtaaccggca aaatcgcgcc gaaggatgtc gctgccgact gggcaatgga gcgcctgccg 2700 gcccagtatc agcccgtcat acttgaagct agacaggctt atcttggaca agaagaagat 2760 cgcttggcct cgcgcgcaga tcagttggaa gaatttgtcc actacgtgaa aggcgagatc 2820 accaaggtag tcggcaaata atagcgggac tctgggaatt tcgacgacct gcagccaagc 2880 ataacttcgt ataatgtatg ctatacgaac ggtaggatcc tctagagtcg acctgcaggc 2940 atgcaagctt ggcgtaatca tggtcatagc tgtttcctgt gtga 2984 <210> 40 <211> 4259 <212> DNA <213> Unknown <220> <223> GalETKM operon containing a 19bp chimeric end recognition site for EZ-Tn5 transposase at its 5' end <400> 40 ttactcagca ataaactgat attccgtcag gctggaatac tcttcgccag gacgcaggaa 60 gcagtccggt tgcggccatt cagggtggtt cgggctgtcc ggtagaaact cgctttccag 120 agccagccct tgccagtcgg cgtaaggttc ggttccccgc gacggtgtgc cgccgaggaa 180 gttgccggag tagaattgca gagccggagc ggtggtgtag accttcagct gcaatttttc 240 atctgctgac cagacatgcg ccgccacttt cttgccatcg cctttggcct gtaacaagaa 300 tgcgtgatcg taacctttca ctttgcgctg atcgtcgtcg gcaagaaact cactggcgat 360 gattttggcg ctgcggaaat caaaagacgt tccggcgaca gatttcaggc cgtcgtgcgg 420 aatgccgcct tcatcaaccg gcagatattc gtccgccaga atctgcaact tgtgattgcg 480 cacgtcagac tgctcgccgt caagattgaa atagacgtga ttagtcatat tcaccgggca 540 aggtttatca actgtggcgc gataagtaat ggagatacgg ttatcgtcgg tcagacgata 600 ttgcaccgtc gcgccgagat tacccgggaa gccctgatca ccatcatctg aactcagggc 660 aaacagcacc tgacgatcgt tctggttcac aatctgccag cgacgtttgt cgaacccttc 720 cggcccgccg tgcagctggt taacgccctg acttggcgaa agcgtcacgg tttcaccgtc 780 aaaggtataa cggctattgg cgatacggtt ggcataacga ccaatagagg cccccagaaa 840 cgcggcctga tcctgatagc attccgggct ggcacagccg agcagcgcct cgcggacgct 900 gccatcggaa agcggaatac gggcggaaag taaagtcgca ccccagtcca tcagcgtgac 960 taccatccct gcgttgttac gcaaagttaa cagtcggtac ggctgaccat cgggtgccag 1020 tgcgggagtt tcgttcagca ctgtcctgct ccttgtgatg gtttacaaac gtaaaaagtc 1080 tctttaatac ctgtttttgc ttcatattgt tcagcgacag cttgctgtac ggcaggcacc 1140 agctcttccg ggatcagcgc gacgatacag ccgccaaatc cgccgccggt catgcgtacg 1200 ccacctttgt cgccaatcac agctttgacg atttctacca gagtgtcaat ttgcggcacg 1260 gtgatttcga aatcatcgcg catagaggca tgagactccg ccatcaactc gcccatacgt 1320 ttcaggtcgc cttgctccag cgcgctggca gcttcaacgg tgcgggcgtt ttcagtcagt 1380 atatgacgca cgcgttttgc cacgatcggg tccagttcat gcgcaacagc gttgaactct 1440 tcaatggtga catcacgcag ggctggctgc tggaagaaac gcgcaccggt ttcgcactgt 1500 tcacgacggg tgttgtattc gctgccaacc agggtacgtt tgaagttact gttgatgatg 1560 acgacagcca cacctttggg catggaaact gctttggtcc ccagtgagcg gcaatcgatc 1620 agcaaggcat gatctttctt gccgagcgcg gaaattagct gatccatgat cccgcagtta 1680 cagcctacaa actggttttc tgcttcctga ccgttaagcg cgatttgtgc gccgtccagc 1740 ggcagatgat aaagctgctg caatacggtt ccgaccgcga cttccagtga agcggaagaa 1800 cttaacccgg caccctgcgg cacattgccg ctgatcacca tgtccacgcc gccgaagctg 1860 ttgttacgca gttgcagatg tttcaccacg ccacgaacgt agttagccca ttgatagttt 1920 tcatgtgcga caatgggcgc atcgagggaa aactcgtcga gctgattttc ataatcggct 1980 gccatcacgc gaactttacg gtcatcgcgt ggtgcacaac tgatcacggt ttgataatca 2040 atcgcgcagg gcagaacgaa accgtcgttg tagtcggtgt gttcaccaat caaattcacg 2100 cggccaggcg cctgaatggt gtgagtggca gggtagccaa atgcgttggc aaacagagat 2160 tgtgtttttt ctttcagact catttcttac actccggatt cgcgaaaatg gatatcgctg 2220 actgcgcgca aacgctctgc tgcctgttct gcggtcaggt ctcgctgggt ctctgccagc 2280 atttcataac caaccataaa tttacgtacg gtggcggagc gcagcagagg cggataaaag 2340 tgcgcgtgca gctgccagtg ttgattctct tcgccattaa atggcgcgcc gtgccagccc 2400 atagagtagg ggaaggagca ctggaagagg ttgtcataac gactggtcag ctttttcaac 2460 gccagcgcca gatcgctgcg ctgggcgtcg gtcaaatcgg tgatccgtaa aacgtgggct 2520 ttgggcagca gtagcgtttc gaacggccag gcagcccagt aaggcacgac ggctaaccag 2580 tgttcggttt cgacaacggt acggctaccg tctgccagct cgcgctgaac ataatccacc 2640 agcattggtg atttctgttc ggcaaaatat tctttttgca ggcggtcttc gcgctcagct 2700 tcgttaggca ggaagctatt tgcccaaatc tgaccgtgcg gatgcgggtt agagcagccc 2760 atcgccgcgc ctttgttttc aaaaacctgc acccatgggt acgttttccc cagttctgcg 2820 gtttgctcct gccaggtttt gacgatttcc gtcaatgctg caacgctgag ctctggcagc 2880 gttttactgt gatccggtga aaagcagatc acccggctgg tgccgcgcgc gctctggcaa 2940 cgcatcagcg gatcgtgact ttctggcgca tctggcgtgt cagacatcaa agccgcaaag 3000 tcattagtga aaacgtaagt cccggtgtaa tcggggtttt tatcgcctgt cacccgcaca 3060 ttacctgcgc agaggaagca atctggatcg tgcgcaggta acacctgttt ggctggcgtt 3120 tcctgcgccc cctgccaggg gcgcttagcg cggtgcggtg aaaccagaat ccattgcccg 3180 gtgagcgggt tgtagcggcg atgtggatga tcaacgggat taaattgcgt catggtcgtt 3240 ccttaatcgg gatatccctg tggatggcgt gactgccagt gccaggtgtc ctgcgccatt 3300 tcatcgagtg tgcgcgttac gcgccagttc agttcacggt cggctttgct ggcgtccgcc 3360 footggccg gaaggtcgcc ctcgcgacgc ggtgcaaaat gataattaac cggtttgccg 3420 caggctttgc tgaaggcatt aaccacgtcc agcacgctgt tgcctacgcc agcgccgagg 3480 ttgtagatgt gtacgcctgg cttgttcgcc agtttttcca tcgccacgac gtgaccgtcc 3540 gccagatcca ttacgtggat gtaatcgcgt acgccagtac catcttcggt cggataatcg 3600 ttaccaaaaa tcgccagcga gtcgcgacgg cctacagcaa cctgggcgat gtatggcatc 3660 aggttattcg gaatgccttg cggatcttcg cccatatcgc ccgacggatg cgcgccaacc 3720 gggttgaagt agcgcagcag ggcaatgctc cagtccggct gggctttttg cagatcggtg 3780 aggatctgtt ccaccatcag cttgcttttg ccgtaagggc tttgcggtgt gccggtcggg 3840 aagctttcaa cgtatggaat tttgggctga tcgccataaa cggtggcgga ggagctaaaa 3900 ataaagtttt tgacgttagc ggcgcgcatg gcgctaatca ggcgcagagt gccgttgaca 3960 ttgttgtcgt aatattccag cggtttttgt accgattcgc ccacggcttt cagcccggcg 4020 aagtggatca cggtgtcgat agcgtgatcg tgcaggatct cggtcatcaa cgcttcgtta 4080 cgaatatcgc cttcaacaaa cgttggatgt ttgccgccta aacgctcgat aacaggcagt 4140 acgctgcgct tactgttaca gaggttatca agaatgatga catcatgacc gttttgcagt 4200 aattgcacac aggtatgact tccaatgtaa ccgctaccac cggtaaccag aactctcat 4259 <210> 41 <211> 6021 <212> DNA <213> unknown <220> <223> Contains the codon-optimized Bbhl gene for E. coli under the control of the Ptet promoter and an expression construct conferring bleomycin resistance <400> 41 tttccccgaa aagtgccacc tgaaattggc cagatgatta attcctaatt tttgttgaca 60 ctctatcatt gatagagtta ttttaccact ccctatcagt gatagagaaa agtgaaatga 120 atagttcgac aaaaatctag aaataatttt gtttaacttt aagaaggaga tatacaaatg 180 agcgatgata acctggccct gaaccagacc gtgaccgcaa gcagctatga agtggcaacg 240 accgcaccgg aaaaagccgt ggatggcgat ctgggtacgc gttggggtac cgcccagaac 300 aaagcggcca atgaatggat tgaagtcggc ctgggcggta ccaaaacggt gaaacagatc 360 aacatcgatt tcgaacgtaa agacgcggat caaaatatca ccagcttcaa agttgaactg 420 aaacagggtg acacctatac gaaagtgtac caaaaagata cccgcgccaa acagcaagaa 480 attatcctgc tggatcaggc acagcaagca agtgctgtta aagtcacggt gctgtccgcc 540 gatggcggta ccatgaactg ggttaatgtc ggtattaacg aaatctccgt ttattcagcc 600 ccgaaagaaa ccgtcctgga caccgcagat acgaaccata tgctgggcgc taccatgacg 660 gcgagctcta atgaaaccgc tacgctgacc ccggacaaag cgattgatca gaaccgtacc 720 ggtcgcaaca atcgttgggc gagtggctat gaaaccccgt ccaatatctg gctgaaagcc 780 gaatttccgc gtctgaccgc agtgaaagac attcgtatct atttctttga acgcgatgtc 840 aacccgaaac cgacgaatgt gcagtcgttc gacctgagct acaccgattc tgaaggtacc 900 gaacacacgc tgaaaagcgg ctatgccatg accgcatctg gcgctggtta cgttgccgac 960 gtggttattc aactggatca ggcggtgaac gcccgcagtc tgaaactgtc caacttcgca 1020 atcaaaagtt ccgaatacaa caatgtgtca gttgccgaat gggaagcata ctcgaacgat 1080 caggctgaac cgggtgcaac cctggactcg gtcgtgagcg atctggaaag caatcatctg 1140 accattgaaa cggacaccga tacgctggca ctgccgacgg tgccggatgg ttataccgtt 1200 aaatttaacg gcgcagacta cgaacagctg atcgcagctg atggtacggt gaatcacccg 1260 ctggttgaca aaaccgtcca ggtggcttat gttgtcaccg atacggcgac cggcaacacc 1320 aaaaccacga gcgacattcc gtacgtggtt aaaggtacca atcagcaaca ggaaggcaac 1380 aatgctaaac cgacgattat cccggaaatc gcggaatggc attctaccag tgcggccaaa 1440 ctggcagctt cagcggtgac caaagtcgtg tatgatgacg attcgctgaa agccgttgtc 1500 gatgaatttg ttgcagacta caaagatttc acgggcatta aactgaccgc caaaaaaggc 1560 gcggccgaag cgggtgcctt taatttcgtg aaaaccgaca gcacggcagc tattgcgcag 1620 ctgggcgatg aaggttatac catggacatc cgcgctgatc gtgtggttgc gaaatcatcg 1680 agcgtgaccg gtaacatgta cgctatgcaa acgattctgc agatgaccaa acaagatgcg 1740 aatggctttg ttatcggtag catgcgcgac tatccgcgtt tcaccacgcg tggtctgctg 1800 ctggatgtcg cacgtaaacc ggtgtctctg gaaatgatgc gcgaaattac gcgcaccatg 1860 cgttattaca aaatgaacga ctttcaggcg cacctgtctg ataactatat cttcctggaa 1920 aattacggca aaggtgacaa cgaagatgaa gcatttaaag cttatgatgc gttccgtctg 1980 gaatctagtc tgacgaatga caaaggtgaa agtccgaccg cagaagatta ctccatcagc 2040 aagaaaacct tcaaacaatt catccaggat gaacgcgcgc tgggcatgaa cgtcgtgccg 2100 gaaattgatg tgccggcaca tgctaatagc tttaccaaaa tctggccgga actgatggtg 2160 aaaggccgtg tctcaccgat taactcgaat cgcccgctga tcgaccacct ggatgttagt 2220 aaaccggaaa ccatcgcgaa aatcaaagaa atcttcgacg attacacgaa aggtgacgat 2280 ccgaccttcg actccgatac cacggttcat attggcgccg atgaatttct gtataactac 2340 accgcatatc gtaaattcat caatgaaatt gtgccgtaca ttaaagatac gaacaccgtt 2400 cgcatgtggg gcggtctgac ctggatcaat gaccataaaa ccgaaatcac gaaagatgca 2460 atcgaaaacg tggaaatgaa tctgtggtca aaagactggg cggatggtct gcagatgtat 2520 aatatgggct acaaactgat caacaccatt gacgattatg gttacatggt gccgaatggc 2580 tcttatggtc gtgcgaacgc ctacggcgac ctgctgaata ttagccgtgt ctttgattct 2640 ttcgaaccga acaaagtgcg ctcctcaggc ggttatcagg cggttccgag cggcgacgat 2700 caaatgctgg gtgcggcctt tgctatttgg agtgacaata tcgataaatc ggcgagcggt 2760 ctgaccgaat ccgacctgta ttggcgcttt ttcgatgcca tgccgtttta cgcagaaaaa 2820 acgtgggcag ctaccggcaa agaaaagggt acggcggcca aactgaccgc actggcagct 2880 aaacagggca cgggtccgcg taccaacccg tattaccaag cgacctctaa aaatagtgtg 2940 tatgaaagct acgactttaa cgatggcctg gcagatgctt ctggcaatgg tcgcgacctg 3000 accattggcg atggtagcaa agcggccgtt aaagatcagt ctctgaaact ggctggcggt 3060 tcgagctatg cgaccagcaa actggataaa ctgggcaacg gtaatgaact gacgtttgac 3120 gtgaccctgc aacaggcagc taaaccgggt gacattctgt tcgaagcgga tgccccgtat 3180 ggcacccatg atatccgtgt tatggaaaac ggcaaactgg gttttacccg cgaactgtac 3240 aactactact tcgattacga actgccggtc ggtaaaacgg ttaccgtcac gattaagtg 3300 gatcacaga ccacgaaact gtatgttgac ggcgaatttg tcagtgatgc gaccggcaaa 3360 tacatcgata aaggtacga aaagaaaacc ggtattacgg cagcaacctt cgcactgccg 3420 ctgcagcgca tcggttccaa aacctcagca atcaacggcg tgatcgataa cgtgatcgtt 3480 aaaaaatctg aagccgaac ggatcagtat aaaaagtt gctggaccgg taccacgaat 3540 tccgaaacgc atataacga caccgaaggc ctgctgcgtt acgcgttttga taacaatccg 3600 agtaccattt ggcactccaa ctggaaggt gcgacggata aactgaccgg ctctaatagt 3660 ttctatgccg aaattgatat gtgtcagaaa tacaccatca atcaatttag cttcacgccg 3720 cgtacctcgc aggacagcgg tcaagttacc aaagcggatc tgtacgtca agcaacgct 3780 aatgacgaat ggaaacaggt ggccaccgat caagttttg aagccctcg tgcgaagaaa 3840 acctttatgt tcgatgaaca ggaagttcgc tatgtcaaat tcgtggcgaa atctagtaac 3900 gatggttggg tcgctgtgtc agaatttggc gtggcgaata aaccgtccctc aaccgttcgt 3960 gtcttcgtgg cagctgatcc ggcagaaggc ggtaccgttt cggtcgcagc agaaggtgaa 4020 accggtacgg acaccgccgt ggatgttgct tctggcgcga gtgtcaccgc gaaagccgtg 4080 gcagctgatg gctatcgctt tagtggttgg ttcaccacgg cctcagaaac ggcagtgtcg 4140 accgacgcga cgtacacctt tgcggccgat ggtaacacgg ccctgaccgc aaaattcacg 4200 aaagactcca ccccggatcc gggtccgaaa ccgacgatct cgagcattgc cgttaccaaa 4260 ccgacggtca ccgattataa agtgggtgac acgtttgatg caaccggtct ggccgtgacg 4320 gcaaccatgt ccgatggttc aacgaaaacc ctgacggccg gcgaatacac gctgagcgca 4380 acccaggacg gtgcagctgt tgcactggat aaagcatttg ctaaagcggg taaagtcacc 4440 gtgacggtta ccgctaatgg caaaacggcg accttcgatg tcacggtgac cgctaaagac 4500 ccggatccgg aaccggcgac gctgaaaagc attaaagtta cctctaaacc ggacaaaacc 4560 acgtatacgg tggatgaaac ctttgccaaa acgggcctgg cagttacggg tacctggtca 4620 gacggcaaaa ccgcgctgct gaaagatggt gaatacaaac tgtcggccgt ggacgcagat 4680 4740. ggtaaaaccg ttgacctgac gaaccgttt accgcggccg gtgatgttac ggtcaccgtg acgtcaggca aactgaccga ttcgttcacc atcacggtta aagccaaaac cgtcacgccg gcaccgggtg aatacaaacc gggcgaaaat aaaccgggtg cggataacc gaaccgaat acgccggacg aagtcgcaaa aacgggtgcc tcagtgtgag cggccgcgtc gacacgcaaa aaggccatcc gtcaggatgg ccttctgctt aatttgatgc ctggcagttt atggcgggcg 4980. tcctgcccgc caccctccgg gccgttgctt cgcaacgttc aaatccgctc ccggcggatt 5040 tgtcctactc aggagagcgt tcaccgacaa acaacagata aaacgaaagg cccagtcttt cgactgagcc tttcgtttta tttgatgcct ggcagttccc tactctcgca tggggagacc 5160 5220. ccacactacc atcatgtatg aatatcctcc ttagttccta ttccgaaggg taatggcatc agggaatggc gaacgcgctc cccacactac catcatgtat gaatcctc cttagttcct attccgaagt tcctattctc tagaaagtat aggaacttcg gtggaacgac gcgtaactca cgttaaggga ttttggtcat gatcagcacg tgttgacaat taatcatcgg catagtatat cggcatagta taatacgaca aggtgaggaa ctaaaccatg gccaagttga ccagtgccgt 5460 tccggtgctc accgcgcgcg acgtcgccgg agcggtcgag ttctggaccg accggctcgg 5520 gttctcccgg gacttcgtgg aggacgactt cgccggtgtg gtccgggacg acgtgaccct 5580 gttcatcagc gcggtccagg accaggtggt gccggacaac accctggcct gggtgtgggt 5640 gcgcggcctg gacgagctgt acgccgagtg gtcggaggtc gtgtccacga acttccggga 5700 cgcctccggg ccggccatga ccgagatcgg cgagcagccg tgggggcggg agttcgccct 5760 gcgcgacccg gccggcaact gcgtgcactt cgtggccgag gagcaggact gagtggcagg 5820 gcggggcgta aggcgcgcca tttaaatgaa gttcctattc cgaagttcct attctctaga 5880 aagtatagga acttcgaagc agctccagcc tacacaatcg ctcaagacgg aacccgcgct 5940 tggcaggaaa gtaataggga tagcagctcc agcctacaca atcgctcaag acgtgtaatg 6000 ctgcacaata accctgctgc a 6021 <210> 42 <211> 4543 <212> DNA <213> Unknown <220> <223> Transposon cassette <400> 42 ggccagatga ttaattccta atttttgttg acactctatc attgatagag ttattttacc 60 actccctatc agtgatagag aaaagtgaaa tgaatagttc gacaaaaatc tagaaataat 120 tttgtttaac tttaagaagg agatatacaa atgaccatga ttacggattc actggccgtc 180 gttttacaac gtcgtgactg ggaaaaccct ggcgttaccc aacttaatcg ccttgcagca 240 catccccct tcgccagctg gcgtaatagc gaagaggccc gcaccgatcg cccttcccaa 300 cagttgcgca gcctgaatgg cgaatggcgc tttgcctggt ttccggcacc agaagcggtg 360 ccggaaagct ggctggagtg cgatcttcct gaggccgata ctgtcgtcgt cccctcaaac 420 tggcagatgc acggttacga tgcgcccatc tacaccaacg tgacctatcc cattacggtc 480 aatccgccgt ttgttcccac ggagaatccg acgggttgtt actcgctcac atttaatgtt 540 gatgaaagct ggctacagga aggccagacg cgaattattt ttgatggcgt taactcggcg 600 ttcatctgt ggtgcaacgg gcgctgggtc ggttacggcc aggacagtcg tttgccgtct 660 gaatttgacc tgagcgcatt tttacgcgcc ggagaaaacc gcctcgcggt gatggtgctg 720 cgctggagtg acggcagtta tctggaagat caggatatgt ggcggatgag cggcattttc 780 cgtgacgtct cgttgctgca taaaccgact acacaaatca gcgatttcca tgttgccact 840 cgctttaatg atgatttcag ccgcgctgta ctggaggctg aagttcagat gtgcggcgag 900 ttgcgtgact acctacgggt aacagtttct ttatggcagg gtgaaacgca ggtcgccagc 960 ggcaccgcgc ctttcggcgg tgaaattatc gatgagcgtg gtggttatgc cgatcgcgtc 1020 acactacgtc tgaacgtcga aaacccgaaa ctgtggagcg ccgaaatccc gaatctctat 1080 cgtgcggtgg ttgaactgca caccgccgac ggcacgctga ttgaagcaga agcctgcgat 1140 gtcggtttcc gcgaggtgcg gattgaaaat ggtctgctgc tgctgaacgg caagccgttg 1200 ctgattcgag gcgttaaccg tcacgagcat catcctctgc atggtcaggt catggatgag 1260 cagacgatgg tgcaggatat cctgctgatg aagcagaaca actttaacgc cgtgcgctgt 1320 1380 gtggatgaag ccaatattga aacccacggc atggtgccaa tgaatcgtct gaccgatgat 1440 ccgcgctggc taccggcgat gagcgaacgc gtaacgcgaa tggtgcagcg cgatcgtaat 1500 cacccgagtg tgatcatctg gtcgctgggg aatgaatcag gccacggcgc taatcacgac 1560 gcgctgtatc gctggatcaa atctgtcgat ccttcccgcc cggtgcagta tgaaggcggc 1620 ggagccgaca ccacggccac cgatattatt tgcccgatgt acgcgcgcgt ggatgaagac 1680 cagcccttcc cggctgtgcc gaaatggtcc atcaaaaaat ggctttcgct acctggagag 1740 acgcgcccgc tgatcctttg cgaatacgcc cacgcgatgg gtaacagtct tggcggtttc 1800 gctaaatact ggcaggcgtt tcgtcagtat ccccgtttac agggcggctt cgtctgggac 1860 tgggtggatc agtcgctgat taaatatgat gaaaacggca acccgtggtc ggcttacggc 1920 ggtgattttg gcgatacgcc gaacgatcgc cagttctgta tgaacggtct ggtctttgcc 1980 gaccgcacgc cgcatccagc gctgacggaa gcaaaacacc agcagcagtt tttccagttc 2040 cgtttatccg ggcaaaccat cgaagtgacc agcgaatacc tgttccgtca tagcgataac 2100 gagctcctgc actggatggt ggcgctggat ggtaagccgc tggcaagcgg tgaagtgcct 2160 ctggatgtcg ctccacaagg taaacagttg attgaactgc ctgaactacc gcagccggag 2220 agcgccgggc aactctggct cacagtacgc gtagtgcaac cgaacgcgac cgcatggtca 2280 gaagccggac acatcagcgc ctggcagcag tggcgtctgg ctgaaaacct cagcgtgaca 2340 ctccccgccg cgtcccacgc catcccgcat ctgaccacca gcgaaatgga tttttgcatc 2400 gagctgggta ataagcgttg gcaatttaac cgccagtcag gctttctttc acagatgtgg 2460 attggcgata aaaaacaact gctgacgccg ctgcgcgatc agttcacccg tgcaccgctg 2520 gataacgaca ttggcgtaag tgaagcgacc cgcattgacc ctaacgcctg ggtcgaacgc 2580 tggaaggcgg cgggccatta ccaggccgaa gcagcgttgt tgcagtgcac ggcagataca 2640 cttgctgatg cggtgctgat tacgaccgct cacgcgtggc agcatcaggg gaaaacctta 2700 tttatcagcc ggaaaaccta ccggattgat ggtagtggtc aaatggcgat taccgttgat 2760 gttgaagtgg cgagcgatac accgcatccg gcgcggattg gcctgaactg ccagctggcg 2820 caggtagcag agcgggtaaa ctggctcgga ttagggccgc aagaaaacta tcccgaccgc 2880 cttactgccg cctgttttga ccgctgggat ctgccattgt cagacatgta taccccgtac 2940 gtttcccga gcgaaaacgg tctgcgctgc gggacgcgcg aattgaatta tggcccacac 3000 cagtggcgcg gcgacttcca gttcaacatc agccgctaca gtcaacagca actgatggaa 3060 accagccatc gccatctgct gcagcgggaa gaaggcacat ggctgaatat cgacggtttc 3120 catatgggga ttggtggcga cgactcctgg agccccgtcag tatcggcgga attccagctg 3180 agcgccggtc gctaccatta ccagttggtc tggtgtcaaa ataaataa ctagcataac 3240 cccttggggc ctctaaacgg gtcttgaggg gttttttgct gaaaccaatt tgcctggcgg 3300 footgcgcg gtggtcccac ctgaccccat gccgaactca gaagtgaaac gccgtagcgc 3360 3420 gaaaggctca gtcgaaagac tgggcctttc gggatccagg ccggcctgtt aacgaattaa 3480 tcttccgcgg cggtatcgat aagcttgata tcgaattccg aagttcctat tctctagaaa 3540 gtataggaac ttcaggtctg aagaggagtt tacgtccagc caagctagct tggctgcagg 3600 tcgtcgaaat tctacgatct cggcttgaac gaattgttag gtggcggtac ttgggtcgat atcaaagtgc atcacttctt cccgtatgcc caactttgta tagagagcca ctgcgggatc 3720. gtcaccgtaa tctgcttgca cgtagatcac ataagcacca agcgcgttgg cctcatgctt gaggagattg atgagcgcgg tggcaatgcc ctgcctccgg tgctcgccgg agactgcgag 3840 atcatagata tagatctcac tacgcggctg ctcaaacctg ggcagaacgt aagccgcgag agcgccaaca accgcttctt ggtcgaaggc agcaagcgcg atgaatgtct tactacggag caagttcccg aggtaatcgg agtccggctg atgttggggag taggtggcta cgtctccgaa 4080. ctcacgaccg aaaagatcaa gagcagcccg catggatttg acttggtcag ggccgagcct acatgtgcga atgatgccca tacttgagcc acctaacttt gttttagggc gactgccctg ctgcgtaaca tcgttgctgc tgcgtaacat cgttgctgct ccataacatc aaacatcgac ccacggcgta acgcgcttgc tgcttggatg cccgaggcat agactgtaca aaaaaacagt 4260 4320. cataacaagc catgaaaacc gccactgcgc cgttaccacc gctgcgttcg gtcaaggttc tggaccagtt gcgtgagcgc atacgctact tgcattacag tttacgaacc gaacaggctt 4380 atgtcaactg ggttcgtgcc ttcatccgtt tccacggtgt gcgctgcact tgaacgtgtg 4440 gcctaatgag gggatcaatt ctctagagct cgctgatcag aagttcctat tctctagaaa 4500 gtataggaac ttcgatggcg cctcatccct gaagccaata ggg 4543 <210> 43 <211> 5692 <212> DNA <213> Unknown <220> <223> Transposon cassette <400> 43 ggccagatga ttaattccta atttttgttg acactctatc attgatagag ttattttacc 60 actccctatc agtgatagag aaaagtgaaa tgaatagttc gacaaaaatc tagaaataat 120 tttgtttaac tttaagaagg agatatacaa atggaacatc gtgccttcaa atggccgcaa 180 ccgctggctg gtaataaacc gcgcatctgg tatggtggtg actataaccc ggatcaatgg 240 ccggaagaag tctgggatga agacgtggca ctgatgcagc aagctggcgt gaacctggtg 300 agtgttgcga tttttagctg ggccaaactg gaaccggaag aaggtgtgta tgatttcgac 360 tggctggatc gtgttattga caaactgggc aaagcgggta tcgccgttga tctggcctca 420 ggtaccgcat cgccgccgat gtggatgacc caggcgcatc cggaaatcct gtgggtggat 480 tatcgtggcg acgtttgtca gccgggtgcc cgtcaacact ggcgtgccac cagcccggtg 540 tttctggatt acgcgctgaa cctgtgtcgc aaaatggccg aacattataa agataatccg 600 tacgtggtta gctggcatgt ttctaacgaa tatggctgcc acaatcgttt tgattactca 660 gaagacgcag aacgcgcttt ccagaaatgg tgtgagaaaa aatatggcac gattgatgca 720 gtgaatgacg cttggggtac cgcgttttgg gcccaacgta tgaacaattt ctcggaaatt 780 atcccgccgc gcttcatcgg cgatggtaac tttatgaatc cgggtaaact gctggattgg 840 aaacgtttta gctctgatgc gctgctggac ttctataaag cggaacgcga tgccctgctg 900 gaaattgcac cgaaaccgca gaccacgaac tttatggtct ctgcgggctg cacggtgctg 960 gattacgaca aatggggtca tgatgttgac ttcgtcagca atgatcatta tttttctccg 1020 ggcgaagcac acttcgatga aatggcttac gcggcatgtc tgaccgatgg tattgcccgt 1080 aaaaacccgt ggttcctgat ggaacatagt acgtccgccg tgaactggcg tccgaccaat 1140 tatcgcctgg aaccgggcga actggttcgt gatagcctgg cacacctggc tatgggtgcg 1200 gacgccattt gctactttca gtggcgccaa tcaaaagcag gcgctgaaaa atggcattcg 1260 gcaatggttc cgcacgctgg tccggattct cagatcttcc gcgacgtctg tgaactgggc 1320 gcggatctga ataaactggc cgacgaaggt ctgctgagta ccaaactggt gaaatccaaa 1380 gtggcgattg tttttgatta tgaaagtcag tgggccaccg aacataccgc aacgccgacc 1440 caagaagtgc gtcactggac cgaaccgctg gattggtttc gtgccctggc ggataatggt 1500 ctgaccgccg atgttgtgcc ggttcgcggt ccgtgggatg aatatgaagc cgttgtcctg 1560 ccgtcactgg caattctgtc ggaacaaacc acgcgtcgcg ttcgtgaata cgtcgccaat 1620 ggcggtaaac tgtttgtgac gtattacacc ggcctggttg atgaccgcga tcatgtctgg 1680 ctgggcggtt atccgggcag catccgtgat gtggttggtg tccgcgtgga agaatttgca 1740 ccgatgggca cggatgctcc gggtaccatg gaccatctgg atctggacaa cggtaccgtg 1800 gcacacgatt tcgctgacgt gattacgagc gttgcggata ccgcccacgt cgtggcgtct 1860 tttaaagccg ataaatggac gggcttcgac ggtgcaccgg ctatcaccgt caatgatttt 1920 ggcgacggta aagcggctta cgtgggtgcc cgtctgggtc gtgaaggtct ggcaaaaagt 1980 ctgccggctc tgctggaaga actgggcatt gaaaccagcg ccgaagatga ccgtggtgaa 2040 gtcctgcgtg tggaacgcgc agatgaaacg ggcgaaaacc attttgtgtt cctgtttaat 2100 cgcacccacg atgttgccgt tgtcgacgtc gaaggtgaac cgctggttgc aagcctggct 2160 caggtcaatg aaagtgaaca caccgctgct atccaaccga acggcgtgct ggtcgtcaaa 2220 ctgtaaacta gcataacccc ttggggcctc taaacgggtc ttgaggggtt ttttgctgaa 2280 accaatttgc ctggcggcag tagcgcggtg gtcccacctg accccatgcc gaactcagaa 2340 gtgaaacgcc gtagcgccga tggtagtgtg gggtctcccc atgcgagagt agggaactgc 2400 caggcatcaa ataaaacgaa aggctcagtc gaaagactgg gcctttcggg atccaggccg 2460 gcctgttaac gaattaatct tccgcggcgg tatcgataag cttgatggcg aaagggggat 2520 gtgctgcaag gcgattaagt tgggttaacgc cagggttttc ccagtcacga cgttgtaaaa 2580 cgacggccag tgaattcgag ctcggtacct accgttcgta taatgtatgc tatacgaagt 2640 tatcgagctc tagagaatga tcccctcctg ccactcatcg cagtactgtt gtattcatta 2700 agcatctgcc gacatggaag ccatcacaaa cggcatgatg aacctgaatc gccagcggca 2760 tcagcacctt gtcgccttgc gtataatatt tgcccatggt gaaaacgggg gcgaagaagt 2820 tgtccatatt ggccacgttt aaatcaaaac tggtgaaact cacccaggga ttggctgaga 2880 cgaaaaacat attctcaata aaccctttag ggaaataggc caggttttca ccgtaacacg 2940 ccacatcttg cgaatatatg tgtagaaact gccggaaatc gtcgtggtat tcactccaga 3000 gcgatgaaaa cgtttcagtt tgctcatgga aaacggtgta acaagggtga acactatccc 3060 atatcaccag ctcaccgtct ttcattgcca tacgtaattc cggatgagca ttcatcaggc 3120 gggcaagaat gtgaataaag gccggataaa acttgtgctt attttcttt acggtcttta 3180 aaaaggccgt aatatccagc tgaacggtct ggttataggt acattgagca actgactgaa 3240 atgcctcaaa atgttcttta cgatgccatt gggatatatc aacggtggta tatccagtga 3300 ttttttctc cattttagct tccttagctc ctgaaaatct cgacaactca aaaaatacgc 3360 ccggtagtga tcttatttca ttatggtgaa agttggaacc tcttacgtgc cgatcaacgt 3420 ctcatttcg ccaaaagttg gcccagggct tcccggtatc aacagggaca ccaggattta 3480 tttattctgc gaagtgatct tccgtcacag gtagaatttc gacgacctgc agccaagcat 3540 aacttcgtat aatgtatgct atacgaacgg taggatcctc tagagtcgac ctgcaggcat 3600 gatgtatgaa tatcctcctt agttcctatt ccgaagttcc tattctctag aaagtatagg 3660 aacttcggcg acgtctaaga aaccattatt atcatgacat taacctataa aaataggcgt 3720 atcacgaggc cctttcgtct tcaagaattc tcatgtttga cagcttatca tcgataagct 3780 ttaatgcggt agtttatcac agttaaattg ctaacgcagt caggcaccgt gtatgaaatc 3840 taacaatgcg ctcatcgtca tcctcggcac cgtcaccctg gatgctgtag gcataggctt 3900 ggtatgccg gtactgccgg gcctcttgcg ggatatcgtc cattccgaca gcatcgccag 3960 tcactatggc gtgctgctag cgctatatgc gttgatgcaa tttctatgcg cacccgttct 4020 cggagcactg tccgaccgct ttggccgccg cccagtcctg ctcgcttcgc tacttggagc 4080 cactatcgac tacgcgatca tggcgaccac acccgtcctg tggatcctct acgccggacg 4140 catcgtggcc ggcatcaccg gcgccacagg tgcggttgct ggcgcctata tcgccgacat 4200 caccgatggg gaagatcggg ctcgccactt cgggctcatg agcgcttgtt tcggcgtggg 4260 tatggtggca ggccccgtgg ccgggggact gttgggcgcc atctccttgc atgcaccatt 4320 ccttgcggcg gcggtgctca acggcctcaa cctactactg ggctgcttcc taatgcagga 4380 gtcgcataag ggagagcgtc gaccgatgcc cttgagagcc ttcaacccag tcagctcctt 4440 ccggtgggcg cggggcatga ctatcgtcgc cgcacttatg actgtcttct ttatcatgca 4500 actcgtagga caggtgccgg cagcgctctg ggtcattttc ggcgaggacc gctttcgctg 4560 gagcgcgacg atgatcggcc tgtcgcttgc ggtattcgga atcttgcacg ccctcgctca 4620 agccttcgtc actggtcccg ccaccaaacg tttcggcgag aagcaggcca ttatcgccgg 4680 catggcggcc gacgcgctgg gctacgtctt gctggcgttc gcgacgcgag gctggatggc 4740 cttccccatt atgattcttc tcgcttccgg cggcatcggg atgcccgcgt tgcaggccat 4800 gctgtccagg caggtagatg acgaccatca gggacagctt caaggatcgc tcgcggctct 4860 taccagccta acttcgatca ctggaccgct gatcgtcacg gcgatttatg ccgcctcggc 4920 gagcacatgg aacgggttgg catggattgt aggcgccgcc ctataccttg tctgcctccc 4980 cgcgttgcgt cgcggtgcat ggagccgggc cacctcgacc tgagtggcag ggcggggcgt 5040 aaggcgcgcc atttaaatga agttcctatt ccgaagttcc tattctctag aaagtatagg 5100 aacttcgaag cagctccagc ctacacaatc gctcaagacg tgtaatgctg caatctgcat 5160 gcaagcttgg cactggccac gcaaaaaggc catccgtcag gatggccttt tgcttaattt 5220 gatgcctggc agtttatggc gggcgtcctg cccgccaccc tccgggccgt tgcttcgcaa 5280 cgttcaaatc cgctcccggc ggatttgtcc tactcaggag agcgttcacc gaaaaac 5340 agataaaacg aaaggcccag tctttcgact gagcctttcg ttttatttga tgcctggcag 5400 ttccctactc tcgcatgggg agaccccaca ctaccatcgg ggggccatcg atgcaggtgg 5460 cacttttcgg ggaaatgtgc gcggaacccc tatttgttta tttttctaaa tacattcaaa 5520 tatgtatccg ctcatgagac aataaccctg ctgcagaggc ctgcatgcaa gcttggcgta 5580 atcatggtca tagctgtttc ctgtgtgaaa ttgttatccg ctcacaattc cacacaacat 5640 acgagccgga agcataaagt gtaaagcctg gggtgcctaa tgagtgagct aa 5692 <210> 44 <211> 28 <212> DNA <213> Unknown <220> <223> PCR primer <400> 44 aacgccgcca gcggtcgtca gactgtcg 28 <210> 45 <211> 28 <212> DNA <213> Unknown <220> <223> PCR primer <400> 45 taagcagaag gccatcctga cggatggc 28 <210> 46 <211> 25 <212> DNA <213> Unknown <220> <223> PCR primer <400> 46 gcggccgcgt cgacacgcaa aaagg 25 <210> 47 <211> 28 <212> DNA <213> unknown <220> <223> PCR primers <400> 47 agtctgcgcg tctttcaggg cttcatcg 28 <210> 48 <211> 31 <212> DNA <213> unknown <220> <223> PCR primers <400> 48 gatcccatgg aagttaaaat cattggtggt c 31 <210> 49 <211> 33 <212> DNA <213> unknown <220> <223> PCR primers <400> 49 gcgcggatcc ttacagtttc acccaagatt ccg 33 <210> 50 <211> 35 <212> DNA <213> unknown <220> <223> PCR primers <400> 50 tataccatgg cttttaaggt ggtgcaaatt tgcgg 35 <210> 51 <211> 39 <212> DNA <213> unknown <220> <223> PCR primers <400> 51 aattcggatc cttaagcgtt atacttttgg gatttcacc 39 <210> 52 <211> 58 <212> DNA <213> unknown <220> <223> PCR primers <400> 52 ctgtctctta tacacatctc ctgaaattgg ccagatgatt aattcctaat ttttgttg 58 <210> 53 <211> 50 <212> DNA <213> unknown <220> <223> PCR primers <400> 53 ctgtctctta tacacatctc agcattacac gtcttgagcg attgtgtagg 50 <210> 54 <211> 47 <212> DNA <213> unknown <220> <223> PCR primers <400> 54 ctgtctctta tacacatctg ggaattgatt ctggtaccaa atgagtc 47 <210> 55 <211> 45 <212> DNA <213> unknown <220> <223> PCR primers <400> 55 ctgtctctta tacacatctc cccaggcttt acactttatg cttcc 45 <210> 56 <211> 54 <212> DNA <213> unknown <220> <223> PCR primers <400> 56 ctgtctctta tacacatctt tactcagcaa taaactgata ttccgtcagg ctgg 54 <210> 57 <211> 55 <212> DNA <213> Unknown <220> <223> PCR primer <400> 57 ctgtctctta tacacatctt tccgttaacg tcggtagtgc tgaccttgcc ggagg 55< / galetkm>
Claims
1. A method for producing fucosylated oligosaccharides, the method comprising the following steps: a) providing at least one genetically engineered cell that has been genetically engineered to express a heterologous fucosyltransferase, wherein the heterologous fucosyltransferase is capable of transferring a fucose residue from a donor substrate to a galactose residue of an acceptor molecule, wherein the acceptor molecule is lacto-N-tetraose (LNT), wherein the heterologous fucosyltransferase is selected from the polypeptide represented by any one of SEQ ID NOs: 19 to 22, SEQ ID NOs: 24 to 26, and SEQ ID NO: 30; b) culturing the at least one genetically engineered cell in the presence of at least one carbon source and under conditions suitable for the at least one genetically engineered cell to transfer the fucose residues from the donor substrate to the acceptor molecule; and c) recovering the fucosylated oligosaccharides.
2. The method of claim 1, wherein the heterologous fucosyltransferase is encoded by a nucleic acid molecule comprising: i) a nucleotide sequence represented by any one of SEQ ID NOs: 4 to 7, SEQ ID NOs: 9 to 11, and SEQ ID NO: 15; or ii) a nucleotide sequence encoding a polypeptide represented by any one of SEQ ID NOs: 19 to 22, SEQ ID NOs: 24 to 26, and SEQ ID NO: 30.
